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ABSTRACT 
 
Chapter 1 A survey of silicon-based reactions and potential for Lewis base catalysis.   
Chapter 2 An efficient site- and enantioselective catalytic silylation of triols is disclosed. 
The protocol is applied to total syntheses of cleroindicins D, F and C. 
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Chapter 3 Catalytic kinetic resolution of β-hydroxyketones is disclosed. A readily 
available amino acid-based catalyst promotes the kinetic resolution with high efficiency.  
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Chapter 4 A presentation of catalytic enantioselective tosylation of syn-1,2-diols. 
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Chapter 1 A Survey of Silicon-based Reactions and Potential for Lewis 
Base Catalysis 
1.1 Basic Concepts of Lewis Base Activation of Silicon 
 Silicon is a truly exceptional element as it serves as a reactive site for an almost 
infinite number of transformations pertinent to synthetic chemistry.1 Importantly, the 
relationship of valency at silicon and its chemical reactivity represents the key to 
understanding and readily allowing us to design novel reactions. Silicon is a group 14 
element and not a transition metal. It is generally accepted that the empty 3d orbitals on 
silicon are too diffuse to engage in meaningful bonding.2 The ability of silicon to expand 
its coordination sphere is due to the ability of silicon 3p orbitals to engage in electron-
rich three-center four-electron (3c-4e) bonding.3  
 Silicon normally bonds with only four other atoms, which completes the 
electronic requirements for an outer-shell octet. In SiL4 compounds, the molecules have a 
tetrahedral geometry, and therefore the central silicon atom displays sp3 hybridization (I, 
Figure 1). Expansion to a trigonal bipyramidal, pentacoordinate silicon complex SiL5 (II) 
requires a p orbital to engage in hypervalent three-center four-electron (3c-4e) bonding, 
and the central silicon atom employs sp2 hybridization. Further expansion of the 
coordination sphere to an octahedral, hexacoordanate complex SiL6 (III), requires a 
second p orbital to engage in hypervalent 3c-4e bonding, and the silicon atom to be 
formally sp hybridized. Consequently, the result of such valency expansion and electron 
                                                
1 Brook, M. A. Silicon in Organic, Organometallic, and Polymer Chemistry, 1st Ed. Wiley-interscience 
1999. 
2 Tandura, S. M.; Voronkov, M. G.; Alekseev, N. V. Top. Curr. Chem. 1986, 131, 99−189. 
3 Curnow, O. J. J. Chem. Ed. 1998, 75, 910−915. 
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redistribution is that the Lewis acidity at silicon is increased and the nucleophilicity of 
ligands around silicon is also increased. It should be noted that complex III is not acting 
as Lewis acid since any further expansion of this valence shell is unusual.4  
Figure 1.1 Valency and Electron Density at Silicon in Organosilicon Compounds
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 Figure 1.2 shows the molecular orbitals of 3c-4e hybrids. The highest occupied 
molecular obiral (HOMO)5 of this hybrid (ψ2) is the nonbonding orbital with a node at 
the central silicon atom and localizes the electron density at the peripheral atoms. 
Therefore, it is clear that how enhancement of both electrophilicity of the central silicon 
atom and nucleophilicity of the ligands around silicon can be generated. 
Figure 1.2 Molecular Orbitals  of 3-c-4-e hybrids
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4 Holmes, R. R. Chem. Rev. 1996, 96, 927–950. 
5 Fleming, I. Frontier Orbital and Organic Chemical Reactions, 1th ed.,Wiley, 1976. 
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Calculation on SiF5− demonstrates such phenomenon.6  The tetra-substituted 
silicon in SiF4 is tetrahedral, with Si–F bond lengths of 1.56 Å, a charge of –0.392 on 
each F, and a charge of +1.568 on central Si (Figure 3).  The facile addition of a fifth 
ligand (F-) leads to a rehybridization of the silicon atom, where the equatorial ligands are 
elongated to 1.62 Å with a charge of –0.571, and the axial ligands are elongated to 1.66 Å 
with a charge of –0.539. More importantly, the overall positive charge on silicon is 
increased from +1.568 to +1.792. 
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 Chemistry involving Lewis base activation of silicon has been reviewed recently.7 
In this survey, a overview of well-developed Lewis base catalyzed reactions will be given 
as examples. Meanwhile, reactions involving silicon-based or mediated reactions that 
have not been successfully catalyzed will also be discussed. 
                                                
6 Ab initio calculations, see (a) Deiters, J. A.; Holmes, R. R. J. Am. Chem. Soc. 1990, 112, 7197-7202.  The 
calculated bond lengths correspond closely to those of the crystal structure of [C6H5CH2N(CH3)3]+[SiF5]-.  
See (b) Schomburg, D.; Krebs, R. Inorg. Chem. 1984, 23, 1378-1381. 
7 For recent reviews, see: (a) Denmark, S. E.; Beutner, G. L. Angew. Chem.; Int. Ed. 2008, 47, 2−81. (c) 
Orito, Y.; Nakajima, M. Synthesis 2006, 1391−1401. (b) Rendler, S.; Oestreich, M. Synthesis 2005, 
1727−1747. 
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1.2 Lewis Base Activation of Silicon for Nucleophilic Addition 
Activation of Si–C bond for Nucleophilic Addition 
 The asymmetric addition of allylmetal reagents to aldehydes has evolved into a 
powerful and selective tactic in modern organic synthesis.8 Lewis base activation of 
allyltrichlorosilane for addition to aldehydes is a well studied area. The mechanism of 
such reaction was first proposed by Sakurai and Kobayashi.9 As illustrated in Scheme 
1.1, coordination of a chiral Lewis base (LB) with allyltrichlorosilane renders the silicon 
center Lewis acidic enough to activate the aldehyde. Allylation takes place through a 
closed chair transition state (intermediate IV in Scheme 1.1), which results in a 
diastereospecific allylation.10 Turnover of the Lewis base is possible by dissociation from 
the trichlorosilyl ether product and re-coordination of allyltrichlorosilane. If a chiral 
Lewis base catalyst is incorporated, enantioselectivity of the allylation reaction is 
determined by the effectiveness of the chirality transfer from the chiral Lewis base to the 
newly formed stereogenic centers. 
 
                                                
8 For selected reviews of allylation reaction, see: (a) Yamatomo, Y.; Asao, N. Chem. Rev. 1993, 93, 
2207−2293. (b) Denmark, S. E.; Fu, J. Chem. Rev. 2003, 103, 2763−2793. 
9 (a) Sakurai, H. Synlett 1989, 1−8. (b) Kira M.; Hino, T.; Sakurai, H. Tetrahedron Lett. 1989, 30, 
1099−1102. (c) Kobayashi, S.; Nishio, K. Tetrahedron Lett. 1993, 34, 3453−3456. (d) Kobayashi, S.; 
Nishio, K. Synthesis 1994, 457−459. 
10 According to different transition state model, allylation reactions are grouped into three categories. For a 
reference, see: Denmark, S. E.; Weber, E. J. Helv. Chim. Acta. 1983, 66, 1655−1660. 
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Scheme 1.1 Mechanism of Lewis Base-catalyzed Allylation with Allyltrichlorosilane
SiCl3R
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 The choice of Lewis base is critical to turnover. Bassindale introduced the 
interesting concept of ‘silaphilicity’.11 It is the relative affinity of certain entities to 
silicon species. As shown in Scheme 1.2, by measuring the average 29Si resonance of the 
reaction mixture, a relative equilibrium constant K was assigned to each reaction, as well 
as a scale of silaphilicity of each Lewis base. Fluoride is known as the strongest silaphilic 
group due to the exceedingly strong Si–F bond. However, because of the strength of Si–F 
bond, fluoride-product dissociation is less likely to happen, thus catalytic turnover is an 
issue. 12  On the other hand, the weakly silaphilic pyridine or triethylamine cannot 
efficiently activate silicon to afford any reactivity.  
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11 Bassindale, A. R. Stout, T. Tetrahedron Lett. 1985, 26, 3406−3408. 
12 For a review of fluoride activating silicon, see: Chult, C.; Corriu, R. J. P.; Reye, C.; Yound, J. C. Chem. 
Rev. 1993, 93, 1371–1448. 
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 According to the considerations discussed above, a variety of Lewis base catalysts 
have been developed for enantioselective allylation of aldehydes. Iseki and co-workers 
reported a chiral monodentate phosphoramide for allylation of aromatic aldehydes (eq. 
1.1).13 In the presence of 10 mol % phosphoramide catalyst 1.1, homoallylic alcohol 1.2 
can be obtained with 88% ee in 83% yield. The reaction proceeds with low efficiency; 
long reaction time (7 days) is needed to obtain maximum yield.  
SiCl3+
N
P NO
H
THF, !78 oC, 7 days
10 mol % 1.1
Ph
OH
(n-Pr)2N
PhCHO
1.1
88% ee, 83%
(eq. 1.1)
1.2
 
 Denmark and co-workers have done systematic mechanistic studies of 
phophoramide-catalyzed allylation of aldehydes. 14  They developed bidentate 
phosphoramide 1.5 (eq. 1.2) for allylation of aromatic and alkenyl aldehydes.  With 5 mol 
% catalyst 1.5, the reaction takes 8 to 10 hours to deliver product 1.2 with 87% ee. 
Crotylation of this catalytic system is shown to be highly diastereodivergent with 98% de 
for most of the cases. 
SiCl3
+
5 mol % 1.5
Ph
OHPhCHO
(eq. 1.2)
N
P
N
N
O
Me
H
H
N
P
N
N
O
Me
(CH2)5
H
H CH2Cl2, (i-Pr)2EtN
!78 oC, 8 to 10 h
1.5R2
R1
1.2 R1=R2=H, 87% ee, 85%
1.3 R1=Me, R2=H, 86% ee, 98% de, 82%
1.4 R1=H, R2=Me, 94% ee, 98% de, 89%
R2 R
1
 
                                                
13 (a) Iseki, K.; Kuroki, Y.; Takahashi, M.; Kobayashi, Y. Tetrahedron Lett. 1996, 37, 5149–5150. (b)Iseki, 
K.; Kuroki, Y.; Takahashi, M.; Kishimoto, S.; Kobayashi, Y. Tetrahedron 1997, 53, 3513–3526. 
14 (a) Denmark, S. E.; Coe, D. M.; Pratt, N. E.; Griedel, B. D. J. Org. Chem. 1994, 59, 6161–6163. (b) 
Denmark, S. E.; Fu, J. J. Am. Chem. Soc. 2000, 122, 12021–12022. (c) Denmark, S. E.; Fu, J.; Coe, D. M.; 
Su, X.; Pratt, N. E.; Griedel, B. D. J. Org. Chem. 2006, 71, 1513–1522. (d) Denmark, S. E.; Fu, J.; Lawler, 
M. J. J. Org. Chem. 2006, 71, 1523–1536. 
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 N-oxide, especially pyridine N-oxide has been used extensively for catalyzing 
enantioselective allylation. Scheme 1.3 lists the some of the recently successful catalysts 
for allylation of aldehydes, including pyridine-based tri-N-oxide 1.6,15 bis-N-oxides 1.716 
and 1.8,17 mono-N-oxides 1.9,18 1.10,19 1.11,20 1.1221 as well as proline N-oxide 1.13.22 
N N
O O
88% ee, 85%
N N
O O
OHHO
PhPh
84% ee, 95%
SiCl3+
Ph
OHCatalyst
Scheme 1.36.   N-Oxide Catalyzed Asymmetric Allylation of Aldehydes with Allyltrichlorosilane
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1.11 Kocovsky
96% ee, 90%
OMe
OMe
OMe
METHOX
 
   
                                                
15 Wong, W.-L.; Lee, C.-S.; Leung, H. K.; Kwong, H.-L. Org. Biomol. Chem. 2004, 2, 1967-1969. 
16 Nakajima, M.; Saito, M.; Shiro, M.; Hashimoto, S.-i. J. Am. Chem. Soc. 1998, 120, 6419-6420. 
17 Shimada, T.; Kina, A.; Ikeda, S.; Hayashi, T. Org. Lett. 2002, 4, 2799-2801. 
18 Malkov, A. V.; Bell, M.; Orsini, M.; Pernazza, D.; Massa, A.; Herrmann, P.; Meghani, P.; Kočovský, P. 
J. Org. Chem. 2003, 68, 9659-9668. 
19 Malkov, A. V.; Dufková, L.; Farrugia, L.; Kočovský, P. Angew. Chem. Int. Ed. 2003, 42, 3674-3677. 
20 Malkov, A. V.; Bell, M.; Castelluzzo, F.; Kočovský, P. Org. Lett. 2005, 7, 3219-3222. 
21 Pignataro, L.; Benaglia, M.; Annunziata, R.; Cinquini, M.; Cozzi, F. J. Org. Chem. 2006, 71, 1458-1463. 
22 Traverse, J. F.; Zhao, Y.; Hoveyda, A. H.; Snapper, M. L. Org. Lett. 2005, 7, 3151-3154. 
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Activation of Si–O bond for Nucleophilic Addition  
 Other than the allylation reaction, aldol reactions have also been successfully 
catalyzed by Lewis bases. Si–O bond is activated for nucleophilic addition in these 
reactions. Denmark and co-workers reported a catalytic enantioselective aldol reaction of 
cyclohexanone derivative 1.14 to benzaldehyde. 23  Reaction was catalyzed by a 
monodentate phosphoramide 1.16; anti-aldol product 1.15 was obtained with 93% ee and 
95% yield. The formation of anti-aldol product from an E-configured enolate 1.14 is 
indicative of a chair-like transition state model V.24 The relative stereoinduction could be 
viewed in terms of a ternary assembly wherein aldehyde, Lewis base, and enolate are 
arranged in a hexacoordinate constellation about the silicon atom. 
Scheme 1.4 Catalytic Enantioselective Aldol Additions of Cyclohexanone Enolate
OSiCl3
+ PhCHO
O OH
Ph
N
P
N
Ph
Ph
Me
Me
O
N
O
Si
O
H
H
R
Cl
Cl
Cl
O
P
R2N NR2
NR2
1.14 1.15
1.16
10 mol %
V
93% ee, 95%
CH2Cl2, !78 C
 
Silicon-based Reactions with Potential to be Catalyzed by Lewis Base  
 As shown in the brief overview above, Si–C and Si–O bonds can be efficiently 
activated by Lewis bases. This strategy might be applicable to a broader range of 
reactions, for example, rearrangements. When 1,5-dienes are substituted with a hydroxy 
group at the C3 position, they undergo a rearrangement to first give enols that are 
                                                
23 For a review of catalytic enantioselective aldol reactions developed by Denmark and co-workers, see: 
Denmark, S. E.; Stavenger, R. A. Acc. Chem. Res. 2000, 33, 432−330.  
24 With a Z-configured enolate, the syn-aldol product was formed predominantly. For reference, see: (a) 
Denmark, S. E.; Wong, K.; Stavenger, R. A. J. Am. Chem. Soc. 1997, 119, 2333−2334. (b) Denmark, S. E.; 
Stavenger, R. A.; Wong, K.; Su, X. J. Am. Chem. Soc. 1999, 121, 4982−4991. 
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subsequently converted to the corresponding δ,ε-unsaturated carbonyl compounds. This 
reaction is referred to as Oxy-Cope rearrangement.25 When the C3 hydorxy group is 
converted to its alkoxide, the rate of the reaction is accelerated by the factors of 
1010−1017 and rearrangement usually occurs below room temperature.26  The reaction goes 
through a highly ordered chairlike transition VI (Scheme 1.5).  
Scheme 1.5 Anionic-oxy Cope Rearrangement
Me
O
O
O
Me
acid
VI  
 Silyl ethers of vinyl allyl alcohols have also been used in oxy-cope 
rearrangement.27 These reactions proceed at 140–180 °C. The concept of Lewis base 
activation of Si–O bond might be applicable here. As shown in Scheme 1.6, if a Lewis 
base can coordinate to the silyl ether and activate it, which makes the ligands around the 
silicon more electron rich (closer to the anionic transition state VI), the oxy-Cope 
reaction might be accelerated and catalyzed. Incorporating a chiral Lewis base, the oxy-
Cope might be promoted in an enantioselective fashion. 
Scheme 1.6 Anionic -oxy Cope Rearrangement
R3SiO
O
O
Me
acid
VII
SiR3
LB
!" !+
 
                                                
25 Viola, A.; Iorio, E. J.; Chen, K. K.; Glover, G. M.; Nayak, U.; Kocienski, P. J. J. Am. Chem. Soc. 1967, 
89, 3462−3470. 
26 Evans, D. A.; Golob, A. M. J. Am. Chem. Soc. 1975, 97, 4765−4766. 
27 Schneider, C.; Rehfeuter, M. Synlett 1996, 212−214. 
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 The [3,3]-sigmatropic rearrangement of silyl ketene acetals to γ,δ-unsaturated 
carboxylic acids is referred to as the Claisen-Ireland rearrangement.28 It has been found 
that with forming a carbanion on substrate 1.17 (Scheme 1.7), the reaction temperature 
can be lowered for the Claisen rearrangement.29 With sodium hydride in the reaction, a 
carbanion was formed α to the p-Ts group. This significantly lowered the reaction 
temperature to 20 °C. Without sodium hydride, the same transformation has to be carried 
out at 100 °C. High diastereoselectivity indicates that the Claisen rearrangement proceeds 
with a chair-like closed transition state. 
Scheme 1.7 Carbanion-accelerated Claisen Rearrangement
O
H3C
Me
p-Ts
p-Ts
O
CH3
CH3
p-Ts
O
CH3
CH3
1.17 1.18 1.19
DMSO, 20 °C, 4 h
NaH
98:2
85%
+
O
H3C
Me
p-Ts
 
 The Ireland-Claisen rearrangement incorporating a silyl ketene acetal might also 
be catalyzed by Lewis base. When a Lewis base activates the silyl ketene acetal (Scheme 
1.8), the silyl ether oxygen should be more electron rich. As show above in Scheme 1.7, 
the carbanion at the same position should accelerate the reaction. In a similar situation, 
Ireland-Claisen rearrangement catalyzed by Lewis base might be feasible. 
                                                
28 The reaction was first reported by R. E. Ireland. For reference, see: Ireland, R. E.; Mueller, R. H. J. Am. 
Chem. Soc. 1972, 94, 5897−5898. 
29 Denmark, S. E.; Harmata, M. A. J. Org. Chem. 1983, 48, 3369–3370. 
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Scheme 1.8 Claisen Rearrangement
OR3SiO
Me
O
Me
O
HOOC
! Me
SiR3
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"# "+
 
1.3 Silicon-Based Lewis Acid Mediated Reactions 
Aldol Reaction and Passerini Reaction as Examples 
 
 The weakly Lewis acidic species, silicon tetrachloride (SiCl4), can be activated by 
Lewis basic ligands, leading to formation of a stronger Lewis acid. The concept of Lewis 
based activation of Lewis acid introduced by Denmark has been applied to catalytic 
enantioselective aldol and other reactions. 
 In the aldol reaction discussed above in Scheme 1.4, the trichlorosilyl enol ether 
nucleophile is activated by Lewis base. In contrast, with the Lewis base activation of 
Lewis acid strategy, the aldehyde electrophile is activated in the aldol reaction (Scheme 
1.9).30 In the presence of 1.1 equivalents of SiCl4 and 5 mol % bidentate catalyst 1.20 in 
15 minutes, high enantioselectivities were observed for the addition of silyl ketene acetal 
to aromatic aldehyde to afford 1.21 and aliphatic aldehyde to afford 1.22 in good yields.  
                                                
30 Denmark, S. E.; Wynn, T.; Beutner, G. L. J. Am. Chem. Soc. 2002, 124, 13405−13407. 
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Scheme 1.9 Aldol Reaction using Lewis Base Activation of Lewis Acid Strategy
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CH2Cl2, !78 °C, 15 min R OMe
OOH
1.21 R=Ph, 93% ee, 97%
1.22 R=Cy, 88%ee, 86%
Si
Cl
O
Cl
OCl
O
(R2N)2P
P(R2N)2
MeN
NMe
R
Cl
VIII  
 As shown in complex VIII (Scheme 1.9), the Lewis basic bidentate 
phosphoramide 1.20 coordinates to SiCl4, followed by dissociation of chloride anion.31 
The process generates a stronger Lewis acidic complex. Subsequent coordination of the 
Lewis basic carbonyl oxygen of aldehyde at the hypervalent silicon-based chiral Lewis 
acid finally leads to intermediate VIII. 
 The aldol reaction is highly stereoconvergent; (E)- or (Z)-configured silyl ketene 
acetal affords the identical product 1.23 (eq. 1.2) with exceptional diastereoselectivity 
(98% de). This finding indicates that the reaction proceeds with an open transition state.32 
The scope of the aldol reaction has been extended to silyl enol ether33 as well as 
vinylogous aldol reaction.34 
                                                
31 For a review of reactions mediated by silicon Lewis Acids, see: Dilman, A. D.; Loffe, S. L. Chem. Rev. 
2003, 103, 733−772.  
32 Denmark, S. E.; Beutner, G. L.; Wynn, T.; Eastgate, M. D. J. Am. Chem. Soc. 2005, 127, 3774–3789. 
33 Denmark, S. E.; Heemstra, J. R. Jr. Org. Lett. 2003, 5, 2303–2306. 
34 Denmark, S. E.; Beutner, G. L. J. Am. Chem. Soc. 2003, 125, 7800–7801. 
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Ph H
O
Ot-Bu
OSiMe2t-Bu
+ 5 mol % 1.20, 1.1 equiv SiCl4
CH2Cl2, !78 °C, 3 h
Ph Ot-Bu
OOH
1.23
Me Me
99% ee, 98% de, 73%
(eq. 1.2)
 
 Denmark and co-workers also reported a catalytic enantioselective Passerini-type 
reaction.35 Isocyanides such as 1.24 are also potential nucleophiles for addition to 
carbonyls. Benzaldehyde was converted into α-hydroxy amide 1.25 with >98% ee in 
96% yield after hydrolysis. 
Scheme 1.10 Catalytic Enantioselective Passerini-type Reaction
Ph H
O
N
t-Bu
C+
5 mol % 1.20, 1.1 equiv SiCl4
CH2Cl2, !74 °C
after hydrolysis
Ph
OH
NHt-Bu
O
1.24 1.25
>98% ee, 96%  
 The concept of Lewis base activation of Lewis acids introduced by Denmark is a 
significant enhancement of catalytic asymmetric addition to carbonyls. In these reactions, 
the actual catalyst is a hypervalent silicon-based Lewis acid, which interacts with the 
electrophilic reactant, thereby lowering its lowest unoccupied molecular ortital (LUMO);5 
the nucleophilic reactant in turn is activated neither by this catalyst nor by the chiral 
additive.  
Reactions with Potential to be Mediated by Silicon-based Lewis Acids 
 Isocyanides undergo a four-component reaction in the presence of an anime, 
aldehyde or ketone and a nucleophile to provide a single condensation product is referred 
                                                
35 Denmark, S. E.; Fan, Y. J. Am. Chem. Soc. 2003, 125, 7825–7827. 
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to as Ugi multicomponent reaction.36 The mechanism of the reaction is shown in Scheme 
1.11. Condensation between an aldehyde and an amine affords an imine intermediate. 
Isocyanide addition followed by nucleophilic attack by water delivers the α-amino amide 
product.  
 The catalytic enantioselective Passerini reaction developed by Denmark and co-
workers involves activation of an aldehyde by a chiral Lewis acidic hypervalent silicon 
complex (Scheme 1.10). If the similar concept is applicable to activation of imine 
intermediates (Scheme 1.11), 37  then catalytic enantioselective Ugi multicomponent 
reaction might be possible.  
Scheme 1.11 Ugi Multicomponent Reaction
R1 H
O
+
R2
NH2
R1 H
NR2 C N R
3 R1R2HN
N
R3
H2O R2
N
H
H
N
R1
O
R3
 
 Takasu, Ihara and co-workers reported a novel enantioselective enol silylation 
process.38 Cyclohexanone 1.24 was desymmetrized by forming an silyl enol ether with 
42% ee at –100 °C. The mechanism of the reaction is believed to involve the pentavalent 
intermediate IX (Scheme 1.10). Generation of IX is likely to occur by an associative 
displacement of the triflate moiety at silicon by amine 1.28, followed by coordination of 
the Lewis basic carbonyl of 1.26. Then the intramolecular proton abstraction by silyl 
amine nitrogen enables differentiation of the enantiotopic protons. This methodology 
                                                
36 (a) Ugi, I.; Meyr, R.; Fetzer, U.; Steinbruchner, C. Angew. Chem. 1959, 71, 386. (b) Ugi, I.; 
Steinbruchner, C. Angew. Chem. 1960, 72, 267–268. (c) (b) Ugi, I. C. Angew. Chem. 1962, 74, 9–22. 
37 For enantioselective silylation of acyclhydrazone using Lewis acidic silicon reagent, see: Berger, R.; 
Rabbat, R. M.; Leighton, J. L. J. Am. Chem. Soc. 2003, 125, 9596−9597. 
38 Takasu, K.; Misawa, K.; Yamada, M.; Furuta, Y.; Taniguchi, T.; Ihara, M. Chem. Commun., 2000, 1739–
1740. 
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replies on the super-stoichiometric amount of a modified chiral silicon reagent since the 
chiral amine is protonated and, thus, consumed in the course of the reaction. 
Scheme 1.12 Enantioselective Enol Silylation
O
MeO2C
Me
N
H
Me
1.26
OSiMe2t-Bu
MeO2C
1.27
3 equiv
1.28
1.2 equiv t-BuMe2SiOTf
CH2Cl2, !100 °C
42% ee, 88%
R O
SiMe2t-BuH
R2
N
"
IX
 
 This methodology might be improved by incorporating a more Lewis acidic 
silicon species, such as SiCl4. Choice of a chiral promoter for the reaction is critical; 
involving a stronger promoter such as phosphoramide, imidazole or N-oxide instead of 
secondary amine would further increase the Lewis acidity of activated hypervalent 
silicon. A general base might also be needed to deprotonate the chiral promoter after 
intramolecular deprotonation, so the chiral promoter is not consumed in the course of 
reaction. These factors might be helpful for making this enantioselective enol silylation 
process into a catalytic protocol with better enantioselectivity. 
1.4 Lewis Base Activation of Silicon by Strain Release Strategy 
 Research groups led by Myers39 and Denmark40 independently discovered that 
enol silacyclobutanes could undergo aldol-like reaction with benzaldehyde while no 
reaction was observed with the corresponding acyclic enol silanes (Scheme 1.13) 
                                                
39 Myers, A. G.; Kephart, S. E.; Chen, H. J. Am. Chem. Soc. 1992, 114, 7922−7923. 
40 (a) Denmark, S. E.; Griedel, B. D.; Coe, D. M. J. Org. Chem. 1993, 58, 988−990. (b) Denmark, S. E.; 
Griedel, B. D.; Coe, D. M.; Schnute, M. E. J. Am. Chem. Soc. 1994, 116, 7026−7043. 
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Scheme 1.13 Aldol Reaction of Cyclic and Acyclic Enol Silanes
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Me Me
+ Ph H
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O
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No Reaction
100 °C
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O
Ph
O
Si
Ph
84% yield  
 This phenomenon responsible for this unusual reactivity was termed “strain-
release Lewis acidity” by Denmark.41 As illustrated in Scheme 1.14, When a tetravalent 
silicon is incorporated into a small (4 or 5-membered) ring, the endocyclic bond angle 
(79° or 90°) is much smaller than the preferred angle of a tetrahedral configuration (109°) 
and adds significant strain to the system. In a pentavalent silicon, the two endocyclic 
bonds can possess the axial and equatorial positions of a trigonal bipyramidal, which has 
a preferred angle of 90°.  Thus, silicon constrained in a small ring has a higher tendency 
to expand its valance and thus possesses higher Lewis acidity. 
Scheme 1.14 Strain-released Lewis Acidity
Si
79° or 90°
Nu
Si
Nun=1,2
Terahedral preferred 
angle: 109 °
79° or 90°
Trigonal bipyramidal
preferred angle: 90 °
n=1,2
 
Enantioselective Strain-released Allylation 
 With this concept, Leighton and co-workers have developed practical allylations 
of aldehydes as well as imines. They examined a variety of chiral allylating reagents 
                                                
41 Denmark, S. E.; Jacobs, R. T.; Dai-Ho, G.; Wilson, S. Organometallics 1990, 9, 3015−3019. 
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incorporated to small rings. Allylsilane 1.29 derived from pseudoephedrine is a highly 
efficient and enantioselective reagent for allylation of various aldehydes (eq. 1.3).42 Later, 
Leighton and co-workers significantly improved the allylation reaction by using a 
modified chiral allylsilane 1.30. Excellent enantioselectivities were obtained for a wide 
range of aldehydes (96-98% ee, eq 1.4).43 
N
Si
O
Me Cl
Ph
R
O
H
+
aliphatic or aromatic
aldehyde
PhMe
!10 oC, 2 h
R
OH
78 to 96% ee
59 to 85% yield
(eq. 1.3)
Me
1.29
CH2Cl2
!10 oC, 20 h R
OH
96 to 98% ee
61 to 90% yield
(eq. 1.4)
N
Si
N Cl
pBr-C6H4
pBr-C6H4
1.30
R
O
H
+
aliphatic or aromatic
aldehyde
 
Houk and co-workers carried out computational mechanistic study and located 
the transition states of the allylation reaction.44 The model (Figure 1.4) based on the 
transition states suggests the components important for the stereoselectivity of the chiral 
allylsilane reagents: 1) attack of aldehyde oxygen on an apical position of the Lewis 
acidic silicon center (anti to a N); 2) an 
antiperiplanar arrangement of an oxygen 
lone-pair and the Si–Cl bond in the chair 
transition state; 3) location of the chlorine 
with the lone pair anti to the lone-pair of 
apical nitrogen. 
                                                
42 (a) Kinnard, J. W. A.; Ng, P. Y.; Kubota, K.; Wang, X.; Leighton, J. L. J. Am. Chem. Soc. 2002, 124, 
7920-7921. 
43 Kubota, K.; Leighton, J. L. Angew. Chem., Int. Ed. 2003, 42, 946-948. 
44 Zhang, X.; Houk, K. N.; Leighton, J. L. Angew. Chem., Int. Ed. 2005, 44, 938-941. 
Figure 1.4 Transition State of the Allylation
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R
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Reactions with Potential to be Catalyzed by Strain Release Strategy 
 Silicon-tethered cycloadditions are useful synthetic tools to access polycyclic 
structures.45 As show in Scheme 1.15, silicon-tethered Diels-Alder reaction proceeds with 
good diastereoselectivity and yield. However, the reaction needs high temperature (190 
ºC) and long reaction time (20 h).46  
Scheme 1.15 Silicon-tethered Intramolecular Diels-Alder Reaction
O
Si
Ph
Ph 190 °C, 20 h
70% yield
O
H Si
Ph
Ph
cis:trans=1:10
1.31
 
 To improve the reaction, silicon-tethered substrates could be modified into more a 
reactive silacyclobutane, such as 1.32 (Scheme 1.16). The silicon in substrate 1.32 is 
highly Lewis acidic, thus, is likely to be activated by silaphilic Lewis base to formation a 
hypervalent silicon complex for strain release. In the activated hypervalent silicon 
intermediate, the diene dienophile might be brought closer toward each other (from 
tetrahedral to trigonal bipyrimidal, angles might change from 109º to 90º), thus the 
intramolecular Diels-Alder reaction might be facilitated and catalyzed by a Lewis base. 
Incorporating substrate 1.33 into a 5-membered ring with chiral backbone might increase 
the reactivity as well as bring in enantioselectivity. Ideally, with appropriate substrate 
with Lewis acidic silicon as well as incorporating an effective chiral Lewis base, the 
silicon-tethered Diels-Alder reaction might be catalyzed in an enantioselective fashion.  
                                                
45 For a review of silicon-tethered reactions, see: Bols, M.; Skrydstrup, T. Chem. Rev. 1995, 95, 12531–
277. 
46 Sieburth, S. M.; Fensterbank, L. J. Org. Chem. 1992, 57, 5279–5281. 
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Scheme 1.16 Possible Improvement of Silicon-tethered Intramolecular DA Reaction
O
Si Lewis Base
O
H Si
Ph
Ph
O
Si
N
N
Me
Me
R
R
or
1.32 1.33  
 In principle, silicon-tethered [5+2] cycloaddition (eq. 1.5)47 as well as 1,3-dipolar 
cycloaddition (eq. 1.6)48 might also be catalyzed by Lewis base by strain release strategy 
if the silicon tether is incorporated into a small ring. 
OO
BzO
O
SiMe2
O
BzO
O
SiMe2
H
O
[5+2]
(eq. 1.5)
O N
Me
Me
COOEt
O
O
Si
Me2
1,3-dipolar
cycloaddition
O SiMe2
NO O
Me
Me
EtOOC
1.34
1.35
1.36
1.37
(eq. 1.6)
Lewis Base
Lewis Base
 
1.5 Conclusion and Outlook 
 In conclusion, some recent significant developments of reaction involving 
hypervalent silicon intermediate have been briefly discussed. The concept of Lewis base 
activation of silicon might be applicable to a broader range of silicon-based or mediated 
reactions that have not been catalyzed before. With the focus on organocatalysis and 
continuing interest in reactions involving silicon, organosilicon chemistry will continue 
to have a significant influence on organic synthesis. 
 
                                                
47 Rumbo, A.; Castedo, L.; Mouino, A.; Mascarenas, J. L. J. Org. Chem. 1993, 58, 5585–5586. 
48 Righi, R.; Marotta, E.; Landuzzi, A.; Rosini, G. J. Am. Chem. Soc. 1996, 118, 9446-9447. 
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Chapter 2 Catalytic Enantioselective Silylation of Acyclic and Cyclic 
Triols: Application to Total Syntheses of Cleroindicins D, F and C 
2.1 Introduction and Background 
Enantioselective Silylation Reaction 
 The importance of the silicon–oxygen linkage to temporarily protect a hydroxy 
group is reflected in its extensive use in the synthesis of complex molecules.49 Silyl 
ethers are easily introduced with a variety of reagents, have the virtue of being quite 
stable to a variety of organic reactions, and are readily removed under specific conditions 
that do not attack other functional groups.50 Thus, development of chiral reagents to 
undergo or, more importantly, chiral catalysts to promote enantioselective silylation can 
greatly increase the efficiency with which optically enriched organic molecules are 
prepared. 
Reagent Controlled Enantioselective Silylation Reaction 
 There are a few examples of reagent controlled enantioselective silylation 
reactions. In the classical formation of a silyl ether, a chlorosilane is treated with an 
alcohol in the presence of a nucleophilic catalyst and stoichiometric amount of base.51 
Ishikawa and co-workers employed chiral guanidine 2.6 as a superbase reagent to 
activate silyl chlorides for enantioselective silylation of secondary alcohols such as 2.1 
and 2.3, and at that time unprecedented, obtained enantioselectivity (Scheme 2.1).52 
                                                
49 Rendler, S.; Oestreich. M. Angew. Chem., Int. Ed. 2008, 47, 248–250. 
50 Wuts, P., Greene, T. Greene’s Protective Groups in Organic Synthesis, 4th ed.,Wiley, New York, 2007, 
pp. 165–221.  
51 Corey, E. J.; Venkateswarlu, A. J. Am. Chem. Soc. 1972, 94, 6190–6191. 
52 Isobe, T.; Fukuda, K.; Araki, Y.; Ishikawa, T. Chem. Commum. 2001, 243–244. 
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Stoichiometric quantity of guanidine 2.6 was used to for these reactions. With TBSCl, the 
enantioselectivity was poor (krel = 2). With bulkier TIPSCl, moderate selectivity was 
obtained (krel = 5 and 6 for substrate 2.1 and 2.3, respectively). Long reaction time was 
required for the chiral guanidine promoted silylation (6 to 10 days). Although this 
silylation reaction requires stoichiometric chiral reagents, long reaction time and only 
achieved moderate enantioselectivity, it still represents the first asymmetric silylation and 
proves that chiral Lewis base activation of silicon for asymmetric silylation of alcohols is 
feasible.  
NHN
Ph Ph
OH
2.6
1 equiv. 2.6
1 equiv. TBSCl
CH2Cl2, 23 °C, 10 d
OTBS OH
+
(±)-2.1 (R)-2.2 (S)-2.1
78%, 31% ee 18% ee
krel = 2
N
Bn
OH
(±)-2.1 (±)-2.3
or
CH2Cl2, 23 °C, 6 d OTIPS
(R)-2.4
79%,58% ee
OH
(R)-2.5
OTIPS
or
15%,70% ee
krel = 5 krel = 6
with TBSCl:
with TIPSCl:
Scheme 2.1 Chiral Guanidine as Superbase for Enantioselective Silylation of Alcohol
2 equiv.
2 equiv. 2 equiv.
1 equiv. 2.6
1 equiv. TBSCl
 
 Wiskur and co-workers recently reported an enantioselective tandem Mukayama 
aldol reaction, consisting of a carbon-carbon bond-forming process and a silylation 
protection step in which the enantioselectivity results exclusively from the silylation 
step.53 The addition of a TMS silyl ketene acetal 2.7 to benzaldehyde 2.8 promoted by a 
Lewis basic chiral ammonium salt (CD-Me+OAc– a methylated cinchoma alkaloid paired 
                                                
53 Patel, S. G.; Wiskur, S.; L. Tetrahedron Lett. 2009, 50, 1164–1166. 
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with acetate, 2.11, Scheme 2.2) afforded aldol product alcohol 2.9 with 68% ee and TMS 
ether 2.10 with 8% ee, both are enantioenriched in the opposite enantiomer. The proposed 
mechanism is shown in Scheme 2.2. The acetate of ammonium salt 2.11 activates the 
silyl ketene acetal 2.7 for nucleophilic attack on the aldehyde to afford the racemic 
alkoxide. Racemic alkoxide pair with chiral cinchonidine cation to form diastereomeric 
salts 2.12 and 2.13. The enantioselectivity arises from the different reactivities of the 
diastereomeric salts with the silyl source, thus it is a kinetic resolution of the second 
silylation step.54 Silyl source could be TMSOAc or silyl ketene acetal 2.7, the authors 
hypothesized it’s the silyl ketene acetal 2.7 because it presents in higher concentration. 
The mechanism of the reaction is still not clear and the enantioselectivity of the silylation 
step is poor (krel=2). 
Scheme 2.2 Enantioselective Silylation in Mukaiyama Aldol Reaction
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 Alternatively, a less established approach of forming an oxygen-silicon bond is 
                                                
54 For a review of kinetic resolution, see: (a) Keith, J. M.; Larrow, J. F.; Jacobsen, E. N. Adv. Synth. Catal. 
2001, 343, 5–26. (b) Vedejs, E.; Jure, M. Angew. Chem., Int.Ed. 2005, 44, 3874–4001. 
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transition metal-catalyzed dehydrogenation, with hydrogen gas as the only byproduct 
generated by this transformation.55 Oestreich and co-workers devised a novel concept 
based on an unprecedented diastereoselective transition metal-catalyzed dehydrogenative 
silicon-oxygen coupling of silicon-stereogenic silane and racemic alcohol (Scheme 2.3).56 
Racemic secondary alcohol 2.14 with a pendant donor can be resolved using 
enantioenriched silane 2.15 (96% ee) with a krel value around 10.  The donor ligand 
(pyridine) of the substrate 2.14 is critical to the selectivity. In the proposed transition state 
model I (Scheme 2.3), the bi-dentate substrate 2.14 chelates to copper, chiral silane 2.15 
undergoes preferential concerted σ-bond metathesis with one of the enantiomeric Cu(I)-
alkoxide complex to afford enantioenriched product 2.16.  
Scheme 2.3 Kinetic Resolution of Secondary Alcohol by Dehydrogenative Coupling 
with Silicon-Stereogenic Silane (Copper System)
N
OH
SiH
N
O Si
+
5 mol % CuCl
10 mol % (3,5-Xylyl)3P
5 mol % NaOt-Bu
toluene, 23 °C
56% conv., krel = 10
+
N
OH
(±)-2.14 (SiR)-2.15 (SiS,S)-2.16
96% ee
0.6 equiv. 55%, 72% de
(R)-2.14
44%, 84% ee
Cu
N O
L H
SiR3
!
I
 
 Later, the same research group found that use of rhodium and N-heterocyclic 
carbene 2.17 (Scheme 2.4) instead of CuCl and phosphine ligand, the selective of the 
dehydrogenative coupling increased significantly (krel > 50 for rhodium system v.s. krel = 
10 for copper system).57 The limitation of this methodology is the strict requirement of 
substrate structure. Two-point binding of substrates emerged as a pivotal feature for 
selectivity, which required pre-installation of pendant nitrogen-containing donor (N-
                                                
55 Corey, J. Advances in Silicon Chemistry, Vol. 1 (Ed.: G. Larson), JAI, Greenwich, 1991, pp. 327–387. 
56 Rendler, S.; Auer, G,; Oestreich, M. Angew. Chem., Int. Ed. 2005, 44, 7620–7624. 
57 Klare, H. F. T.; Oestreich, M. Angew. Chem., Int. Ed. 2007, 46, 9335–9338. 
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containing ligands shows in Scheme 2.4) on substrates. 
Scheme 2.4 Kinetic Resolution of Secondary Alcohol by Dehydrogenative Coupling 
with Silicon-Stereogenic Silane (Rhodium System)
All the substrates possessing these N-containing donor ligands:
N N
N
N N
N
N
N
N N
N
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>99% ee
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+
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10 mol % 2.17•HCl
20 mol % NaOt-Bu
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50.8% conv., krel = 900
(SiS,S)-2.16
50%, 98% de
(R)-2.14
45%, >99% ee
+ N N
iPr
iPr iPr
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Catalytic Enantioselective Silylation Reaction 
 Chiral catalyst that can promote important transformations to obtain organic 
molecules with high enantiomeric purity is critical to modern chemical synthesis.58 A 
chiral catalyst for enantioselective silylation can increase the efficiency of synthesis. The 
example shown in Scheme 2.5 illustrates this point. Silyl ether 2.24 is a valuable building 
block used to prepare several biologically active entities in the optically active form (for 
example, neocarzinostatins, prostaglandins, thromboxane and nucleosides). Several 
procedures are known for the preparation of optically enriched 2.24. One of the most 
widely utilized routes is the five-step procedure (through 2.20 and 2.21) reported by 
Paquette and co-workers, which involves a 10-day deacylation reaction to obtain β–
hydroxyketone 2.21.59 Later, Myers and co-workers noted that “aspects of this protocol 
were found to be inconvenient for rapid and large-scale material throughput” and 2.24 
was produced with eroded optical purity. To overcome the recemization problem, Myers 
                                                
58 Thayer, A. “Chiral catalysts” Chem. Eng. News 2005, 83, 40–48. 
59 Paquette, L. A.; Earle, M. J.; Smith. G. F. Org. Synth. 1995, 36–40. 
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and co-workers developed a seven–step sequence to synthesize enantiomerically pure 
2.24, including four steps of protecting group manipulation.60  
1) PivCl, DMAP
OPiv
OH
2) K2CO3, MeOH
3) TBSCl, DMAP
4) DIBAL, PhMe
OH
OAc
OH
OTBS
>99% ee
O
OTBS
5) PCC
2) wheat germ lipase
10 days
1) PCC
NaOAc
O
OAc
O
OH
3) TBSCl
>99% ee
OH
OH
1) Ac2O
2) enzymatic
de-acylation
DMAP
Catalytic asymmetric silylation of alcohols?
Scheme 2.5  Enantioselective Silylation Could Increase the Efficiency of Chemical Synthesis
2.18 2.19
2.20 2.21
2.24
2.22
2.23
 
 
A chiral catalyst that directly converts achiral diol 2.18 to optically enriched silyl 
ether 2.23 would present a two-step sequence to optically enriched 2.24.  Thus, by 
shortening the synthesis route, waste production can be minimized and time efficiency is 
enhanced.  In contrast to enzymatic or biomimetic enantioselective acylation reactions, 
there is no example of enantioselective silylation in biological systems. 
 Hoveyda, Snapper and co-workers recently identified an amino acid-based small 
organic molecule 2.25 (Scheme 2.6) as catalyst for enantioselective silylation of meso 
diols.61 As illustrated in Scheme 2.6, a variety of meso diols can be catalytically 
desymmetrized with good enantioselectivity and yield, including cyclic meso 1,2-diols 
with different ring sizes (Scheme 2.6, 2.26–2.29) and acyclic meso 1,2-diol (2.30). 
Moreover, desymmetrization of selected meso 1,3-diols was also accomplished with the 
                                                
60 Myers, A.; Hammond, M.; Wu, Y. Tetrahedron Lett. 1996, 37, 3083–3086. 
61 Zhao, Y.; Rodrigo, J. M.; Hoveyda, A. H.; Snapper, M. L. Nature 2006, 443, 67–70. 
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same strategy (Scheme 2.6, 2.31 and 2.23).  
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Scheme 2.6 First Example of Catalytic Enantioselective Silylation
proposed transition state model
II
 
 
 The proposed transition state model II is shown in Scheme 2.6. Catalyst 2.25 is 
formed of two parts: N-methyl imidazole moiety and amino acid-based chiral backbone. 
N-methyl imidazole is a proven silaphilic activator of chlorosilanes.51 On the basis of 
principles presented by Guttmann62 and developed by Denmark,63 by serving as a donor 
ligand to the Si center, the imidazole moiety promotes redistribution of electron density 
and enhancement of Si electrophilicity. Substrate-catalyst association by H-bonding,64 
secondary amine and amide sites of the catalyst 2.25 serving as H-bond acceptors from 
                                                
62 Gutmann, V. The Donor–-Acceptor Approach to Molecular Interactions, Plenum, New York, 1978. 
63 Denmark, S.; Beutner, L.; Wynn, T.; Eastgate, M. J. Am. Chem. Soc. 2005, 127, 3774–3789. 
64 Vasbinder, M.; Jarvo, E.; Miller, S. Angew. Chem., Int. Ed. 2001, 40, 2824–2827. 
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the diol substrates, results in silylation of one enantiotopic alcohol.65 A shortcoming of 
this methodology is that it requires relatively high catalyst loading. Routinely used 
catalyst loadings are 20-30 mol %, leaving room for improvement. However, this 
deficiency is tempered by the practical advantage that the chiral catalyst is easily 
recovered in quantitative yield after a mild aqueous wash. The recovered catalyst can be 
re-used with the initial efficiency and enantioselectivity.   
 Later, Hoveyda, Snapper and co-workers extended this catalytic enantioselective 
silylation from desymmetrization of meso diols to kinetic resolution of unsymmetrically 
substituted 1,2-diols.66 Kinetic resolution of chiral 1,2-diols is more complex than that of 
desymmetrization of meso diols. An effective kinetic resolution, must involve preferable 
with one enantiomer of the substrate (rate of a→b » ent-a→ent-b; Scheme 2.7). This 
class of transformation, however, demands an additional and critical attribute: the 
silylation must proceed with high site selectivity (rate of a→b » a→ent-c).  
RS
OHHO
RL
RS
OHHO
RL
chiral 
silylation 
catalyst
TBSCl
RS
OHTBSO
RL
RS
OTBSHO
RL
RS
OHTBSO
RL
RS
OTBSHO
RL
a
ent-a
b
c
ent-b
ent-c
Scheme 2.7  Enantio- and Site-selectivities for kinetic resolution of Chiral Racemic 1,2-Diols
+
+
a!b >> ent-a!ent-b " enantioselective; a!b >> a!ent-c " site selective  
 Scheme 2.8 demonstrates the representative substrates of kinetic resolution of 
chiral 1,2-diols catalyzed by small organic molecule 2.25. Primary/secondary diol rac-
                                                
65 For H-bonding between alcohols and amines adentified in gas phase, see (a) Millen, D. J.; Zabicky, J. 
Nature 1962, 196, 889–890. (b) Ginn, S. G. W.; Wood, J. L. Nature 1963, 200, 467–468.  
66 Zhao, Y.; Mitra, A.; Hoveyda, A.; Snapper, M. Angew. Chem., Int. Ed. 2007, 46, 8471–8474. 
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2.32 and primary/tertiary diol rac-2.33 can be catalytically resolved with remarkable 
selectivity (krel > 50),67 (S)-2.32 and (R)-2.33 can be recovered as a single enantiomer, 
primary hydroxy groups are silylated over secondary and tertiary hydroxy groups 
exclusively in the reaction. Silylation of compound rac-2.34 demonstrates the highly 
discriminating nature of the catalyst 2.25 that it is able to differentiate small steric 
variations (methyl group versus ethyl group in a vicinal diol). Kinetic resolution of rac-
2.34 proceeds with good site selectivity (97:3 favoring methyl vicinal alcohol) and good 
enantioselectivity (krel = 29). Compound (2S,3R)-2.23 was obtained with 98% ee. Syn 
1,2-diols such as 2.34 are not available through Sharpless asymmetric dihydroxylation.68  
Me
N
N
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H
t-Bu
O
H
N
t-Bu
Me
TBSCl, (i-Pr)2EtN, THF, temp.
20!30 mol %
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H
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H H
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Scheme 2.8 Representative Substrates of Enantio- and Site-Selective Silylation of Chiral Racemic 1,2-Diols
proposed transition state model
R3
R1
OH
R2
TBSO
R3
R1
OH
R2
HO
R3+
OH
t-Bu
HO OH
t-Bu
HO
Me
Me
OH
Et
HO
(R)-2.33
>98% ee; 52% conv.
krel > 50
(S)-2.32
>98% ee; 55% conv.
krel > 50
(2S, 3R)-2.34
98% ee; 57% conv.
krel = 29 RS
RL
III
(±)
 
  
 The proposed transition state model III (Scheme 2.8) is similar to that of 
enantioselective silylation of meso diols (II in Scheme 2.6). The only difference is that 
for kinetic resolution, chiral 1,2-diols associate with catalyst through H-bonding, putting 
the hydroxy group with the smaller RS group close to the bulky activated hypervalent 
                                                
67 Kagan, H.; Fiaud, J. Topics in Stereochemistry, Wiley, New York, 1988, 18, pp. 249–330. 
68 Kolb, H.; VanNieuwenhze, M.; Sharpless, K. Chem. Rev. 1994, 94, 2483–2547. 
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silicon moiety, which accounts for the high site selectivity.  
 The recent findings by Hovayda, Snapper and co-workers have rapidly advanced 
the area of catalytic enantioselective silylation. The reactions are operational simple. A 
variety of 1,2-diols and selected 1,3-diols are effective substrates for the methodology. 
Expanding the substrate scope of enantioselective silylation to more complex system 
such as polyols and introducing more effective catalysts (<5 mol % catalyst loading and 
shorter reaction time) will make this methodology truly practical. 
Synthetic Utility and Synthesis of Chiral Triols 
 Polyoxygenated molecules are entities commonly found in biologically active 
agents. Chiral polyols, especially 1,2,3-triols are useful building block for asymmetric 
synthesis. Two examples shown in Scheme 2.9 demonstrate the synthetic utility of chiral 
triols. In an enantioselective totally synthesis of aquayamicin, compound 2.36 (Scheme 
2.9) was needed as a key intermediate of AB ring that contains many oxygen 
functionalities.69 In order to obtain 2.36 with high enantiomeric purity, Suzuki and co-
workers synthesized meso bis acetate 2.35. Enzymatic hydrolysis of 2.35 selectively took 
off one of the two enantiotopic acetates to afford chiral 1,2,3-triol mono acetate 2.36 as a 
single enantiomer in 94% yield.70 All-secondary 1,2,3-triol 2.38 was used in asymmetric 
synthesis of (–)-palitantin.71 To obtain compound 2.38 with good enantioselectivity, 
racemic acetate 2.37 was subjected to enzymatic kinetic resolution. The acetate group of 
one enantiomer was selectively cleaved to yield acetonide protected all-secondary triol 
                                                
69 (a) Matsumoto, T.; Yamaguchi, H.; Hamura, T.; Tanabe, M.; Kuriyama, Y.; Suzuki, K. Tetrahedron Lett. 
2000, 41, 8383–8387. (b) Yamaguchi, H.; Konegawa, T.; Tanabe, M.; Nakamura, T.; Matsumoto, T.; 
Suzuki, K. Tetrahedron Lett. 2000, 41, 8389–8392. (c) Matsumoto, T.; Yamaguchi, H.; Tanabe, M.; Yasui, 
Y.; Suzuki, K. Tetrahedron Lett. 2000, 41, 8393–8396. 
70 Matsumoto, T.; Konegawa, T.; Yamaguchi, H.; Nakamura, T.; Sugai, T.; Suzuki, K. Synlett 2001, 10, 
1650–1652. 
71 Dumortier, L.; Van der Eycken, J.; Vandewalle, M. Tetrahedron Lett. 1989, 30, 3201–3204. 
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2.38 with good enantioselectivity.  
AcO OAc
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Scheme 2.9 Synthesis and Synthetic Utility of chiral 1,2,3-Triols
Pig liver esterase
2.35 2.36
2.38
 
 Outside of the enzymatic world, there are only two examples of desymmetrization 
of triols through catalytic asymmetric protocols to date. Miller and co-workers developed 
a ‘kinase mimic’ strategy for catalytic asymmetric phosphorylation of benzyl protected 
myo-inositol 2.39 (Scheme 2.10).72 π-Methyl histidine-containing peptide catalysts were 
shown to act as minimal kinase mimics for phosphorylation reaction. Peptide 2.31 was 
identified as a highly site- and enantioselective catalyst through random screening 
algorithm. Myo-inositol derivative 2.39 was selectively phosphorylated with catalyst 2.42 
to afford phosphate 2.40 with >98% ee in 65% yield. Later, the same research group 
discovered that peptide 2.43 with a β-turn secondary structure (induced by incorporation 
of proline) efficiently catalyzed the same reaction but affords the opposite enantiomer of 
the product. Phosphate ent-2.29 was obtained with >98% ee and 56% yield.73 
                                                
72 Sculimbrene, B.; Miller, S. J. Am. Chem. Soc. 2001, 123, 10125–10126. 
73 Sculimbrene, B.; Morgan, A.; Miller, S. J. Am. Chem. Soc. 2002, 124, 11653–11656. 
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 Kang and co-workers have developed copper-catalyzed benzoylation reactions of 
acyclic 1,2,3-triols.74 Alkyl or aryl substituted triols (Scheme 2.11) can be desymmetrized 
using CuCl2 with either BOX type ligand 2.44 or pyridyl imine ligand 2.45 with 
enantioselectivities up to 95%. 
PhCOCl, Et3N, 23 °C
CuCl2, 2.44 or 2.45
R = alkyl or aryl up to 95% ee
N
N
Br
N
O
Ph
t-Bu
N
O
N
O
MeMe
BnBn
Scheme 2.11 Copper-Catalyzed Enantioselective Benzoylation 
of Acyclic 1,2,3-Triols
HO OH
HO R
BzO OH
HO R
2.44 2.45
 
 In summary, polyoxygenated molecules are important chiral building blocks for 
chemical synthesis. Catalytic asymmetric protocols that deliver chiral triols or polyols are 
                                                
74 (a) Jung, B.; Hong, M.; Kang, S. Angew. Chem., Int. Ed. 2007, 46, 2616–2618. (b) Jung, B.; Kang, S. 
Proc. Natl. Acad. Sci. USA 2007, 104, 1471–1475. 
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rare and still present its great challenge in catalysis.  
 
2.2 Catalytic Enantioselective Silylation of Acyclic and Cyclic Triols 
Initial Inspiration and Retrosynthetic Analysis of Cleroindicin D 
 Catalyst that promotes site-selective modification of poly-functional molecules 
can be of significant utility in selective chemical synthesis.75 Of particular importance are 
chiral catalysts that initiate site- and enantioselective functionalization of polyoxygenated 
molecules–entities commonly found in biologically active agents. Our interests in 
developing methods for catalytic enantioselective silylation of triols (eq. 2.1) were 
inspired in part by a retrosynthesis of cleroindicin D (Scheme 2.12).  
 
HO OH
RHO
R3SiO OH
RHO
chiral silylation catalyst
R3SiCl
(eq. 2.1)
R = H, alkyl or aryl  
 Cleroindicin D was isolated from clerodendrum indicum, a plant used in China to 
treat malaria and rheumatism. The structure of cleroindicin D was first assigned as trans 
diol (2.46, Figure 2.1). 76  A racemic synthesis of cleroindicin D revised the 
stereochemistry of the nature product to cis diol (2.47),77 which is critical to our synthesis.  
                                                
75 Lewis, C.; Miller, S. Angew. Chem., Int. Ed. 2006, 45, 5616–5619. 
76 Tian, J.; Zhao, Q.; Zhang, H.; Lin, Z.; Sun, H. J. Nat. Prod. 1997, 60, 766–769. 
77 Barradas, S.; Carreño, M.; González-López, Latorre, A. Urbano, A. Org. Lett. 2007, 9, 5019–5022. 
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Figure 2.1 Structure revision of cleroindicin D
 
 A retrosynthesis of cleroindicin D is shown in Scheme 2.12. We envisioned that 
intramolecular conjugative cyclization of enone 2.48 would afford the target 
hydrobenzofuran. Enantiomerically enriched enone 2.48 would be prepared by a selective 
β-elimination of β-hydroxy kenone 2.49, which in turn, could be accessed by site- and 
enantioselective silylation of tetraol 2.50. 
O
O
OH
OH
H
cleroindicin D
Scheme 2.12 A Retrosynthesis of Cleroindicin D
O
OSiR3
OH
HO
O
OSiR3
OH
HO
HO
O
OH
OH
HO
HO
2.48 2.49 2.50  
 
 On the basis of previously proposed mechanistic models, enantioselective 
conversion of 2.50 to silyl ether 2.49 might involve the association of a catalyst (e.g. 2.25) 
with either a 1,2-diol or 1,3-diol moiety through H-bonding.  
 
Possible Modes of Interaction between 1,2,3-triols and Catalyst 
 In our laboratories, we have reported enantioselective silylation of diols. 
Compared to that of 1,2-diols, enantioselective silylation of 1,2,3-triols is more complex. 
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Whereas enantioselective silylations of cyclic as well as acyclic 1,2-diols have been 
largely proven to be highly selective (>80% ee), the related transformation of 1,3-diols 
can proceed with inferior selectivity. The examples in Scheme 2.13 are illustrative. 
Cyclic and acyclic 1,2-diols are all selectively silylated to afford highly enantioenriched 
products 2.27, 2.30, 2.33. Whereas the silylation reactions of the corresponding cyclic 
1,3-diol, acyclic 1,3-diol and primary acyclic 1,3-diol are much less selective, silyl ether 
of 1,3-diols 2.54, 2.55 and 2.5678 are obtained with low enantiomeric purity. Thus the 
complication regarding enantioselective silylation reaction of 1,2,3-triols (such as 2.51, 
2.52 and 2.53 in Scheme 2.13) is whether the 1,2-diol (high selectivity) or the 1,3-diol 
(potential inferior selectivity) moieties more dominantly associate with the catalyst 
through H-bonding. 
Me
OH
Me
TBSO
OH
TBSO
HO OH
Me Me
OHOH
OH
92% ee, !28 °C 90% ee, !28 °C
1,2-diol 
interaction OH
tBu
TBSO
krel > 50, !78 °C
Me
HO OH
PhHO
Me Me
OHTBSOTBSO OH OHTBDPSO
Ph
25% ee, !40 °C 13% ee, !78 °C 30% ee, !78 °C
1,3-diol 
interaction
Scheme 2.13 Possible Modes of Interaciton between Substrates and Catalyst
OH
2.27 2.30 2.33
251 2.52 2.53
2.54 2.55 2.56
 
 
                                                
78 Jason Rodrigo, Boston College, unpublished results. 
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Catalytic Enantioselective Silylation of Acyclic 1,2,3-Triols 
 Acyclic 1,2,3-triols were the class of substrates that was first tested. Substrates 
were synthesized in few steps from commercially available material. 79  Trizma 
hydrochloride 2.57 (Scheme 2.14) is protected as acetonide 2.58. Oxidative cleavage with 
sodium periodate under acidic condition delivers ketone 2.59. Alkylation of the ketone 
2.59 followed by deprotection of the acetonide affords the final 1,2,3-triols.  
NH2
OH OH
OH
MeO OMe
MeMe
p-TsOH, DMF
O O
H2N OH
NaIO4, KH2PO4
H2O O O
O
1. RMgBr
2. HCl (aq)
>95% yield
80-90% yield 30-50% yield
•HCl
HO OH
RHO
Scheme 2.14 Synthsis of Acyclic 1,2,3-Triols
2.57 2.58 2.59  
  
 Acyclic 1,2,3-triols were subjected to catalytic enantioselective silylation 
conditions, 30 mol % catalyst 2.25, 1.5 equivalents of TBSCl and (i-Pr)2EtN were used. 
The results of desymmetrization of 1,2,3-triols are summarized in Table 2.1. As shown in 
entries 1–3, triols with large alkyl substituents are silylated with high enantioselectivity 
(93% ee to >98% ee) to afford the desired mono silyl ether products 2.60–2.62 in 78–
85% yield after purification. The reactions of the corresponding aryl-substituted triols 
(entries 4–6, Table 2.1) are equally efficient and enantioselective. Silylation of the triol 
that bears a less sterically demanding allyl group substituent (entry 7, Table 2.1) proceeds 
with equal efficiency with a lower enantioselectivity (89% ee).  
                                                
79 (a) Forbes, D.; Ene, D.; Doyle, M. Synthesis 1998, 879–882. (b) Jung, B.; Hong, S.; Kang, S. Angew. 
Chem., Int. Ed. 2007, 46, 2616–2618. 
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Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
TBSCl, (i-Pr)2EtN, THF
Entry
1
2
3
4
5
6
7
8
Product t (h)
96
96
96
120
120
120
96
120
Yield [%][b]
78
85
81
70
68
75
62
57
ee[%][c]
93
94
>98
>98
95
96
89
50
Temp. [°C]
!30
!30
!30
!50
!50
!50
!30
!50
Table 2.1 Catalytic Enantioselective Silylation Reactions of Acyclic Triols[a]
2.25 (30 mol %)
e.r.[%][c]
96.5:3.5
97:3
>99:1
>99:1
97.5:2.5
98:2
94.5:5.5
75:25
[a] Conditions: 1.0 M in THF, 1.5 equiv TBSCl, 1.5 equiv DIPEA; >98% primary silyl ether
observed in all cases. [b] Yield of isolated product after purification. [c] enantiomeric ratios
and ee values detemined by chiral GLC or HPLC analysis (see Supporting Information for
details).
HO OH
RHO
TBSO OH
RHO
TBSO OH
tBuHO
TBSO OH
CyHO
TBSO OH
iPrHO
TBSO OH
PhHO
TBSO OH
pOMePhHO
TBSO OH
pFPhHO
TBSO OH
HO
TBSO OH
OHMe
2.60
2.61
2.62
2.63
2.64
2.65
2.66
2.67
 
 
 The results in entries 1–7 in Table 2.1 show that enantioselective silylation 
reactions of acyclic 1,2,3-triols proceed with high level of selectivity. These findings, as 
well as the previous observation regarding reactions of 1,2 and 1,3-diols (see Scheme 
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2.13), suggest that the silylation acyclic 1,2,3-triols proceed predominantly via complex 
established through H-bonding between the chiral catalyst and two adjacent alcohols of 
the substrate.  
N
N
N
N
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H
H
H
H
O O
H H
Si
MetBu
Me
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!" !+
RL
CH2OH
N
N
N
N
O
H
H
H
H
O O
H H
Si
MetBu
Me
Cl
!" !+
CH2OH
CH3
IV V
Figure 2.2 Proposed Model for Enantioselectivie Silylation of 1,2,3-Triols
 
 
 The sense of enantiodifferentiation in the transformation of acyclic 1,2,3-triols is 
likely controlled by the complexation between the catalyst and the substrate in a manner 
that leads to minimal unfavorable steric repulsion (IV in Figure 2.2). Large substituent, 
RL, is positioned away from amino acid-based structure of the catalyst, while smaller 
hydroxy methylene unit is pointing towards the catalyst. This suggested scenario is also 
consistent with the level of enantioselectivity in entries 1–7 in Table 2.1. Higher 
selectivities are obtained with more sizable large alkyl or aryl groups (e.g. entries 1–6 in 
Table 1). Silylation of the substrate bearing a less steric demanding allyl group results in 
lower enantioselectivity (entry 7 in Table 2.1). To further test this working model, a triol 
with a methyl substituent was made and subjected to silylation condition. Lower 
selectivity was obtained (50% ee, entry 8 in Table 2.1), more importantly, it’s the 
opposite sense of enantioselectivity. The reversal of selectivity is likely because of the 
smaller size of a methyl substituent versus a hydroxy methylene unit. In this case, smaller 
methyl group is positioned towards catalyst chiral backbone while the hydroxy methylene 
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unit is away from the catalyst (V, Figure 2.2). The level of enantioselectivity is low (50% 
ee) because of the diminished steric difference between methyl and hydroxy methylene 
groups.  
Catalytic Enantioselective Silylation of Cyclic 1,2,3-Triols 
 The less selective reactions of triols that contain a linear alkyl substituent at the 
central carbinol site (e.g. 2.66 in entry 7, Table 2.1) did not bode well for the projected 
plan for total synthesis of cleroindicin D (Scheme 2.12). Cyclic 1,2,3-triols with a linear 
alkyl substituent at the central carbinol site were further tested. Meso triol substrates were 
synthesized using the directed dihydroxylation method. 80  Bromination followed by 
elimination of ketone 2.68 delivers enone 2.69.81 Allylic alcohol 2.70 is synthesized using 
the standard Lush reduction conditions. The allylic alcohol directed dihydroxylation 
using stoichiometric osmium tetraoxide and TMEDA as the chelating reagent affords the 
desired meso-triol 2.71 with >10:1 diastereomeric ratio, favoring all the hydroxy groups 
syn to one another. 
Scheme 2.15 Synthesis of meso Cyclic 1,2,3-Tiols
O
Me
1. NBS, CHCl3, 75 °C
2. LiBr, Li2CO3, 130 °C
O
Me
70% yield over 2 steps
CeCl3, NaBH4
MeOH, 0 °C
96% yield
OH
Me
OsO4 (1.05 equiv)
TMEDA, CH2Cl2
!78 °C
37% yield, >10:1 dr
HO OH
HO Me
2.68 2.69 2.70
2.71  
                                                
80 Donohoe, T.; Blades, K.; Moore, P.; Waring, M.; Winter, J.; Helliwell, M.; Newcombe, N.; Stemp, G. J. 
Org. Chem. 2002, 67, 7946–7956. 
81 (a) Stotter, P.; Hill, K. J. Org. Chem. 1973, 38, 2576–2578. (b) Hua, D.; Chen, Y.; Sin, H.; Maroto, M.; 
Robinsin, P.; Newell, S.; Perchellet, E.; Ladesich, J.; Freeman, J.; Perchellet, J.; Chiang, P. J. Org. Chem. 
1997, 62, 6888–6896. 
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 Cyclic triols bearing a central tertiary hydroxy group are sterically more hindered. 
So smaller TESCl was used instead of TBSCl for this type of substrates to achieve 
maximum efficiency.82 Silylation reactions were carried with 20 mol % catalyst loading, 
at –78 ºC for 2 days. As summarized in Table 2.2, desired monosilylated cyclic triols 
2.72–2.74 are isolated in 60–85% yield with >98% ee, regardless of the size of central 
alkyl group and the ring size of the substrates (entries 1–3). It is noteworthy that, in this 
single silylation step, three stereogenic centers are established including a synthetically 
challenging tertiary alcohol center with exceptional level of enantioselectivity. These 
silyl-protected triols obtained by this protocol cannot be selectively prepared by 
asymmetric dihydroxylation83 or stoichiometric dehydroxylations (including the directed 
variants).80 
                                                
82 Enantioselective silylation reactions using TBSCl afford low conversion even at elevated temperature.  
83 Kolb, H.; VanNieuwenhze, M.; Sharpless, K. Chem. Rev. 1994, 94, 2483–2547. 
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Table 2.2 Catalytic Enantioselective Silylation of Cyclic Triols.[a]
TESO OH
TESO OH
TESO OH
Entry
1
2
3
Product Yield [%][b]
60
85
84
ee[%][c]
>98
>98
>98
HO OH
n
RHO
TESO OH
n
RHO
MeHO
npentHO
MeHO
Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
TESCl, DIPEA, THF, !78 °C, 48 h
2.25 (20 mol %)
2.72
2.73
2.74
e.r.[%][c]
>99:1
>99:1
>99:1
[a] Conditions: 0.5 M in THF, 1.25 equiv TESCl, 1.5 equiv DIPEA; >98% primary
silyl ether in all cases. [b-c] See Table 1.  
 
 The exceptional enantiopurity obtained of the six-membered ring triol product 
2.74 is in contrast to the inferior level of enantioselectivity with which the corresponding 
silylation of cyclohexane-1,3-diol proceeds (38% ee with TBSCl, Scheme 2.13). This 
again suggests that it is more likely that two adjacent alcohols are involved in interacting 
with catalyst’s chiral backbone through H-bonding. The sense of the enantioselectivity 
comes from the exo mode of substrate-catalyst association, as depicted in VI (Figure 2.3). 
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Figure 2.3 Proposed Model for Cylic 1,2,3-Triols
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Catalytic Enantioselective Silylation of All-Secondary 1,2,3-Triols 
 Enantioselective silylations of all-secondary triols present an additional challenge 
for the chiral catalyst. The external hydroxy groups and the internal hydroxy group of the 
meso all-secondary triols reside in a less differentiable environment and they are with 
diminished steric difference. In order to efficiently desymmetrize this type of substrate, 
chiral catalyst should be able to silylate the external hydroxy groups over the internal one 
(rate of a→b » a→c; Scheme 2.16). The central hydroxy group silylated product c is still 
a meso compound. The chiral catalyst should be able to silylate the two external hydroxy 
groups selectively (rate of a→b » a→ent-b). 
chiral 
silylation
catalyst
TBSCl
TBSO
OH
OH HO
OH
OTBS HO
OTBS
OH
Enantioselectivity?
Site-selectivity?
HO
OH
OH
b c
Scheme 2.16 Challenges for Enantioselective Silylation of All Secondary Triols
ent-ba
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 Enantioselective silylations of all secondary triols, summarized in Table 2.3, 
uniformly proceed with exceptional selectivity (from 96% to >98% ee), regardless of the 
substrate ring size. The outcomes of theses transformations (sense and level of 
enantioselectivity) are consistent with the mechanistic proposal outlined above in Figure 
2.3. The transformation illustrated in entry 3 of Table 2.3 requires 100 mol % of the 
chiral catalyst and a relatively elevated temperature (0 ºC) because of the low solubility 
of the cyclohexyl triol.84 Notably, processes shown in Table 2.3 proceed with exceptional 
site selectivity: less than 2% of the product derived from the silylation of the central 
secondary alcohol is observed. These silyl-proteced triols are valuable building blocks for 
asymmetric synthesis,71 and again are not available from asymmetric or directed 
hydroxylation.68,80  
                                                
84 In the presence of 30 mol % catalyst 2.14 (0 ºC) and after 72 h of reaction time, silyl ether 2.65 is 
isolated in 32% yield and 97% ee.  
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Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
TBSCl, DIPEA, THF
Table 2.3 Catalytic Enantioselective Silylation of All-Secondary Triols.[a]
OH
HO OH
OH
TBSO OH
TBSO
OH
OH
TBSO
OH
OH
OH
OHTBSO
OH
OHTBSO
2.75
2.76
2.77
2.78
Entry Product Mol % 1 Temp. [°C] t [h] Yield [%][b] e.r.[c] ee[%][c]
1
2
3
4
30
100
30
30
!30
0
!30
!50
96
24
120
120
70
51
65
72
98:2
>99:1
>99:1
>99:1
96
>98
>98
>98
[a] Conditions: 1 M in THF, 1.5 equiv TESCl, 1.5 equiv DIPEA; >98% secondary silyl ether in all cases. 
[b-c] See Table 4.1.
2.25
 
Enhancement of Enantioselectivity by the Third Hydroxy Group 
 As illustrated in the sections above, a variety of triols can be catalytically silylated 
with exceptional selectivity (Table 2.1, 2.2 and 2.3). The enantioselectivity of silylation 
of triols is significantly higher than that of the corresponding diols. Silylation of 
cycloheptane-1,2-diol affords the silyl ether product 2.28 (Scheme 2.17) with 93% ee at -
40 ºC. In comparison, the silyl ether of cycloheptane-1,2,3-triol 2.76 is obtained as a 
single enantiomer (>98% ee) at –30 ºC. Six-membered ring diol and triol also show the 
same enantioselectivity difference (92% ee of 2.27 versus >98% ee of 2.76) even the 
silylation of cyclohexane-1,2,3-triol is performed at relatively elevated temperature.  
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!40 °C
93% ee
!30 °C
>98% ee
OH OH
OH
!28 °C
92% ee
0 °C
>98% ee
TBSOTBSO
TBSO
OH
TBSO
OH
OH
Scheme 2.17 Comparison of Enantioselectivity of Diols and the Corresponding Triols
2.28 2.272.77 2.76
 
 It is very likely that there is a so-called ‘correction’ mechanism in the catalytic 
processes that helps ‘polish’ the enantioselectivity of mono silylated product.85 The detail 
is depicted in Scheme 2.18. The initial desymmetrization step controlled by chiral 
catalyst 2.25 might afford both enantiomers of the mono silyl ether (2.76 and ent-2.76 in 
Scheme 2.18). The dihydroxy unit of the minor enantiomer ent-2.76 still has the right 
geometry to interact with the chiral catalyst, which could be further silylated to form the 
bis-silyl ether 2.79. Both the initial desymmetrization step and the secondary kinetic 
resolution step are controlled by catalyst 2.25. So the net result of the reaction is that 
mono-silyl ether 2.76 is obtained as a single enantiomer while bis-TBS ether is also 
isolated. It should be noted that, in contrast, silylation reactions of 1,2-diols, <2% bis-
silyl ether product is obtained in all case.  
OH
OHHO
Desymmetrizaiton
OH
OHTBSO
OH
OTBSHO
major
minor
Kinetic Resolution
slower
OH
OTBSTBSO
OH
OTBSTBSO
Kinetic Resolution
fast
Scheme 2.18 'Correction' Mechanism of Enantioselective Silylation of Triols
2.76
ent-2.76
2.51
2.79
2.79
Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
2.14
 
                                                
85 Schreiber, S. L.; Schreiber, T. S.; Smith, D. B. J. Am. Chem. Soc. 1987, 109, 1525–1529. 
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 Examples in Scheme 2.19 show that various amount of bis silyl ether by-product 
is generated from the silylation reaction, while the ‘polished’ desired mono silyl ether 
product is obtain as a single enantiomer.  
>98% ee, 81%
8% bis
TBSO OH
HO
TBSO
OH
OH
TBSO OH
OH
>98% ee, 65% 
18% bis
>98% ee, 72% 
12% bis
TESO OH
HO Me
>98% ee, 84%
5% bis
2.62 2.742.77 2.78
Scheme 2.19 'Polished' mono Silyl Ether of Triols
 
2.3 Application to Total Synthesis of Cleroindicins D, F and C 
 A variety of acyclic and cyclic 1,2,3-triols can be enantioselectively silylated with 
catalyst 2.25. The results of cyclic triols bearing a central tertiary group (Table 2.2) bode 
especially well with the target nature product cleroindicin D. The retrosynthesis is shown 
in Scheme 2.12.  
O
O
OH
OH
H
cleroindicin D
Scheme 2.12 A Retrosynthesis of Cleroindicin D
O
OSiR3
OH
HO
O
OSiR3
OH
HO
HO
O
OH
OH
HO
HO
2.48 2.49 2.50  
 
 The synthesis begins with a two-step sequence involving commercially available 
para-substituted phenol 2.80 (Scheme 2.20); pretection of the primary alcohol and 
subsequent conversion into cyclic dienone 2.82 through oxidative dearomatization86 
                                                
86 Felpin, F. Tetrahedron Lett. 2007, 48, 409–412. 
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proceed in 69% overall yield. Directed epoxidation of the two electrophilic alkenes in 
2.82 proceeds with exceptional diastereoselectivity,87 affording bis-epoxide 2.83 in 92% 
yield after silica gel chromatography. X–ray crystal structure analysis88 further confirms 
that the tertiary alcohol and two epoxides of 2.83 are exclusively syn. Site selective 
reduction of the two electronically activated C–O bonds in 2.83 using Adam’s catalyst 
under hydrogen atmosphere89 yields the labile bis β−hydroxy ketone 2.84.90 Conversion 
of 2.84 into the dimethylacetal proceeds with concomitant removal of the primary silyl 
ether to deliver the meso tetraol 2.85 in 40% overall yield.  
TBSCl, Imidazole
OH O
OH69% over 2 steps
H2O2, K2CO3
THF/H2O 
0 °C, 6 h
92% yield
dr > 20:1
O
OH
OO
OH
THF, 0 °C, 1 h
PhI(OAc)2
CH3CN/H2O 
0 °C, 20 min
HO TBSO
TBSO
TBSO
Scheme 2.20 Synthesis towards the meso Tetraol Intermediate
2.80 2.81 2.82
2.83
4 wt% PtO2
1 atm H2
EtOAc, 23 °C
O
OH
TBSO
2.84
HO OH
OH
HO
2.85
HO OH
OMeMeO
10 mol % ppTS
MeoH, 55 °C, 2h
40% over 2 steps
 
 Enantioselective silylation of meso tetraol 2.85 is the key step of total synthesis. 
Tetraol 2.85 is a challenging substrate. Multiple H-bonding, as well as multiple Lewis 
basic sites of the substrate 2.85 necessitate a higher degree of precision of the catalyst 
2.14 to effectively desymmetrize it. Enantioselective silylation of 2.85 in the presence of 
                                                
87 a) McKillop, A.; Taylor, R.; Watson, R.; Lewis, N. Synlett 1992, 1005–1006.  
For a review of hydroxyl-directed epoxidations, see:b) Hoveyda, A.; Evans, D.; Fu, G. Chem. Rev. 1993, 
93, 1307–1370. 
88 See supporting information for data of X-ray crystal structure analysis. 
89 Lei, X.; Zaarur, N.; Sherman, M.; Porco, J. J. Org. Chem. 2005, 70, 6474–6483. 
90 Other reduction condition, such as SmI2 or Zn/Cu give various by-products with a maximum 20% 
optimized yield. 
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20 mol % catalyst 2.25 and 2.25 equivalents of TESCl led to the formation of 2.86 
(Scheme 2.21) in >98% ee and 83% yield. The primary alcohol is protected first then one 
of the secondary hydroxy groups is selectively silylated. Three stereogenic centers are 
generated in a single step including a tertiary alcohol. 
Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
TESCl (2.25 eq) 
(i-Pr)2EtN (2.5 eq)
THF, !78 °C, 48 h
20 mol%
>98% ee, 83% yield
OH
HO
HO OH
MeO OMe
OH
TESO
HO OTES
MeO OMe
Scheme 2.21 Key Step of Total Synthesis of Cleroindicin D
2.85 2.86
2.25
 
 With chiral silyl ether 2.86 in hand, Scheme 2.22 shows the end game of the total 
synthesis of cleroindicin D. Subsequent conversion of 2.86 into mesylate 2.87 was 
performed under standard conditions, affording the desired product in 92% yield. 
Treatment of 2.87 with five equivalents of HCl in aqueous THF (0 °C to 22 °C) for four 
hours led to the formation of enantiomerically pure cleroindicin D, which was isolated in 
45% overall yield as a single diastereomer. Thus enantioselective total synthesis of 
cleroindicin D was achieved in eight steps from commercially available material.  
MsCl, DIPEA
92% yield
CH2Cl2
0 °C to 23 °C
10 h
5 eq HCl
OH
OHO
H
O
(!)cleroindicin D 
>98% ee (8 steps)
>98% ee
THF/H2O
0 °C to 23 °C
4 h
45% yield
OH
TESO
HO OTES
MeO OMe
OH
TESO
MsO OTES
MeO OMe
Scheme 2.22 End Game of Total Synthesis of Cleroindicin D
2.86 2.87
 
 Conversion of 2.87 into the target molecule under aqueous acid condition 
constitutes a five-step sequence involving removal of the two silyl groups to afford 
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mesylate 2.89 (Scheme 2.23), conversion of the acetal into the ketone 2.90, and β-
elimination of the mesylate group to furnish the requisite enone 2.91, which undergoes 
intramolecular conjugate addition to afford the furan ring of the nature product.  
 
5 eq HCl
THF/H2O
0 °C
OH
OHO
H
O
(!)cleroindicin D
5 eq HCl
THF/H2O
0 °C
5 eq HCl
THF/H2O
23 °C
5 eq HCl
THF/H2O
23 °C
5 eq HCl
THF/H2O
23 °C
>98% ee, 45% yield
OH
TESO
MsO OTES
MeO OMe
OH
HO
MsO OTES
MeO OMe
OH
HO
MsO OH
MeO OMe
OH
HO
MsO OH
O
OH
HO
OH
O
Scheme 2.23 One Pot, Five Transformations
2.87 2.88 2.89
2.90 2.91
 
 
 As illustrated in Scheme 2.24, cleroindicin D can be easily and efficiently 
converted into cleroindicins F and C under standard dehydration and hydrogenation 
conditions.  
 
OH
O
H
O
(!)cleroindicin F
OH
O
H
O
(!)cleroindicin C
MsCl, DIPEA
92% yield
CH2Cl2
0 °C, 16 h
H2, Pd/C
>98% yield
MeOH
0 °C, 16 hOH
OHO
H
O
(!)cleroindicin D
Scheme 2.24 Syntheses of Cleroindicins F and C
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2.4 Conclusion 
 In summary, catalytic enantioselective silylation has been extended beyond the 
previously reported 1,2-diols.61,66 The process detailed above is applicable to variety of 
triol substrates and delivers otherwise difficult–to–access polyoxygenated small 
molecules of exceptional enantiomeric purity, significantly expanding the utility of 
catalytic enantioselective silylation reactions. The synthetic utility of this methodology is 
demonstrated in the total syntheses of cleroindicins D, F and C.  
2.5 Experimental and Supporting Information 
General information 
Infrared (IR) spectra were recorded on a Perkin Elmer 781 spectrophotometer, νmax in 
cm-1.  Bands are characterized as broad (br), strong (s), medium (m), and weak (w).  1H   
NMR spectra were recorded on a Varian GN-400 (400 MHz) instrument. Chemical shifts 
are reported in ppm with the solvent reference as the internal standard (CHCl3: δ 7.26; 
CD3OD: δ 4.87, 3.31; pyridine-d5: δ 8.74, 7.58, 7.22 ppm).  Data are reported as follows: 
chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, br = broad), and coupling constants (Hz).  13C NMR spectra were recorded 
on a Varian GN-400 (100 MHz) with complete proton decoupling. Chemical shifts are 
reported in ppm with the solvent reference as the internal standard (CHCl3: δ 77.23, 
CD3OD: δ 49.15; pyridine-d5: δ 150.35, 135.91, 123.87 ppm).   Melting points (mp) were 
taken with a Laboratory Devices Mel-Temp and are uncorrected.  Enantiomeric ratios 
were determined by gas liquid chromatography (GLC) on a Hewlett Packard HP 6890 
with a Beta Dex 120 (30 m x 0.25 mm x 0.25 µm film thickness), or a Gamma Dex 120 
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(30 m x 0.25 mm x 0.25 µm film thickness) column; or by analytical liquid 
chromatography (HPLC) on a Shimadzu chromatograph ((Chiral Technologies Chiralpak 
AS (4.6 x 250 mm), or Chiral Technologies Chiralpak OD (4.6 x 250 mm)).  Optical 
rotations were measured on a Rudolph Research Analytical Autopol IV Automatic 
Polarimeter.  High resolution mass spectrometry (HRMS) was performed by the mass 
spectrometry facility at Boston College.  
 Chlorotriethylsilane (TESCl) was distilled from 3Å molecular sieves prior to use. 
Methanesulfonyl chloride (MsCl) was distilled from P2O5 prior to use. Tetrahydrofuran 
(THF) was dried on alumina columns by a solvent dispensing system prior to use. All 
other reagents were used as received. 
 
General procedure for desymmetrization of 1,2,3-triols through catalytic 
enantioselective silylation with TBSCl 
Catalyst 2.25 (19 mg, 0.06 mmol) and the triol substrate (0.2 mmol) were weighed 
into a 10 x 75 mm test tube. THF (48 µL) and DIPEA (52 µL, 0.3 mmol) were added 
with a Gilson Pipetman. The tube was capped with a septum, and the mixture was 
allowed to cool to –78 oC using an aceton dry-ice bath.  TBSCl (45 mg, 0.3 mmol) was 
dissolved in THF (55 µL, total volume ~ 100 µL) and added to the test tube with a Gilson 
Pipetman.  The test tube was capped with a septum, wrapped with Teflon tape and the 
mixture was allowed to stir at the appropriate temperature (see below for details) in a 
Cryocool® apparatus for the reported period of time.  The reaction was quenched by 
addition of DIPEA (25 µL) and methanol (25 µL).  The mixture was allowed to warm to 
23 oC, diluted with ethyl acetate (20 mL) and washed with 10% citric acid aqueous 
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solution (10 mL).  The aqueous layer was washed with ethyl acetate (2 x 15 mL) and the 
combined organic layer was dried over MgSO4, filtered and concentrated to afford a 
yellow oil.  The crude product was purified by silica gel chromatography (10% diethyl 
ether in hexanes to 1:1 diethyl ether:hexanes) and analyzed by GLC (Supelco Beta, or 
Gamma Dex 120) or HPLC. 
The aqueous layer was basified with 3 N NaOH until pH 12 and washed with CH2Cl2 
(3 x 15 mL).  The combined organic layer was dried over MgSO4, filtered and 
concentrated under high vacuum to provide the recovered catalyst 1 as a white solid 
(mass recovery > 90%).  The recovered catalyst was re-used directly for the silylation 
reactions with the same efficiency and selectivity. 
 
General procedure for desymmetrization of 1,2,3-triols through catalytic 
enantioselective silylation with TESCl 
Catalyst 2.25 (12 mg, 0.04 mmol) and the triol substrate (0.2 mmol) were weighed 
into a 10 x 75 mm test tube. THF (148 µL) and DIPEA (52 µL, 0.3 mmol) were added 
with a Gilson Pipetman. The tube was capped with a septum, and the mixture was 
allowed to cool to –78 oC.  TESCl (42 µL, 0.25 mmol) was dissolved in THF (158 µL, 
total volume ~ 200 µL) and added to the test tube with a Gilson Pipetman.  The test tube 
was capped with a septum, wrapped with Teflon tape and the mixture was allowed to stir 
at –78 oC in a cryocool apparatus for 48 h.  The reaction was quenched by addition of 
DIPEA (25 µL) and methanol (25 µL).  The mixture was allowed to warm to 23 oC, 
diluted with ethyl acetate (20 mL) and washed with 10% citric acid (10 mL).  The 
aqueous layer was washed with ethyl acetate (2 x 15 mL) and the combined organic layer 
 52 
was dried over MgSO4, filtered and concentrated to afford a yellow oil.  The crude 
product was purified by silica gel chromatography (10% diethyl ether in hexanes to 1:1 
diethyl ether:hexanes) and analyzed by GLC (Supelco Beta, or Gamma Dex 120). 
Characterization Data 
(R)-2-((tert-Butyldimethylsilyloxy)methyl)-3,3-dimethylbutane-1,2-diol (2.60, Table 
2.1, entry 1):  
IR (neat, thin film): 3491 (br), 2955 (m), 2926 (s), 2855 (m), 1463 (w), 1254 (w), 1082 
(m), 937 (w), 837 (s), 777 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 3.81 (1H, d, J = 10.0 
Hz), 3.74 (1H, d, J = 10.0 Hz), 3.66 (2H, m), 3.18 (1H, s), 2.80 (1H, t, J = 6.4 Hz), 0.93 
(9H, s), 0.91 (9H, s), 0.10 (6H, s). 13C NMR (CDCl3, 100 MHz): δ 75.38, 66.59, 64.66, 
36.15, 26.10, 25.66, 18.44, −5.25, −5.32. HRMS [M++H]: Calculated for C13H31O3Si: 
236.2043; Found: 236.2053. Optical Rotation: [α]20D  −1.2 (c = 1.0, CHCl3). 
Compound 2.60 was derivatized to the corresponding aldehyde by PCC oxidation. 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m x 
0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC, 1 oC/min, 8 psi.); chromatograms 
are illustrated below for a 93% ee sample: 
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2-tert-Butylpropane-1,2,3-triol:  
White solid. MP: 77.0–78.0 °C. IR (neat): 3347 (br), 3238 (br), 2958 (m), 2875 (w), 
1718 (w), 1468 (w), 1408 (m), 1389 (m), 1233 (w), 1028 (s), 1000 (s), 927 (m), 873 (w), 
564 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 3.85 (2H, d, J = 10.8 Hz), 3.76 (2H, d, J = 
10.8 Hz), 2.78 (3H, br), 0.94 (9H, s). 13C NMR (CDCl3, 100 MHz): δ 75.73, 66.32, 
28.22, 25.51. HRMS [M++NH4]: Calculated for C7H20N1O3: 166.1443; Found: 166.1450. 
 
(R)-3-(tert-Butyldimethylsilyloxy)-2-cyclohexylpropane-1,2-diol (2.61, Table 2.1, 
entry 2): 
IR (neat, thin film): 3421 (br), 2927 (s), 2854 (m), 1470 (w), 1450 (w), 1253 (m), 1084 
(s), 836 (s), 776 (s), 671 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 3.69 (1H, d, J = 10 
Hz), 3.63 (1H, d, J = 10 Hz), 3.62 (1H, dd, J = 11.2, 5.2 Hz), 3.54 (1H, dd, J = 11.2, 5.2 
Hz), 2.82 (1H, s), 2.45 (1H, dd, J = 7.2, 5.2 Hz), 1.78-1.48 (6H, m), 1.25-0.74 (5H, m), 
0.91 (9H, s), 0.090 (3H, s), 0.086 (3H, s). 13C NMR (CDCl3, 100 MHz): δ 74.67, 66.69, 
65.81, 43.10, 27.32, 27.16, 27.05, 26.80, 26.11, 18.48, −5.24. HRMS [M++H]: 
Calculated for C15H33O3Si: 289.2199; Found: 289.2211. Optical Rotation: [α]25D  −1.8 
(c = 1.0, CHCl3). 
Compound 2.61 was derivatized to the corresponding aldehyde by PCC oxidation. 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m x 
0.15 mm x 0.25 µm film thickness), 140 oC hold 110 min, 15 psi.); chromatograms are 
illustrated below for a 94% ee sample: 
HO OH
tBu OH
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2-Cyclohexylpropane-1,2,3-triol: 
White solid. MP: 93.0–95.2 °C. IR (neat): 3271 (br), 2919 (m), 2850 
(m), 1447 (w), 1120 (w), 1057 (m), 1029 (s), 672 (w), 649 (w), 627 (w), 564 (w) cm-1. 1H 
NMR (CDCl3, 400 MHz): δ 3.75 (2H, d, J = 10.8 Hz), 3.64 (2H, d, J = 10.8 Hz), 2.92 
(1H, br), 2.40 (2H, br), 1.79-1.48 (6H, m), 1.23-0.90 (5H, m). 13C NMR (CDCl3, 100 
MHz): δ 74.88, 66.71, 43.62, 27.17, 26.95, 26.71. HRMS [M++NH4]: Calculated for 
C9H22N1O3: 192.1600; Found: 192.1598. 
 
(R)-2-((tert-Butyldimethylsilyloxy)methyl)-3-methylbutane-1,2-diol (2.62, Table 2.1, 
entry 3): 
IR (neat, thin film): 3413 (br), 2956 (m), 2929 (s), 2883 (w), 2857 (m), 1470 (m), 1389 
(w), 1362 (w), 1254 (m), 1094 (s), 1021 (w), 836 (s), 777 (s) cm-1. 1H NMR (CDCl3, 400 
MHz): δ 3.69 (1H, d, J = 9.6 Hz), 3.64 (1H, dd, J = 11.2, 4.8 Hz), 3.63 (1H, d, J = 9.6 
Hz), 3.55 (1H, dd, J = 11.2, 7.2 Hz), 2.82 (1H, s), 2.44 (1H, dd, J = 7.2, 4.8 Hz), 1.86 
(1H, septet, J = 6.8 Hz), 0.92 (6H, d, J = 6.8 Hz), 0.91 (9H, s), 0.094 (6H, s). 13C NMR 
(CDCl3, 100 MHz): δ 74.86, 66.36, 65.57, 32.37, 26.10, 18.46, 17.24, 17.10, −5.25. 
HO OH
Cy OH
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HRMS [M++NH4]: Calculated for C12H32N1O3Si: 266.2151; Found: 266.2149. Optical 
Rotation: [α]20D  −1.0 (c = 1.0, CHCl3). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 115 oC hold 90 min, 15 psi.); chromatograms are 
illustrated below for a >98% ee sample: 
  
  
 
 
(R)-3-(tert-Butyldimethylsilyloxy)-2-phenylpropane-1,2-diol (2.63, Table 2.1, entry 
4): 
IR (neat, thin film): 3424 (br), 2953 (m), 2929 (m), 2884 (w), 2857 (m), 1604 (w), 1509 
(m), 1254 (m), 1226 (m), 1084 (s), 1032 (w), 834 (s), 815 (m), 778 (s) cm-1.  1H NMR 
(CDCl3, 400 MHz): δ 7.46 (2H, m), 7.36 (2H, m), 7.28 (1H, m), 4.00 (1H, d, J = 10 Hz), 
3.95 (1H, dd, J = 11.6, 5.6 Hz), 3.75 (1H, d, J = 10 Hz), 3.72 (1H, dd, J = 11.6, 7.2 Hz), 
3.39 (1H, s), 2.43 (1H, dd, J = 7.2, 5.6 Hz), 0.87 (9H, s), 0.04 (3H, s), 0.01 (3H, s). 13C 
NMR (CDCl3, 100 MHz): δ 141.74, 128.46, 127.62, 125.47, 76.10, 69.55, 68.49, 26.05, 
18.48, −5.29. HRMS [M++NH4]: Calculated for C15H30N1O3Si: 300.1995; Found: 
300.1992. Optical Rotation: [α]20D  −0.72 (c = 1.3, CHCl3). 
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Enantiomeric purity was established by HPLC analysis (Chiralpak OD column (25 
cm × 0.46 cm), 99/1 hexanes/i-PrOH, 1 mL/min, 220 nm); chromatograms are illustrated 
below for a >98% ee sample: 
  
 
 
 
 
 
 
(R)-3-(tert-Butyldimethylsilyloxy)-2-(4-methoxyphenyl)propane-1,2-diol (2.64, Table 
2.1, entry 5): 
IR (neat, thin film): 3433 (br), 2952 (m), 2928 (m), 2856 (m), 1611 (w), 1512 (m), 1463 
(m), 1302 (w), 1248 (s), 1178 (w), 1082 (m), 1007 (m), 833 (s), 777 (s) cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.37 (2H, m), 6.89 (2H, m), 3.95 (1H, d, J = 10 Hz), 3.92 (1H, dd, 
J = 11.2, 5.2 Hz), 3.80 (3H, s), 3.72 (1H, d, J = 10 Hz), 3.70 (1H, dd, J = 11.2, 7.6 Hz), 
3.33 (1H, s), 2.41 (1H, dd, J = 7.6, 5.2 Hz), 0.87 (9H, s), 0.05 (3H, s), 0.02 (3H, s). 13C 
NMR (CDCl3, 100 MHz): δ 159.11, 133.77, 126.71, 113.89, 75.77, 69.64, 68.62, 55.51, 
26.08, 18.49, −5.26. HRMS [M++Na]: Calculated for C16H28O4Na1Si: 335.1655; Found: 
335.1646. Optical Rotation: [α]20D  −0.41 (c = 0.5, CHCl3). 
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Enantiomeric purity was established by HPLC analysis (Chiralpak OD column (25 
cm × 0.46 cm), 99/1 hexanes/i-PrOH, 1 mL/min, 220 nm); chromatograms are illustrated 
below for a 95% ee sample: 
  
 
 
 
 
 
 
 
(R)-3-(tert-Butyldimethylsilyloxy)-2-(4-fluorophenyl)propane-1,2-diol (2.65, Table 
2.1, entry 6): 
IR (neat, thin film): 3418 (br), 2953 (m), 2928 (m), 2883 (w), 2856 (m), 1463 (w), 1252 
(m), 1088 (m), 1070 (m), 1037 (m), 833 (s), 775 (s), 758 (m), 698 (s), 669 (w) cm-1. 1H 
NMR (CDCl3, 400 MHz): δ 7.42 (2H, m), 7.04 (2H, m), 3.95 (1H, d, J = 10 Hz), 3.91 
(1H, d, J = 11.2 Hz), 3.72 (1H, d, J = 10 Hz), 3.68 (1H, d, J = 11. 2 Hz), 3.37 (1H, br), 
2.38 (1H, br), 0.87 (9H, s), 0.04 (3H, s), 0.01 (3H, s). 13C NMR (CDCl3, 100 MHz): 
δ 127.34, 127.26, 115.34, 115.13, 75.91, 69.27, 68.28, 26.03, 18.46, −5.29. HRMS 
[M++NH4]: Calculated for C15H29N1O3Si: 318.1901; Found: 318.1897. Optical Rotation: 
[α]20D  −1.3 (c = 1.0, CHCl3). 
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Enantiomeric purity was established by HPLC analysis (Chiralpak OD column (25 
cm × 0.46 cm), 99.3/0.7 hexanes/i-PrOH, 1 mL/min, 220 nm); chromatograms are 
illustrated below for a 96% ee sample: 
  
 
 
 
 
 
 
2-(4-Fluorophenyl)propane-1,2,3-triol: 
White solid. MP: 65.5–67.0 °C. IR (neat): 3246 (br), 2964 (w), 2908 
(w), 1606 (w), 1510 (m), 1421 (w), 1234 (m), 1045 (s), 1002 (m), 841 (s), 722 (m), 640 
(m), 550 (s), 534 (s) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.43 (2H, m), 7.07 (2H, m), 
3.96 (2H, dd, J = 11.2, 6.0 Hz), 3.77 (2H, dd, J = 11.2, 4.0 Hz), 3.42 (1H, s), 2.25 (2H, 
br). 13C NMR (CDCl3, 100 MHz): δ 127.30, 127.22, 115.75, 115.54, 76.39, 68.71. 
HRMS [M++NH4]: Calculated for C9H15N1O3: 204.1036; Found: 204.1032. 
 
(R)-2-((tert-Butyldimethylsilyloxy)methyl)pent-4-ene-1,2-diol (2.66, Table 2.1, entry 
7): 
HO OH
pFPh OH
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IR (neat, thin film): 3404 (br), 2953 (m), 2929 (m), 2857 (m), 1463 (w), 1252 (m), 1093 
(s), 912 (w), 834 (s), 774 (s), 669 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 5.85 (1H, ddt, 
J = 16.4, 10.8, 7.6 Hz)), 5.13, (1H, m), 5.10 (1H, m), 3.59 (1H, d, J = 10 Hz), 3.57 (1H, 
dd, J = 10.4, 4 Hz), 3.54 (1H, d, J = 10 Hz), 3.50 (1H, dd, J = 10.4, 5.6 Hz), 2.68 (1H, s), 
2.27 (3H, m), 0.88 (9H, s), 0.083 (3H, s), 0.081 (3H, s). 13C NMR (CDCl3, 100 MHz): 
δ 133.18, 118.69, 73.56, 67.25, 66.79, 39.33, 26.09, 18.47, −5.25. HRMS [M++H]: 
Calculated for C12H27O3Si: 247.1730; Found: 247.1735. Optical Rotation: [α]20D  −2.3 
(c = 1.0, CHCl3).  
 
Stereochemistry Proof: Compound 2.66 was derivatized to (S)-(2-
allyloxiran-2-yl)methanol. : [α]20D  −8.0 (c = 0.2, CHCl3). Previously 
reported optical rotation: : [α]20D  −36 (c = 1.0, CHCl3) for enantiopure S enantiomer.91 
Compound 2.66 was derivatized to the corresponding mono acetate. Enantiomeric 
purity was established by GLC analysis (Supelco Beta Dex 120 (30 m x 0.15 mm x 0.25 
µm film thickness), 110 oC hold 150 min, 15 psi.); chromatograms are illustrated below 
for a 89% ee sample: 
  
  
 
                                                
91 A. L. Garner, K. Koide. Org. Lett. 2007, 9, 5235–5238.  
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(S)-3-(tert-Butyldimethylsilyloxy)-2-methylpropane-1,2-diol (2.67, Table 2.1, entry 
8):  
1H NMR (CDCl3, 400 MHz): δ 3.63 (1H, d, J = 10.0 Hz), 3.61 (1H, d, J = 10.8 Hz), 3.51 
(1H, d, J = 10.0 Hz), 3.45 (1H, d, J = 10.8 Hz), 2.77 (1H, s), 2.36 (1H, s), 1.11 (3H, s), 
0.91 (9H, s), 0.09 (6H, s). 13C NMR (CDCl3, 100 MHz): δ 72.19, 69.37, 68.62, 26.10, 
21.19, 18.49, −5.24, −5.27. Optical Rotation: [α]20D  0 (c = 1.0, CHCl3). 
Compound 2.67 was derivatized to the corresponding mono acetate. Enantiomeric 
purity was established by GLC analysis (Supelco Beta Dex 120 (30 m x 0.15 mm x 0.25 
µm film thickness), 102 oC hold 60 min, 25 psi.); chromatograms are illustrated below for 
a 50% ee sample: 
  
  
 
 
(1S,2S,5R)-1-Methyl-5-(triethylsilyloxy)cyclopentane-1,2-diol (2.72, Table 2.2, entry 
1): 
IR (neat, thin film): 3379 (br), 2956 (s), 2912 (m), 2876 (m), 1457 (w), 1413 (w), 1375 
(w), 1239 (w), 1165 (w), 1065 (s), 991 (s), 842 (s), 730 (s), 674 (w) cm-1. 1H NMR 
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(CDCl3, 400 MHz): δ 3.75 (1H, t, J = 6.0 Hz), 3.62 (1H, dt, J = 7.6, 5.2 Hz), 3.34 (1H, s), 
2.70 (1H, d, J = 7.6 Hz), 1.86-1.63 (4H, m), 1.19 (3H, s), 0.96 (9H, t, J = 8.0 Hz), 0.63 
(6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 78.03, 77.41, 76.60, 30.90, 30.39, 
24.49, 6.96, 5.04. HRMS [M++H]: Calculated for C12H27O3Si: 247.1730; Found: 
247.1731. Optical Rotation: [α]20D  0 (c = 0.5, CHCl3). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 110 oC to 180 oC, 0.3 oC /min, 15 psi.); 
chromatograms are illustrated below for a >98% ee sample: 
  
  
 
 
(1S,2S,5R)-1-Pentyl-5-(triethylsilyloxy)cyclopentane-1,2-diol (2.73, Table 2.2, entry 
2): 
IR (neat, thin film): 3450 (br), 2955 (s), 2933 (s), 2876 (m), 1459 (m), 1239 (w), 1089 
(s), 1006 (s), 975 (w), 857 (w), 728 (s). 1H NMR (CDCl3, 400 MHz): δ 3.79 (1H, t, J = 5. 
6 Hz), 3.68 (1H, q, J = 6.4 Hz), 3.46 (1H, s), 2.91 (1H, d, J = 6.4 Hz), 1.80-1.66 (4H, m), 
1.42-1.26 (8H, m), 0.97 (9H, t, J = 8.0 Hz), 0.89 (3H, t, J = 6.8 Hz), 0.63 (6H, q, J = 8.0 
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Hz). 13C NMR (CDCl3, 100 MHz): δ 78.15, 76.64, 75.59, 38.71, 32.70, 31.05, 30.55, 
23.39, 22.89, 14.31, 6.97, 5.10. HRMS [M++H]: Calculated for C16H35O3Si: 303.2356; 
Found: 303.2357. Optical Rotation: [α]20D  −12.2 (c = 1.0, CHCl3). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 132 oC hold 350 min, 10 psi.); chromatograms are 
illustrated below for a >98% ee sample: 
  
  
 
 
(1R,2s,3S)-2-Pentylcyclopentane-1,2,3-triol:  
IR (neat, thin film): 3378 (br), 2953 (m), 2930 (s), 2870 (m), 1458 (w), 
1402 (w), 1378 (w), 1158(w), 1059 (s), 969 (m), 896 (w), 837 (w). 1H NMR (CDCl3, 400 
MHz): δ 3.76 (2H, br), 3.45 (1H, br), 2.99 (2H, br), 1.89-1.75 (4H, m), 1.40-1.20 (8H, 
m), 0.87 (3H, t, J = 6.8 Hz). 13C NMR (CDCl3, 100 MHz): δ 79.54, 76.25, 37.32, 32.62, 
29.98, 23.28, 22.83, 14.26. HRMS [M++NH4]: Calculated for C10H24 N1O3: 206.1756; 
Found: 206.1761. 
 (1S,2S,6R)-1-Methyl-6-(triethylsilyloxy)cyclohexane-1,2-diol (2.74, Table 2.2, entry 
3): 
npentHO
HO OH
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IR (neat, thin film): 3430 (br), 2941 (m), 2912 (w), 2875 (m), 1458 (m), 1414 (w), 1362 
(w), 1079 (m), 1252 (m), 1041 (s), 1005 (s), 992 (s), 944 (w), 872 (m), 795 (m), 724 (s), 
682 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 3.53 (1H, t, J = 6.0), 3.36 (1H, m), 2.72 
(1H, br), 2.64 (1H, br), 1.77-1.58 (6H, m), 1.24 (3H, s), 0.96 (9H, t, J = 8.0 Hz), 0.61 
(6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 76.52, 75.42, 73.24, 30.43, 30.23, 
23.24, 17.52, 7.09, 5.20. HRMS [M+ + H]: Calculated for C13H29O3Si: 261.1886; Found: 
261.1886. Optical Rotation: [α]20D  −14.2 (c = 1.0, CHCl3). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 140 oC hold 80 min, 15 psi.); chromatograms are 
illustrated below for a >98% ee sample: 
  
  
 
 
(1S,2S,3R)-3-(tert-Butyldimethylsilyloxy)cyclopentane-1,2-diol (2.75, Table 2.3, entry 
1): 
IR (neat, thin film): 3463 (br), 2953 (s), 2929 (s), 2857 (m), 1471 (w), 1254 (m), 1102 
(s), 1004 (w), 887 (w), 836 (s), 778 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 4.14 (1H, 
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q, J = 4.4 Hz), 3.98 (1H, dq, J = 8.4, 4.4 Hz), 3.75 (1H, dt, J = 7.2, 4.8 Hz), 2.96 (1H, d, J 
= 7.2 Hz), 2.67 (1H, d, J = 8.4 Hz), 1.88-1.82 (1H, m), 1.79-1.74 (1H, m), 0.91 (9H, s), 
0.114 (3H, s), 0.108 (3H, s). 13C NMR (CDCl3, 100 MHz): δ 73.90, 73.84, 72.84, 30.55, 
30.38, 26.05, 18.33, −4.40, −4.71. HRMS [M++H]: Calculated for C11H25O3Si: 233.1573; 
Found: 233.1569. Optical Rotation: [α]25D  −18.3 (c = 1.0, CHCl3). 
Compound 2.75 was derivatized to the corresponding bis-acetate. Enantiomeric 
purity was established by GLC analysis (Supelco Beta Dex 120 (30 m x 0.15 mm x 0.25 
µm film thickness), 118 oC hold 130 min, 25 psi.); chromatograms are illustrated below 
for a 96% ee sample: 
  
  
 
 
(1S,2S,3R)-3-(tert-Butyldimethylsilyloxy)cyclohexane-1,2-diol (2.76, Table 2.3, entry 
2): 
White solid.  MP: 73.5–75.2 °C. IR (neat, thin film): 3431 (br), 2930 (m), 2886 (w), 
2857 (m), 1471 (w), 1252 (m), 1110 (m), 1047 (s), 990 (m), 873 (m), 832 (s), 774 (s), 
665 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 3.92 (1H, m), 3.75 (1H, m), 3.57 (1H, m), 
3.08 (1H, br), 2.58 (1H, d, J = 6.4), 1.24-1.86 (6H, m), 0.91 (9H, s), 0.12 (3H, s), 0.09 
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(3H, s). 13C NMR (CDCl3, 100 MHz): δ 73.21, 72.20, 71.83, 30.51, 30.30, 26.03, 18.26, 
16.12, −4.51, −4.64. HRMS [M++H]: Calculated for C12H27O3Si: 247.1730; Found: 
247.1729. Optical Rotation: [α]20D  −13.4 (c = 1.5, CHCl3).  
 
Stereochemistry Proof: Compound 2.76 was derivatized to compound 
(3aR,4R,7aS)-2,2-dimethylhexahydrobenzo[d][1,3]dioxol-4-ol. Optical 
rotation: [α]20D  10.5 (c = 0.6, CHCl3). Previously reported optical 
rotation: [α]20D  10.8 (c = 1.0, CHCl3) for enantiopure (3aR,4R,7aS)- enantiomer.92 
 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 102 oC hold 300 min, 15 psi.); chromatograms are 
illustrated below for a >98% ee sample: 
  
  
 
 
                                                
92 S. K. Vadivel, S. Vardarajan, R. I. Duclos, Jr., J. T. Wood, J. Guo, A. Makriyannis. Bioorg. Med. Chem. 
Lett. 2007, 17, 5959–5963.  
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(1S,2S,3R)-3-(tert-Butyldimethylsilyloxy)cycloheptane-1,2-diol (2.77, Table 3, entry 
3): 
IR (neat, thin film): 3435 (br), 2928 (s), 2857 (m), 1462 (w), 1254 (m), 1071 (s), 1034 
(m), 1230 (w), 835 (s), 776 (s), 671 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 4.08 (1H, 
m), 3.88 (1H, m), 3.66 (1H, br), 3.10 (1H, d, J = 6.8 Hz), 2.73 (1H, d, J = 10.0 Hz), 1.9-
1.35 (8H, m), 0.92 (9H, s), 0.12 (3H, s), 0.09 (3H, s). 13C NMR (CDCl3, 125 MHz): 
δ 77.00, 75.82, 73.31, 31.97, 31.22, 26.03, 23.23, 21.76, 18.18, −4.57, −4.75. HRMS 
[M++H]: Calculated for C13H29O3Si: 261.1886; Found: 261.18960. Optical Rotation: 
[α]20D  −18.8 (c = 0.5, CHCl3). 
Compound 2.77 was derivatized to the corresponding acetonide. Enantiomeric 
purity was established by GLC analysis (Supelco Gamma Dex 120 (30 m x 0.15 mm x 
0.25 µm film thickness), 92 oC hold 210 min, 25 psi.); chromatograms are illustrated 
below for a >98% ee sample: 
 
 
 
 
  
 
 
(2S,3S,4R)-4-(tert-Butyldimethylsilyloxy)pentane-2,3-diol (2.78, Table 2.3, entry 4):  
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IR (neat, thin film): 3408 (br), 2956 (m), 2930 (m), 2887 (w), 2858 (m), 1471 (w), 1463 
(w), 1254 (m), 1088 (m), 1055 (m), 995 (m), 938 (w), 832 (s), 774 (s), 675 (w) cm-1. 1H 
NMR (CDCl3, 400 MHz): δ 3.96 (1H, dq, J = 5.2, 6.4 Hz), 3.84 (1H, quintet, J = 6.4 Hz), 
3.38 (1H, dd, J = 6.4, 5.2 Hz), 2.27 (1H, br), 2.03 (1H, br), 1.25 (3H, d, J = 6.4 Hz), 1.20 
(3H, d, J = 6.4 Hz), 0.89 (9H, s), 0.092 (3H, s), 0.086 (3H, s). 13C NMR (CDCl3, 100 
MHz): δ 78.656, 70.147, 68.658, 26.049, 19.441, 18.911, 18.241, −3.936, −4.645. 
HRMS [M++H]: Calculated for C11H27O3Si: 235.1730; Found: 245.1725. Optical 
Rotation: [α]20D  −15.5 (c = 1.0, CHCl3). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC, 2 oC/min, 15 psi.); chromatograms 
are illustrated below for a >98% ee sample: 
  
  
 
Enantioselective total syntheses of cleroindicins D, F, C 
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TBSCl, Imidazole
THF, 0 °C, 1 h
69% over 2 steps
CH3CN/H2O
0 °C, 20 min
OH
HO
2.80
OH
TBSO
O
OH
TBSO
2.82
PhI(OAc)2
2.81  
4-(2-(tert-Butyldimethylsilyloxy)ethyl)-4-hydroxycyclohexa-2,5-dienone (2.82, 
Scheme 2.20):  
To a mixture of 2-4-(2-hydroxyethyl)phenol 2.80 (1.52 g, 11 mmol) and imidazole (824 
mg, 12.1 mmol) in THF (5 mL) at 0 ºC was added a solution of TBSCl (1.82 g, 12.1 
mmol in 5 mL THF) dropwise. The mixture was allowed to stir at 0 ºC for 1 h before 
dilution with Et2O (50 mL) and aqueous 10% citric acid solution (30 mL). The mixture 
was partitioned and the organic layer was collected. The aqueous layer was washed with 
Et2O (50 mL x 2). The organic layers were combined and dried over anhydrous MgSO4. 
The mixture was filtered and solvent was removed in vacuo to yield a colorless oil (~ 3 
g). To a solution of the oil in THF (56 mL) and H2O (17 mL) at 0 ºC was added 
PhI(OAc)2 (4.25 g, 13.2 mmol) portionwise. The reaction turned to dark brown upon 
addition of PhI(OAc)2. After 20 min, the reaction was quenched by addition of saturated 
aqueous Na2SO3 solution (30 mL), and then washed with Et2O (100 mL x 3). The organic 
layer was dried over anhydrous MgSO4, filtered and solvent was removed in vacuo to 
yield a viscous yellow oil, which was purified by chromatography (10% Et2O/hexanes to 
Et2O, gradient) to yield desired product 2.82 as a pale yellow solid (2.04 g, 69% yield 
over 2 steps). MP: 52.4–53.6 °C. IR (neat, thin film): 3368 (br), 3177 (br), 2951 (m), 
2928 (m), 2856 (m), 1665 (s), 1612 (s), 1470 (w), 1397 (m), 1250 (m), 1083 (s), 1061 (s), 
1005 (m), 831 (s), 769 (s), 712 (m), 659 (m) cm-1.1H NMR (CDCl3, 400 MHz): δ 6.95 
(2H, d, J = 10.4 Hz), 6.12 (2H, d, J = 10.4 Hz), 4.43 (1H, br), 3.92 (2H, t, J = 6.0 Hz), 
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1.93 (2H, t, J = 6.0 Hz), 0.90 (9H, s), 0.0 (6H, s). 13C NMR (CDCl3, 100 MHz): 185.64, 
151.27, 127.52, 69.77, 60.79, 41.70, 26.02, 18.28, −5.34. HRMS [M++ H]: Calculated for 
C14H25O3Si: 269.1573; Found: 269.1568. 
 
O
OH
TBSO
O
OH
TBSO
O O
H2O2, K2CO3
THF/H2O, 0 °C, 6h
92% yield
dr > 20:1
2.82 2.83  
4-(2-(tert-Butyldimethylsilyloxy)ethyl)-4-hydroxycyclohexa-2,5-diepoxide (2.83, 
Scheme 2.20): 
To dienone 2.82 (900 mg, 3.36 mmol) in THF (28 mL) and H2O (25 mL) at 0 ºC was 
added H2O2 (30% in H2O, 3.8 mL, 34 mmol), followed by K2CO3 (3.7 g, 27 mmol). The 
mixture was stirred at 0 ºC for 4 h. The reaction was then quenched by addition of 
saturated aqueous Na2SO3 solution (20 mL), washed with EtOAc (50 mL x 4). The 
organic layer was dried over anhydrous MgSO4, filtered and solvent was removed in 
vacuo to yield the crude product as a pale yellow solid which was purified by 
chromatography (1:1 Et2O/hexanes) to yield desired product 2.83 as a white solid (930 
mg, 92% yield). MP: 70.0–71.6 °C. IR (neat, thin film): 3467 (s), 3030 (w), 2954 (m), 
2927 (m), 2884 (w), 2857 (s), 1702 (s), 1334 (w), 1254 (m), 1089 (m), 1072 (m), 1057 
(m), 924 (m), 833 (s), 771 (s) 726 (m), 508 (s) cm-1.1H NMR (CDCl3, 400 MHz): δ 3.88 
(2H, t, J = 5.6 Hz), 3.60 (1H, d, J = 4.0 Hz), 3.46 (2H, d, J = 4.0 Hz), 3.30 (1H, s), 2.01 
(2H, t, J = 5.6 Hz), 0.88 (9H, s), 0.06 (6H, s). 13C NMR (CDCl3, 100 MHz): δ 198.86, 
69.26, 64.40, 58.35, 57.24, 39.16, 26.14, 18.49, −5.25. HRMS [M++H]: Calculated for 
C14H25O3Si: 301.1471; Found: 301.1465. 
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40% over 2 steps
H2 (1 atm)
PtO2 (4 wt%)
EtOAc, 23 °C, 12 h
PPTS (10 mol %)
MeOH, 55 °C, 2 h
2.84  
2-(2-Hydroxyethyl)-5,5-dimethoxycyclohexane-1,2,3-triol (2.85, Scheme 2.20): 
To epoxide 2.83 (400 mg, 1.3 mmol) in EtOAc (13 mL) at 23 ºC was added PtO2 (16 mg, 
4 wt%). The reaction was allowed to stir at 23 ºC under a hydrogen balloon for 12 h. 
Solvent was removed and the crude reaction mixture was purified by chromatography 
(1:1 Et2O/EtOAc to EtOAc, gradient) to furnish triol 2.84 as a colorless oil (~200 mg). 
MeOH (2 mL) and pyridinium p-toluenesulfonate (17 mg) was added to the oil. The 
mixture was heated to 55 ºC for 2 h. Solvent was removed in vacuo and the crude 
reaction mixture was purified by silica gel chromatography (CH2Cl2 to 10% MeOH in 
CH2Cl2, gradient) to yield desired tetraol 2.85 as a white solid (125 mg, 40% yield over 2 
steps). MP: 124.0–126.0 °C. IR (neat, thin film): 3425 (br), 3238 (br), 2955 (w), 2943 
(w), 2903 (w), 1419 (w), 1334 (m), 1311 (m), 1241 (w), 1062 (m), 1025 (s), 993 (m), 948 
(s), 892 (w) cm-1. 1H NMR (CD3OD, 400 MHz): δ 3.70 (4H, m), 3.65 (2H, t, J = 4.8 Hz), 
3.43 (2H, dd, J = 12.0, 4.8 Hz), 3.18 (3H, s), 3.15 (3H, s), 2.02 (2H, m), 1.98 (2H, t, J = 
6.0 Hz), 1.72 (2H, t, J = 12.0 Hz). 13C NMR (CD3OD, 100 MHz): δ 100.32, 76.03, 
73.67, 70.70, 62.41, 58.83, 48.21, 38.79, 36.88. HRMS [M++Na]: Calculated for 
C10H20O6Na: 259.1158; Found: 259.1159. 
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TES-Ether (2.86, Scheme 2.21): 
Catalyst 1 (6 mg, 0.02 mmol) and the tetraol substrate 2.85 (24 mg, 0.1 mmol) were 
weighed into a 10 x 75 mm test tube. THF (110 µL) and DIPEA (43 µL, 0.25 mmol) 
were added with a Gilson Pipetman. The tube was capped with a septum, and the mixture 
was allowed to cool to –78 oC.  A solution of TESCl (42 µL, 0.225 mmol) in THF (58 
µL, total volume ~ 100 µL) was added to the test tube with a Gilson Pipetman.  The test 
tube was capped with a septum, wrapped with Teflon tape and the mixture was allowed 
to stir at –78 ºC for 48 h.  The reaction was quenched by addition of DIPEA (25 µL) and 
methanol (25 µL) at to –78 oC.  The mixture was allowed to warm to 23 oC. The crude 
reaction mixture was directly purified by silica gel chromatography (10% diethyl ether in 
hexanes to 1:1 diethyl ether:hexanes) to yield desired product 2.86 as a clear oil ( 39 mg, 
83% yield). IR (neat, thin film): 3462 (br), 2953 (m), 2911 (w), 2877 (m), 2829 (w), 
1458 (w), 1414 (w), 1238 (w), 1082 (m), 1048 (s), 1004 (m), 920 (w), 725 (s), 675(w) 
cm-1.  1H NMR (CDCl3, 400 MHz): δ 4.49 (1H, d, J = 4.4 Hz), 3.89 (1H, ddd, J = 11.2, 
9.2, 2.4 Hz), 3.71 (1H, m), 3.56 (2H, m), 3.21 (3H, s), 3.16 (3H, s), 2.43 (1H, s), 2.13 
(1H, m), 2.09 (1H, m), 1.99 (1H, m), 1.77 (2H, q, J = 12.0 Hz), 1.70 (1H, ddd, J = 14.8, 
8.8, 2.8 Hz), 0.97 (9H, t, J = 8.0 Hz), 0.96 (9H, t, J = 8.0 Hz), 0.64 (6H, q, J = 8.0 Hz), 
0.62 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 99.08, 75.07, 71.47, 69.97, 
58.91, 48.04, 47.98, 38.90, 36.43, 35.38, 7.16, 6.94, 5.38, 4.50. HRMS [M++Na]: 
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Calculated for C22H48O6NaSi2: 487.2887; Found: 487.2885. Optical Rotation: [α]20D 
+1.9 (c = 1.33, CHCl3). 
Compound 2.86 was derivatized to the corresponding mono benzoate. Enantiomeric 
purity was established by HPLC analysis (Chiralpak AS column (25 cm × 0.46 cm), 
99.5/0.5 hexanes/i-PrOH, 0.5 mL/min, 254 nm); chromatograms are illustrated below for 
a >98% ee sample: 
  
 
 
 
 
 
 
 
 
MsCl (2.5 eq), DIPEA (3.5 eq)
CH2Cl2, 0 °C to 22 °C, 12hOH
TESO
OMeMeO
HO OTES
2.86
OH
TESO
OMeMeO
MsO OTES
2.87  
Mesylate (2.87, Scheme 2.22): 
To TES-ether 2.86 (23 mg, 0.05 mmol) in CH2Cl2 (1 mL) at 0 ºC was added DIPEA (30 
µL, 0.175 mmol) followed by MsCl (10 µL, 0.125 mmol). The mixture was allowed to 
warm to 22 ºC and stir for 12 h upon which TLC analysis indicated complete conversion. 
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The crude reaction mixture was directly purified by silica gel chromatography (10% 
diethyl ether in hexanes to 1:1 diether ether : hexanes) to afford desired product 2.87 as a 
clear oil ( 25 mg, 92% yield).  IR (neat, thin film): 3521 (br), 2954 (s), 2911 (m), 2877 
(s), 1459 (w), 1414 (w), 1352 (m), 1328 (m), 1240 (w), 1173 (s), 1091 (s), 1051 (s), 1003 
(s), 969 (m), 947 (m), 876 (w), 850 (m), 796 (s) cm-1. 1H NMR (CDCl3, 400 MHz): δ 
4.69 (1H, dd, J = 12.0, 4.8 Hz), δ 3.84 (2H, t, J = 6.0 Hz), δ 3.75 (1H, dd, J = 11.6, 4.8 
Hz), 3.20 (3H, s), 3.18 (3H, s), 3.06 (1H, s), 2.40-2.34 (1H, m), 2.15 (1H, t, J = 12.0 Hz), 
2.07 (1H, q, J = 6.4 Hz), 2.02 (1H, m), 1.91 (1H, dt, J = 14.0, 6.0 Hz), 1.79 (1H, t, J = 
12.0 Hz), 0.97 (9H, t, J = 8.0 Hz), 0.96 (9H, t, J = 8.0 Hz), 0.64 (6H, q, J = 8.0 Hz), 0.62 
(6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 98.56, 80.33, 74.85, 70.53, 59.59, 
48.24, 48.11, 39.49, 36.69, 36.55, 34.07, 7.14, 7.0, 5.49, 4.43. HRMS [M++Na]: 
Calculated for C23H50O8NaSi2S: 565.2663; Found: 565.2639. Optical Rotation: [α]20D 
−4.9 (c = 0.4, CHCl3).  
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H
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cleroindicin D
HCl (1M in H2O, 5 eq)
THF/H2O
0 °C to 22 °C, 4 hOH
TESO
OMeMeO
MsO OTES
2.87  
 
Cleroindicin D (Scheme 2.22): 
To mesylate 2.87 (11 mg, 0.02 mmol) in THF (1 mL) and H2O (0.9 mL) at 0 ºC was 
added 1 M aqueous HCl solution (100 µL). The mixture was allowed to warm to 22 ºC 
and stir for 4 h after which, saturated aqueous NaHCO3 solution (2 mL) was added. The 
mixture was washed with EtOAc (5 mL x 3). The combined organic layers were dried 
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over anhydrous MgSO4, filtered and solvent was removed in vacuo to deliver a viscous 
yellow oil which was purified by chromatography (Et2O to 1:1 Et2O/EtOAc to EtOAC) to 
yield desired product cleroindicin D as a clear oil (1.5 mg, 45% yield). IR (neat, thin 
film): 3394 (br), 2881 (w), 1708 (s), 1398 (w), 1247 (w), 1051 (s), 1014 (m), 872 (w) cm-
1. 1H NMR (pyridine-d5, 400 MHz): δ 4.36 (2H, m), δ 3.99 (2H, m), 3.23 (1H, dd, J = 
16.8, 4.8 Hz), 3.02 (1H, dd, J = 16.8, 6.4 Hz), 2.87 (1H, dd, J = 16.8, 3.6 Hz), 2.84 (1H, 
dd, J = 16.8, 3.2 Hz), 2.28 (2H, m). 1H NMR (CDCl3, 400 MHz): δ 4.14 (1H, m), δ 4.01 
(2H, m), 3.91 (1H, q, J = 8.8 Hz), 2.87 (1H, dd, J = 16.8, 4.4 Hz), 2.61 (1H, dd, J = 16.8, 
5.6 Hz), 2.58 (2H, m), 2.14 (2H, m). 13C NMR (pyridine-d5, 100 MHz): δ 208.76, 84.36, 
79.55, 71.85, 67.10, 44.34, 43.20, 39.78. 13C NMR (CDCl3, 100 MHz): δ 207.08, 82.97, 
78.91, 71.28, 66.37, 42.53, 41.90, 39.07. HRMS [M++H]: Calculated for C8H13O4: 
173.0814; Found: 173.0811. Optical Rotation: [α]20D +26.3 (c = 0.095, MeOH); [α]20D 
+21.3 (c = 0.15, MeOH). 
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MsCl, DIPEA, CH2Cl2
0 °C to 22 °C, 16h
92% yield
cleroindicin D cleroindicin F  
Cleroindicin F (Scheme 2.24): 
To cleroindicin D (3.4 mg, 0.02 mmol) in CH2Cl2 (400 µL) at 0 ºC was added 
diisopropylethylamine (8 µL, 0.044 mmol), followed by addition of a solution of MsCl 
(1.9 µL, 0.024 mmol) in CH2Cl2 (100 µL). The mixture was stirred at 0 ºC for 16 h upon 
which TLC analysis indicated complete conversion. The crude reaction mixture was 
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directly purified by silica gel chromatography (Et2O to 1:1 Et2O/EtOAc to EtOAc) to 
afford desired product cleroindicin F as clear oil (2.8 mg, 92% yield). IR (neat, thin 
film): 3378 (br), 2956 (s), 2924 (s), 2854 (s), 1726 (w), 1688 (s), 1462 (m), 1377 (m), 
1261 (w), 1157 (w), 1069 (w) cm-1.  1H NMR (pyridine-d5, 400 MHz): δ 6.96  (1H, d, J = 
10.0 Hz), 6.17  (1H, d, J = 10.0 Hz), 4.52 (1H, t, J = 4.8 Hz), 4.07 (1H, m), 3.89 (1H, q, J 
= 8.0 Hz), 3.01 (1H, dd, J = 16.4, 4.0 Hz), 2.87 (1H, dd, J = 16.4, 4.8 Hz), 2.46 (1H, m), 
2.22 (1H, m).  1H NMR (CDCl3, 400 MHz): δ 6.75 (1H, dd, J = 10.4, 1.6 Hz), 6.03 (1H, 
d, J = 10.4 Hz), 4.25 (1H, ddd, J = 6.0, 4.8, 1.2 Hz), 4.08 (1H, dt, J = 6.4, 8.8 Hz), 3.96 
(1H, dt, J = 6.4, 8.8 Hz), 2.78 (1H, dd, J = 16.8, 4.8 Hz), 2.61 (1H, dd, J = 16.8, 6.0 Hz), 
2.33 (1H, ddd, J = 12.8, 8.0, 6.0 Hz), 2.23 (1H, ddd, J = 12.8, 8.0, 6.4 Hz), 2.10 (1H, br). 
13C NMR (pyridine-d5, 100 MHz): δ 197.42, 128.48, 82.49, 75.37, 66.89, 41.07, 40.87. 
13C NMR (CDCl3, 100 MHz): δ 196.49, 147.57, 129.19, 81.99, 76.09, 66.48, 40.51, 
39.89. HRMS [M++H]: Calculated for C8H11O3: 155.0708; Found: 155.0700. Optical 
Rotation: [α]20D  0 (c = 0.016, MeOH). 
Enantiomeric purity was established by GLC analysis (Supelco Beta Dex 120 (30 m 
x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC, 2 oC/min, 15 psi.); chromatograms 
are illustrated below for a >98% ee sample: 
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MeOH, 22 °C, 12 h
>98% yield
cleroindicin F cleroindicin C  
Cleroindicin C (Scheme 3): 
To cleroindicin F (1.5 mg, 0.01 mmol) in THF (400 µL) was added Pd/C (0.8 mg, 50 % 
wt). The mixture was stirred at 22 ºC under H2 (1 atm. involving a hydrogen balloon) for 
1 h. TLC indicated complete conversion. The crude reaction mixture was directly purified 
by silica gel chromatography (1:1 Et2O/EtOAc to EtOAC) to afford desired product 
cleroindicin C as clear oil (1.5 mg, >98% yield).  IR (neat, thin film): 3398 (br), 2919 
(m), 2872 (m), 1713 (s), 1647 (w), 1407 (m), 1337 (w), 111(w), 1062 (m), 995 (m) cm-1.  
1H NMR (pyridine-d5, 400 MHz): δ 4.29 (1H, t, J = 4.4 Hz), 3.94 (2H, m), 2.97 (1H, dd, 
J = 16.0, 4.4 Hz), 2.78 (1H, dd, J = 16.0, 4.0 Hz), 2.67 (1H, m), 2.36 (1H, m), 2.22 (2H, 
m), 2.07 (1H, m). 1H NMR (CDCl3, 400 MHz): δ 3.97 (2H, m), 3.88 (1H, dt, J = 7.6, 8.8 
Hz), 2.72 (1H, dd, J = 16.0, 4.8 Hz), 2.56 (1H, dd, J = 16.0, 4.8 Hz), 2.48 (1H, m), 2.28 
(1H, m), 2.11 (4H, m). 13C NMR (pyridine-d5, 100 MHz): δ 210.05, 85.03, 77.23, 66.71, 
43.53, 41.41, 36.28, 34.78. 13C NMR (CDCl3, 100 MHz): δ 209.38, 83.75, 77.95, 66.17, 
42.62, 40.91, 35.25, 33.72. HRMS [M++H]: Calculated for C8H13O3: 157.0865; Found: 
157.0862. Optical Rotation: [α]20D  25.9 (c = 0.082, MeOH). 
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Chapter 3 Kinetic Resolution of 4-Hydroxy-2-cyclopentenones through 
Catalytic Enantioselective Silylation 
3.1 Introduction and Background 
 As mentioned in chapter 2, catalytic enantioselective silylation has been applied 
to polyols, including diols,61,66 triols and tetraols.93 In these systems, it has been shown 
that vicinal hydroxy groups are necessary for reactivity as well as enantioselectivity. A 
useful advancement would be to extend this catalytic enantioselective protocol to 
substrates that do not possess multiple hydroxy groups. Hydroxyketones are a class of 
interesting substrates for enantioselective silylation; instead of having two H-bonding 
donors, there potentially exists a H-bonding donor and an H-bonding acceptor. 
Enantioselective silylation of hydroxyketones will also provide valuable information for 
mechanistic studies of enantioselective silylation reactions.  
 4-Hydroxy-2-cyclopentenones are important chiral building blocks for 
enantioselective preparation of natural product targets. Few catalytic enantioselective 
methods are available for synthesizing enantioenriched 4-hydroxy-2-cyclopentenones. 
Given these parameters, we decided to study kinetic resolution of 4-hydroxy-2-
cyclopentenones through catalytic enantioselective silylation.  
Synthetic Utility of 4-Hydroxy-2-cyclopentenones 
 Enantioenriched 4-hydroxy-2-cyclopentenones (Figure 1) have been extensively 
used in enantioselective synthesis. The three-component coupling method utilizing 3.1, 
pioneered by Noyori, has emerged as one of the most general and useful synthetic routes 
                                                
93 You, Z.; Hoveyda, A. H.; Snapper, M. L. Angew.Chem., Int. Ed. 2009, 48, 547–550. 
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to prostaglandins.94 Access to enantiomerically pure 4-hydroxy-2-cyclopentenone 3.1 
typically involves enzymatic desymmetrization of the corresponding cis-cyclopenten-1,3-
diol or diacetate.95 Substituted hydroxycyclopentenones in enantioenriched forms (3.2 
and 3.3 in Figure 3.1) are also used widely in total synthesis. The enantioselective 
preparation of erythronolide by Stork and co-workers96 and Tanis’s synthesis of (–)-
fastigilin97 clearly demonstrate the synthetic utility of these compounds. Due to the dearth 
of direct enantioselective methods, multi-step syntheses are usually required to prepare 
these compounds in enantioenriched fashion.98 Thus, development of a practical method 
for preparation of 4-hydroxy-2-cyclopentenones with good enantiomeric excess will be 
useful and will increase the efficiency of chemical syntheses.  
O
OH
O
OH
O
OH
Me
Me
Figure 3.1 4-Hydroxy-2-cyclopentenones
3.1 3.2 3.3  
Catalytic Enantioselective Methods Based on Desymmetrization for Preparing 4-
Hydroxy-2-cyclopentenone 
 There are a few examples of efficient syntheses of 4-hydroxy-2-cyclopentenone 
3.1 bearing different protecting groups forms using catalytic asymmetric protocols. Trost 
                                                
94 (a) Noyori, R.; Suzuki, M. Angew. Chem., Int. Ed. 1984, 23, 847−876. (b) Noyori, R. Asymmetric 
Catalysis in Organic Synthesis; Wiley, New York, 1994, pp 298–322. 
95 Deardorff, D.; Windham, C.; Craney, C. Org. Synth., 1998, Coll. Vol. 9, 487−492. 
96 Stork, G.; Paterson, I.; Lee, F. K. C. J. Am. Chem. Soc. 1982, 104, 4686−4688. 
97 Tanis, S. P.; Robinson, E. D.; McMills, M. C.; Watt, W. J. Am. Chem. Soc. 1992, 114, 8349-8362. 
98 (a) Preparation of enantioenriched 3.2 involving an asymmetric hydroboration followed by multi-step 
transformations, for reference, see: Partridge, J. J.; Chadha, N. K.; Uskokovic, M. R. J. Am. Chem. Soc. 
1973, 95, 532-540. (b) Preparation of enantioenriched 3.3 involving enzymatic resolution with low 
selectivity factor, for reference, see: Babiak, K. A.; Ng, J. S.; Dygos, J. H.; Weyker, C. L.; Wang, Y.-F.; 
Wong, C.-H. J. Org. Chem. 1990, 55, 3377−3381. 
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and co-workers developed a palladium-catalyzed enantioselective oxidation of allylic 
esters and carbonates.99 Sterically hindered nitronate 3.6 (Scheme 3.1) is used as a 
nucleophilic oxidant100 to minimize C-alkylation.101 In the presence of nitronate 3.6, 0.9 
mol % palladium source and 3 mol % of Trost ligand 3.7, allylic ester 3.4 can be 
selectively oxidized to benzoyl-protected 4-hydroxy-2-cyclopentenone 3.5 with 99% 
enantiomeric excess in 61% yield. 
OBz
OBz
Scheme 3.1 Palladium-catalyzed Enantioselective Oxidation of Allylic Esters
3.4
NH HN
O
Ph2P
O
PPh2
i-Pr
N
O
Ph
O
K
0.9 mol % [!3-C3H5PdCl]2
3 mol % 3.7
OBz
3.5
O
3.6
3.7
+
THF, 0.6 h
99% ee, 61%  
 Jacobsen and co-workers reported an efficient synthesis of enantioenriched 4-
hydroxy-2-cyclopentenone through a chromium-catalyzed enantioselective epoxide ring 
opening (Scheme 3.2).102 The enantioselective ring opening of meso epoxide 3.8 is 
effected by using salenCr(N3) complex 3.11 to afford azide 3.9. Basic alumina-promoted 
azide elimination followed by distillation under reduced pressure provide the desired 
TMS-protected 4-hydroxy-2-cyclopentenone 3.10 with 94% ee in 70% overall yield from 
epoxide 3.8. 
                                                
99 Trost, B. M.; Richardson, J.; Yong, K. J. Am. Chem. Soc. 2006, 128, 2540−2541. 
100 (a) Hass, H. B.; Bender, M. L. J. Am. Chem. Soc. 1949, 71, 1767−1769. (b) Hass, H. B.; Bender, M. L. 
Org. Synth. 1950, 30, 99−101. 
101 Trost, B. M.; Surivet, J.-P. Angew. Chem.; Int. Ed. 2000, 43, 3122−3124. 
102 Leighton, J. L.; Jacobsen, E. N. J. Org. Chem. 1996, 61, 389−390. 
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Scheme 3.2 Chromium-catalyzed Enantioselective Epoxide Ring Opening
O
O
+ TMSN3
O
TMSO N3
O
TMSO
3.8 3.9 3.10
N N
t-Bu
t-Bu
t-Bu
t-BuO O
Cr
N3
3.11
2 mol % 3.11
Et2O, !10 °C
Al2O3
CH2Cl2
94% ee
77% overall yield  
 More recently, Hoveyda, Snapper and co-workers developed a catalytic 
enantioselective silylation of meso diols using amino acid-based catalyst 3.15.61 Meso- 
1,3-diol 3.12 can be desymmetrized with TBSCl to afford silyl ether 3.13 with 87% ee in 
55% yield. Upon oxidation, the enantioenriched TBS ether of 4-hydroxy-2-
cyclopentenone 3.14 is obtained. Among all of the protected forms of 4-hydroxy-2-
cyclopentenone, TBS silyl ether 3.14 remains the most widely used in organic synthesis.  
Me
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t-Bu
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 (i-Pr)2EtN, THF
!78 °C, 48 h
20 mol %
3.15
Scheme 3.3 Desymmetrization of meso 1,3-diols through Catalytic Enantioselective Silylation
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 These catalytic enantioselective protocols for efficient preparation of 4-hydroxy-
2-cyclopentenone with good enantiomeric excess represent attractive alternatives to 
existing enzyme-base procedures. 
Catalytic Enantioselective Methods Based on Kinetic Resolution for Preparing 4-
Hydroxy-2-cyclopentenone 
 In Comparison to the great challenge presented in enantioselective preparation of 
4-hydroxy-2-cyclopentenone, the racemic form of the compound is readily available from 
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commercial sources. Under acidic conditions, furfuryl alcohol 3.16 rearranges to rac-3.1 
(eq. 3.1).103 The starting material is commercially available and inexpensive. The reaction 
proceeds well when scaled up. The product can be easily obtained through continuous 
extraction of the crude reaction mixture. Given the readily availability of rac-4-hydroxy-
2-cyclopentenone, kinetic resolution should present a potentially expeditious and efficient 
way to access such compounds in an enantioselective fashion.  
O
OH
H3PO4/KH2PO4
H2O, reflux
O
OH
$35/Kg, Aldrich (±)-3.1
3.16
(eq. 3.1)
 
 Due to the sensitivity and instability of rac-3.1 (retro aldol-aldol reaction leads to 
racemization and polymerization), catalytic kinetic resolution of this substrate turns out to 
be challenging. The only two examples, to date, were developed by Noyori and co-
workers. Cationic rhodium-BINAP complex 3.18 (Scheme 3.4) catalyzes isomerization 
of rac-4-hydroxy-2-cyclopentenone to 1,3-cyclopentanedione 3.17. 104  The starting 
material is recovered after trapping with TBSCl to afford a more stable and synthetically 
useful silyl ether 3.14 with 91% ee and 27% yield. The krel value of the enantioselective 
isomerization is 5. Noyori and co-workers pioneered the area of kinetic resolution of rac-
4-hydroxy-2-cyclopentenone. The limitation of this method is the reaction time (14 days) 
and the moderate enantioselectivity (krel =5). 
                                                
103 For a representative method for preparing racemic 4-hydroxy-2-cyclopentenones, see: Scettri, A.; 
Plancatelli, G.; D’Auria, M.; David, G. Tetrahedron, 1979, 35, 135−138. 
104 Kitamura, M.; Manabe, K.; Noyori, R.; Takaya, H. Tetrahedron Lett., 1987, 28, 4719− 4720. 
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Scheme 3.4 Rhodium-catalyzed Enantioselective Isomerization
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+
91% ee, 27%
krel = 5
0.5 mol %
THF, 0 °C, 14 days
(±)-3.1 3.17 (!)-3.14
3.18
 
 Later, Noyori and co-workers developed a ruthenium-BINAP catalyzed 
enantioselective hydrogenation of allylic alcohols.105 In the presence of 0.1 mol % of 
catalyst 3.20, rac-3.1 can be resolved with 98% ee and 32% isolated yield after TBS 
protection delivering a krel value of 11. 
Scheme 3.5 Ruthenium-catalyzed Enantioselective Hydrogenation
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P
P
Ph2
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OH
H2, MeOH, 30 °C
then TBSCl, DMAP
O
OTBS
O
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+
98% ee, 32%
krel = 11
O
O
O
O
0.1 mol %
(±)-3.1 (!)-3.143.19
3.20
 
 Catalytic kinetic resolutions pioneered by Noyori and co-workers demonstrate the 
power of such methods to obtain synthetically challenging chiral molecules from readily 
available racemic mixtures. Developing more enantioselective kinetic resolutions that are 
applicable to a broader range of 4-hydroxy-2-cyclopentenones will make the methods 
truly practical.  
                                                
105 Kitamura, M.; Kasahara, I.; Manabe, K.; Noyori, R.; Takaya, H. J. Org. Chem. 1988, 53, 708−710. 
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3.2 Catalyst Screen through Positional Scanning 
Initial Results 
We initiated our studies by studying the kinetic resolution of rac-4-hydroxy-2-
cyclopentenone 3.1 using the catalyst 3.15 found to be optimal for enantioselective 
silylation of cis-1,3-cyclopentenediol 3.12. As shown in Scheme 3.6, in the presence of 
10 mol % catalyst 3.15, product (–)-3.14 is obtained with 66% ee. The reaction proceeded 
with 5% conversion affording a krel value of 6.  
Me
N
N
N
H
O
H
N
t-Bu
Me
 (i-Pr)2EtN, THF
!78 °C, 48 h
20 mol %
3.15
Scheme 3.3 Desymmetrization of meso 1,3-diols through Catalytic Enantioselective Silylation
EtMe
3.12 3.13
+ TBSCl
87% ee, 55%
OH
OH
OTBS
OH
PCC
OTBS
O
3.14
 
The enantioselective excess of the recovered starting material (eersm) and ee of 
product (eeprod) were determined by chiral GLC analysis.  These results were used to 
calculate the conversion (c, eq 3.2) and krel value (eq 3.3) of the reaction based on the 
method developed by Kagan.106 
c = eersm / (eeprod + eersm)                                                                                     (eq 3.2) 
krel = ln[(1-c)(1-eersm)]/ln[(1-c)(1+eersm)] = ln[1-c(1+eeprod)]/ln[1-c(1-eeprod)]   (eq 3.3) 
 This encouraging initial finding indicates that kinetic resolution of 4-hydroxy-2-
cyclopentenone using amino acid-based catalyst is possible, however, with low 
conversion. By replacing TBSCl with the less sterically hindered TESCl, the catalytic 
                                                
106 Kagan, H. B.; Fiaud, J. C. Top. Stereochem. 1998, 18, 249-330. 
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reaction proceeds efficiently. For catalyst optimization through positional scanning 
discussed in the following section, TESCl is used instead of TBSCl.  
Catalyst Optimization: N-Terminus (Silaphilic Portion) 
 The catalyst was optimized through a position scanning strategy.107 The N-
terminus, which is the silaphilic portion of the catalyst to afford reactivity, was first 
investigated. A variety of iso-leucine derived catalysts with different Lewis basic 
functionalities were tested for kinetic resolution of rac-4-hydrox-2-cyclopentenone 3.1. 
R
N
H
O
H
N
t-Bu
Me
0.8 equiv (i-Pr)2EtN
THF, !78 °C, 1 h
10mol %
Table 3.1 N-Terminus Screen for Catalyst Optimization
EtMe
(±)-3.1
+ TESCl
O
OH OTES
O
(!)-3.1
O
OH
3.21
+
0.8 equiv
catalyst R eersm[%] eeprod[%] conv.[%] krel
N
R'
N
R' = Me
R' = Et
R' = Ph
N
R'
N
R' = Me
R' = H
N
NMe2
N
3.15
3.22
3.23
3.24
3.25
3.26
3.27
44
30
8
57
54
52
44
36
13
6
4
3
<2
<2
<2
<2
23
18
<2
<2
36 21 37 3
15 8 35 2
entry
1
2
3
4
5
6
7
 
                                                
107 Cole, B. M.; Shimizu, K. D.; Kruger, C. A.; Harrity, J. P. A.; Snapper, M. L. Hoveyda, A. H. Angew. 
Chem., Int. Ed. 1996, 35, 1668−1671. 
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 As illustrated in Table 3.1, enantioselective silylation is sensitive to the identity of 
the N-terminus of the catalyst. With 10 mol % N-methylimidazole-based catalyst 3.15 
and TESCl, the enantioselective silylation reaction proceeds with 44% conversion and a 
krel value of 6 (entry 1, Table 3.1). By simply changing the methyl on imidazole to an 
ethyl group to afford catalyst 3.22, both conversion and enantioselectivity drop (entry 2). 
Catalyst 3.23 bearing a phenyl group on the imidazole ring, changing both sterics and 
electronics of the catalyst, leads to poor reactivity and selectivity (entry 3). Catalyst 3.24, 
a constitutional isomer of 3.15, affords no enantioselectivity (entry 4). Catalyst 3.25 is 
also nonselective in the catalytic silylation (entry 5). The results in entries 4 and 5 clearly 
show that the position with which the imidazole ring is connected to the chiral amino 
acid-based side chain is essential for enantioselectivity of the kinetic resolution. Catalysts 
bearing other silaphilic groups such as DMAP 3.26 or pyridine 3.27 afford poor 
selectivity (entries 6 and 7). From the N-terminus screen, N-methylimidazole-derived 
catalyst turned out to be optimal affording promising reactivity and enantioselectivity. 
Catalyst Optimization: Amino Acid Portion 
 With the Lewis basic portion fixed as N-methylimidazole from the N-terminus 
study, catalysts incorporating different amino acids were tested in the kinetic resolution 
of rac-3.1. Catalyst incorporating proline as the amino acid moiety does not afford any 
conversion, which clearly indicates the importance of the secondary amine for catalysis. 
Results of amino acid screen are summarized in Table 3.2.  
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N
H
R
O
H
N
t-Bu
Me
1 equiv (i-Pr)2EtN
THF, !78 °C, 1 h
10mol %
Table 3.2 Amino Acid Screen for Catalyst Optimization
(±)-3.1
+ TESCl
O
OH OTES
O
(!)-3.1
O
OH
3.21
+
0.8 equiv
catalyst AA conv.[%] krel
i-Leu
allo-i-Leu
Leu
Val
Chg
Cha
Phg
Pha
1-Nal
2-Nal
3.15
3.28
3.29
3.30
3.31
3.32
3.33
3.34
3.35
3.36
44
44
36
34
42
28
54
46
56
50
6
5
4
4
6
4
6
5
6
6
entry
1
2
3
4
5
6
7
8
9
10
Me
N
N
catalyst AA conv.[%] krel
Tle
Thr(tBu)
Thr(Bn)
Thr(Trt)
allo-Thr(tBu)
Thr
Pen(Trt)
His(Trt)
Cys(Trt)
Asp(Trt)
3.37
3.38
3.39
3.40
3.41
3.42
3.43
3.44
3.45
3.46
41
52
42
46
52
44
39
32
28
32
9
13
8
10
4
4
9
4
4
5
entry
11
12
13
14
15
16
17
18
19
20  
 Iso-leucine-based diastereomeric catalysts 3.15 and 3.28 essentially afford the 
same reactivity and selectivity (entries 1 and 2 in Table 3.2). Fine tuning the sterics of the 
catalyst, such as incorporating leucine 3.29, valine 3.30, cyclohexylglycine 3.31 or 
cyclohexylalanine 3.32 does not lead to significant improvement (entries 3 to 6). Phenyl-
substituted or naphthyl-substituted amino acid-based catalysts (3.33 to 3.36) also promote 
the kinetic resolution with moderate selectivity (entries 7 to 10).  
 When the catalyst bears a bulky tert-leucine 3.37, the enantioselectivity of the 
reaction is improved and krel value of 9 is obtained (entry 11). This finding suggests that a 
sterically hindered amino acid is beneficial to enantioselectivity, leading us to investigate 
more amino acids with sterically demanding substituents. Protected threonines are also 
sterically encumbered and with a big extension in the three dimensional structure. O-tert-
Butyltheonine, O-benzylthreonine and O-tritylthreonine derived catalysts 3.38, 3.39 and 
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3.40 were tested in the kinetic resolution, 3.38 affords 52% conversion with a 
synthetically useful krel value of 13 (entries 12 to 14). Generally, a krel value greater than 
10 is considered to be synthetically useful.54 The stereogenic center in the O-tert-
butylthreonine might be responsible for this significant improvement in 
enantioselectivity. Diastereomeric catalyst 3.41 was tested, however, much lower 
selectivity was observed (krel=5, entry 15). This result shows that catalyst 3.38 is the 
matched case for the kinetic resolution while catalyst 3.41 is mismatched. Without a 
sterically demanding protecting group on the hydroxy group, threonine derived catalyst 
3.42 affords low selectivity (krel=4, entry 16). Catalyst with a bulky S-tritylpenicillamine 
3.43 promotes the kinetic resolution with a krel value of 9 (entry 17).  
 Finally, catalysts derived from amino acids with functionalized side chains such 
as cysteine, various protected histidines and aspartic acid prove to be inferior to O-tert-
butylthreonine-based catalyst 3.38 (entries 18 to 20).  
Catalyst Optimization: C-Terminus 
 With N-methylimidazole and O-tert-butylthreonine as fixed portion of the catalyst 
structure, C-terminus optimization was carried out. Various chiral and achiral amines 
with steric as well as electronic differences were examined. Diastereomeric catalysts 3.38 
and 3.48 afford krel values of 14 and 7, respectively (entries 1 and 2, Table 3.3). Thus, 
catalyst 3.38 is the matched case. Catalysts with phenyl substituted chiral amines 3.49 
and 3.50, with electron withdrawing chloro group 3.51 and 3.52, or with electron 
donating methoxy group 3.53 and 3.54 do not afford any improvement in the catalytic 
kinetic resolution (entries 3 to 8). Aniline derived catalysts 3.55, 3.56 and 3.57 were also 
tested (entries 9 to 11). With an electron withdrawing CF3 group on the aniline, the 
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catalyst promotes the kinetic resolution with similar levels of efficiency and 
enantioselectivity (44% conversion with a krel value 13). Achiral amine derived catalyst 
3.58 affords moderate selectivity (entry 12). From the C-terminus screen, a catalyst more 
efficient and enantioselective than 3.38 was not identified. 
N
H
O
1 equiv (i-Pr)2EtN
THF, !78 °C, 1 h
10mol %
Table 3.3 C-Terminus Screen for Catalyst Optimization
(±)-3.1
+ TESCl
O
OH OTES
O
(!)-3.1
O
OH
3.21
+
0.8 equiv
catalyst R conv.[%] krelentry
Me
N
N
catalyst R conv.[%] krelentry
Ot-BuMe
H
N
t-Bu
Me
H
N
t-Bu
Me
R
H
N
Ph
Me
H
N
Ph
Me
H
N
p-ClPh
Me
H
N
p-ClPh
Me
H
N
p-OMePh
Me
H
N
p-OMePh
Me
H
N
Ph
H
N
p-CF3Ph
H
N
p-OMePh
H
N
t-Bu
t-Bu
1
2
3
4
5
6
3.38
3.48
3.49
3.50
3.51
3.52
7
8
9
10
11
12
3.53
3.54
3.55
3.56
3.57
3.58
14
7
8
12
7
8
11
11
10
13
12
8
31
34
37
44
33
43
53
52
49
46
41
38
 
 With systematically optimized catalyst 3.38, other parameters of the reaction were 
also studied.  
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3.3 Reaction Condition Optimization 
Effect of Silylating Reagent 
 As mentioned briefly in the sections above, the size of the silylating reagents 
effects the outcome of enantioselective silylation of rac-4-hydroxy-2-cyclopentenone 3.1. 
We systematically studied the effect of silyl chlorides with different substituents for the 
kinetic resolution.  
N
H
O
H
N
t-Bu
Me
1 equiv (i-Pr)2EtN
THF, !78 °C, 12 h
10mol %
Table 3.4 Silylating Reagents Study
Ot-BuMe
(±)-3.1
+ R1R2R3SiCl
O
OH OSiR1R2R3
O
(!)-3.1
O
OH
+
0.8 equiv
R1R2R3SiCl eersm[%] eeprod[%] conv.[%] krelentry
Me
N
N
3.38
R1=R2=Me, R3=t-Bu
R1=R2=Me, R3=Cy
R1=R2=Me, R3=i-Pr
R1=R2=Me, R3=n-Bu
R1=R2=R3=Et
R1=R2=R3=n-Pr
1
2
3
4
5
6
<5
50
52
61
92
79
80
60
42
41
62
45
5
45
55
60
64
60
9
6
4
4
14
6  
 Using bulky TBSCl, the kinetic resolution proceeds with 5% conversion with a 
krel value of 9 (entry 1 in Table 3.4). Increasing the temperature causes a drop in 
enantioselectivity. As the size of the silyl chlorides decreases (from tert-butyl to 
cyclohexyl, iso-propyl and n-butyl), the conversion of the reaction increases but 
enantioselectivity drops significantly (entries 2 to 4). Triethylsilyl chloride (TESCl) 
affords significantly better results; starting material (−)-3.1 can be obtained in 92% ee 
giving a krel value of 14 (entry 5). Further increasing the triethyl substituents to tri-n-
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propyl units, the enantioselectivity drops (entry 6). The silylating reagent study revealed 
that the enantioselective silylation reaction is sensitive to the size of silylating reagents. 
TESCl is the optimal reagent for kinetic resolution of rac-3.1.  
Solvent Effect 
 A variety of solvents were evaluated for catalytic kinetic resolution of rac-4-
hydroxy-2-cyclopentenone 3.1. Results are illustrated in Table 3.5. Compared to the 
reaction inTHF, reactions in diethyl ether and tert-butyl methyl ether are much less 
enantioselective (entries 2 and 3). Use of ethyl acetate also proves to be not as selective 
as THF (entry 4). Performing reactions in methylene chloride, toluene and hexanes 
affords poor enantioselectivies (entries 5 to 7).  
N
H
O
H
N
t-Bu
Me
1 equiv (i-Pr)2EtN
solvent, !78 °C, 4 h
10mol %
Table 3.5 Solvent Effect Study
Ot-BuMe
(±)-3.1
+ TESCl
O
OH OTES
O
(!)-3.1
O
OH
+
0.8 equiv
Me
N
N
3.38
3.21
solvent conv.[%] krel
THF
Et2O
t-BuOMe
EtOAc
55
52
52
52
12
4
6
9
entry
1
2
3
4
solvent conv.[%] krel
CH2Cl2
toluene
hexanes
56
68
41
3
<2
3
entry
5
6
7
 
 Other parameters of the reaction including temperature, bases and ratio of 
reagents were also optimized. It was found that carrying out the reactions at –78 ºC with 
0.8 equivalent TESCl and 1 equivalent (i-Pr)2EtN were the optimal conditions for the 
catalytic kinetic resolution of rac-3.1. 
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Catalyst Loading and Reaction Time Study 
 For catalyst and reaction condition optimization, 10 mol % catalyst loading was 
used. In the presence of optimized catalyst 3.38, TESCl and (i-Pr)2EtN in THF at –78 ºC, 
catalyst loading and reaction time were also studied for the enantioselective silylation 
reaction.  
catalyst 3.38 [mol %] eersm[%] eeprod[%] conv.[%] krelentry
2
1
0.5
0.1
0.05
0.01
1
2
3
4
5
6
91
90
76
80
70
20
62
63
70
66
71
70
60
59
53
55
50
20
14
13
13
12
12
7
reaction time [h]
1
1
3
10
10
20
Table 3.6 Catalyst Loading and Reaction Time Study
 
 It is noteworthy, especially considering the catalyst loading in our earlier studies 
of enantioselective silylation of diols and polyols,61,66,93 that catalyst loading in these 
kinetic resolutions can be lowered to 0.05 mol % without adversely affecting the krel 
value (entry 5, Table 3.6, with 0.05 mol % catalyst, krel=12,). With 2 mol % of catalyst 
3.38, the kinetic resolution reaction proceeds with 62% conversion in 1 hour, recovered 
starting material can be obtained in 91% ee with a krel value of 14 (entry 1). Catalyst 3.38 
promotes kinetic resolution of rac-4-hydrxoy-2-cyclopentenone 3.1 with great efficiency. 
Such low catalyst loading is rare in organocatalytic reactions. 108  In contrast, 
enantioselective silylation reactions of substrates possessing multiple hydroxy groups 
                                                
108 For selected recent examples of enantioselective organocatalysis with catalyst loading lower than 1 mol 
%, see: (a) Vachal, P.; Jacobsen, E. N. J. Am. Chem. Soc. 2002, 124, 10012−10014. (b) Saaby, S.; Bella, 
M.; Jørgensen, K. J. Am. Chem. Soc. 2004, 126, 8120−8121. (c) Shirakawa, S.; Yamamoto, K.; Kitamura, 
M.; Ooi, T.; Maruoka, K. Angew. Chem., Int. Ed. 2005, 44, 625−628. (d) Kitamura, M.; Shirakawa, S.; 
Maruoka, K. Angew. Chem., Int. Ed. 2005, 44, 1549−1551. (e) Ooi, T.; Takada, S.; Doda, K.; Maruoka, K. 
Angew. Chem., Int. Ed. 2006, 45, 7606−7608. (f) Terada, M.; Machioka, K.; Sorimachi, K. Angew. Chem., 
Int. Ed. 2006, 45, 2254−2257. (g) Terada, M.; Nakano, M.; Ube, H. J. Am. Chem. Soc. 2006, 128, 
16044−16045. (h) He, M.; Uc, G.; Bode, J. J. Am. Chem. Soc. 2006, 128, 15088−15089. (i) Liu, T.; Cui, 
H.; Long, J.; Li, B.; Wu, Y.; Ding, L.; Chen, Y. J. Am. Chem. Soc. 2007, 129, 1878−1879. 
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usually requires 20 to 30 mol % catalyst loading and 3 to 5 days. This finding suggests 
that enantioselective silylation of hydroxyketones may proceed through a distinct 
mechanism. Detailed studies will be discussed in mechanistic study section. 
Racemization Problem of Recovered 4-Hydroxy-2-cyclopentenone during Purification 
 With optimized catalyst and reaction conditions, a krel value of 14 can be achieved 
for the kinetic resolution of rac-4-hydroxy-2-cyclopentenone; starting material is 
enantioenriched with 91% ee (entry 1 in Table 3.7). However, upon purification to 
separate the remaining starting material (−)-3.1 from the product 3.21, the recovered 
starting material (−)-3.1 is racemized to 67% ee while the product 3.21 maintained the 
same enantiomeric purity (entry 2). This racemization problem could be due to trace 
desilylation of TES ether 3.21 upon purification using silica gel chromatography. Thus, 
instead of using slightly acidic silica gel, base-washed silica gel, neutral alumina and 
basic alumina were also tested. These attempts did not resolve the racemization problem. 
Recovered starting material (−)-3.1 continued to racemize to a certain extent during 
purification. Another suspected cause of the racemization could be the thermal instability 
of 4-hydroxy-2-cyclopentenone.109 Derivatization of the remaining starting material to a 
more stable compound should solve this problem.  
                                                
109 4-Hydroxy-2-cyclopentenones are sensitive compounds, they are easy to racemize and polymerize. In 
kinetic resolutions developed by Noyori and co-workers, they derivatized the 4-hydroxy-2-cyclopentenones 
to a TBS ether before isolation.  
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N
H
O
H
N
t-Bu
Me
1 equiv (i-Pr)2EtN
THF, !78 °C, 1 h
2 % mol %
Table 3.7 Racemization of Recovered Starting Material Upon Purification
Ot-BuMe
(±)-3.1
+ TESCl
O
OH OTES
O
(!)-3.1
O
OH
+
0.8 equiv
Me
N
N
3.38
3.21
reaction time conv.[%]
1 h
after purification
60
entry
1
2
ee of 3.21 [%] krel
62
62
14
ee of (!)-3.1 [%]
91
67  
 To derivatize the remaining 4-hydroxy-2-cyclopentenone, acetate 3.59 (eq. 3.4) 
was formed. We chose an acetate group, since the acetate protection is fast and the 
resulting acetate 3.59 is easily separated from silyl ether 3.21. As shown in eq. 3.2, the 
derivatized 4-hydroxy-2-cyclopentenone 3.59 can be isolated with 91% ee in 34% yield. 
N
H
Me
N
N
Me Ot-Bu
H
N
O
Me
t-Bu
2 mol %
2. Ac2O/Py, DMAP, 
CH2Cl2, 23 °C, 1 h
1. TESCl, DIPEA, THF, !78 °C
3.38
(±)-3.1
O
OH OTES
O
3.59
O
OAc
+
3.21
91% ee, 34% 62% ee, 60%
60% conv., krel=14
(eq. 3.2)
 
3.4 Substrate Scope of Kinetic Resolution of 4-hydroxy-2-cyclopentenones through 
Enantioselective Silylation 
Substrates of 4-Hydroxy-2-cyclopentenones  
 As illustrated in Table 3.8, a variety of 4-hydroxy-2-cyclopentenones can be 
resolved with 2 mol % catalyst loading with synthetically useful levels of selectivity (krel 
≥ 10). Kinetic resolution of rac-3.1 proceeds with 60% conversion in 1 h, subsequent 
acylation delivering 3.59 with 91% ee and 34% isolated yield (krel = 14) (entry 1 in Table 
3.8). Substituted 4-hydroxy-2-cyclopentenones, such as rac-3.2 and rac-3.3, can also be 
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efficiently resolved; compounds 3.66 and 3.67 can be obtained with 94% ee and 95% ee, 
respectively (entries 2 and 3). The enantioselective silylation is extremely sensitive to 
sterics of the substrates. With a methyl substituent at the 5 position cis to the hydroxy 
group, substrate rac-3.60 undergoes kinetic solution with lower selectivity (krel = 7, entry 
4). Other substitutions at the 5-position, such as R3 = Et or allyl group, afford lower 
selectivities (krel = 8 and 9, respectively, entries 5 and 6).  Incorporating substitution other 
than a methyl group at the 2-position (R1=Et or allyl) leads to less enantioselective kinetic 
resolutions (krel = 4-6 versus krel = 14, entries 7 and 8).  
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N
H
Me
N
N
Me Ot-Bu
H
N
O
Me
t-Bu
2 mol %
2. Ac2O/Py, DMAP, 
CH2Cl2, 23 °C, 2 h
1
2
3
4
5
6
7
8
9
unreacted 
hydroxyketone
60
63
59
64
69
63
66
68
41
3.59 91; 34
3.66 94; 34
3.67 95; 36
3.68 82, 34
3.69 80; 39
3.70 92; 30
3.71 70; 31
3.72 83; 31
3.73 31; 41
14
13
14
7
9
8
4
6
3
1
4
5
2
6
1
6
6
2
+
1. TESCl, DIPEA, THF, !78 °C
3.21 62; 60
3.74 58; 58
3.75 57; 60
3.76 47, 55
3.77 57; 59
3.78 42; 66
3.79 36; 62
3.80 39; 63
3.81 44; 26
reaction
time [h]
Table 3.8 Kinetic Resolution of 4-Hydroxy-2-cyclopentenones through Catalytic Enantioselective Silylation
conv. [%]entry
eersm [%]
yield [%]
eeprod [%]
yield [%]
krel
O
R1 R2
OH O
R1 R2
R3
OAc O
R1 R2
OTES
R3 R3
O OH
O OH
Me
O OH
Et
O OH
Allyl
O OH
Me
O OH
Et
O OH
Allyl
O OH
Me
(!)-3.1
(!)-3.2
(!)-3.3
3.60
3.61
3.62
3.63
3.64
3.65
3.38
(±)-3.1!(±)-3.3
(±)-3.60!(±)-3.65
3.59
3.66!3.73
3.21
3.74!3.81
O OH
Me
 
 The kinetic resolution of a 4-hydroxy-2-cyclopentenone bearing substitution at 
the 3-position (rac-3.65) gives poor selectivity (R2 = Me, krel = 3, entry 9). We 
hypothesize that substitution at the 3-position results in a disfavored steric interaction 
with the nucleophilic moiety of the catalyst-silicon complex (a hypervalent silicon 
complex), which accounts for the low selectivity and reactivity. 
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 As shown in Table 3.6, kinetic resolution can be performed with catalyst loading 
as low as below 0.1 mol %. Racemic substrates can be resolved on a gram-scale with 
only 0.08 mol % catalyst loading (i.e. < 3 mg of 3.38) with reactions set up in air on the 
bench top.  The examples in eq. 3.3 and eq. 3.4 are representative.  The synthetically 
valuable TES ethers 3.21 and 3.74 can be obtained in useful yields and enantiomeric 
purities.  
O
OH
0.08 mol % 3.38
+ TESCl
0.5 equiv 0.75 equiv (i-Pr)2EtN
THF, !78 °C, 3 h
40% conv.; krel = 16
O
OTES
(±)-3.1
1g 81% ee, 39%
3.21
(eq. 3.3)
O
OH
0.08 mol % 3.38
+ TESCl
0.5 equiv 0.75 equiv (i-Pr)2EtN
THF, !78 °C, 12 h
41% conv.; krel = 16
O
OTES
(±)-3.2
1g 80% ee, 41%
3.74
(eq. 3.4)Me Me
 
Substrates of Acyclic β-Hydroxyketones 
 In addition to 4-hydroxy-2-cyclopentenones, acyclic β−hydroxyketones can also 
be catalytically resolved with moderate enantioselectivities. Catalyst and reaction 
conditions were also optimized for acyclic β−hydroxyketones. Catalyst 3.38 remained the 
optimal catalyst for kinetic resolution of this class of substrates. As illustrated in Table 
3.9, rac-3.82 can be catalytically resolved with a krel value of 7; enantioenriched 3.82 can 
be recovered in 84% ee (entry 1). Additional steric bias on either side of the acyclic 
β−hydroxyketones does not improve the selectivity of this kinetic resolution (entries 2 
and 3). 
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N
H
Me
N
N
Me Ot-Bu
H
N
O
Me
t-Bu
2 mol %
1
2
3
unreacted 
hydroxyketone
65
54
27
84; 27
68; 41
22; 57
7
7
5
4
4
4
+
1 equiv (i-Pr)2EtN
THF, !78 °C
3.85 47; 60
3.86 57; 50
3.87 59; 22
reaction
time [h]
Table 3.9 Kinetic Resolution of Acyclic "-Hydroxyketones through Catalytic Enantioselective Silylation
conv. [%]entry
eersm [%]
yield [%]
eeprod [%]
yield [%]
krel
3.82
3.83
3.84
3.38
(±)-3.82!(±)-3.84 3.82!3.84 3.85!3.87
R2 R1
OOH
R2 R1
OOH
R2 R1
OTESO
+ TESCl
0.8 equiv
Me Me
OOH
Me Et
OOH
n-Pr Me
OOH
 
3.5 Limitations of the Methodology and Failed Substrates 
 The current limitations of the substrate scope of the catalytic kinetic resolution are 
summarized below.  
Scheme 3.7 Limitations of the Current Methodology: Sensitivity to Sterics
O
Me
OH
59% conv.; krel=14
O
Allyl
OH
68% conv.; krel=6
O
i-Pr
OH
O
Ph
OH
30% conv.; krel=4 10% conv.; krel=4
(±)-3.3 (±)-3.64 (±)-3.88 (±)-3.89
O
OH
63% conv.; krel=13
O
OH
64% conv.; krel=7
O
OH
30% conv.; krel=4
(±)-3.2 (±)-3.60 (±)-3.90
Me Me
Me
Me
O
OH
(±)-3.65
Me
41% conv.; krel=3  
 The reaction is sensitive to steric modification of substrates. As illustrated in 
Scheme 3.7, methyl-substituted substrate rac-3.3 undergoes enantioselective silylation 
with good reactivity and enantioselectivity (59% conv.; krel=14). As the size of the 
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substituent at the 2-position is increased to an allyl group (rac-3.64), the 
enantioselectivity drops (krel=6). For the substrate bearing a more sterically demanding 
iso-propyl (rac-3.88) or phenyl group (rac-3.89), both reactivity and enantioselectivity of 
the kinetic resolution suffer (krel=4).  
 Enantioselective silylation of rac-3.2 proceeds with 63% conversion and a krel 
value of 14. Diastereomeric compound rac-3.60 with methyl the substituent cis to the 
hydroxy group undergoes kinetic resolution with lower enantioselectivity (krel=7). With 
gem-dimethyl substitution at the 5 position (rac-3.90), the kinetic resolution is inefficient. 
Enantioselective silylation of rac-3.65 with a methyl group at the 3 position proceeds 
with poor enantioselectivity (krel=3). 
 We hypothesized that bulky substituent on the ring causes the substrate-catalyst 
interaction to become less available due to disfavored steric interactions.  
 The catalytic kinetic resolution is also sensitive to electronic modifications. 
Substrates rac-3.91 (Figure 3.1) and rac-3.92, with an electronically withdrawing bromo 
group at the 2 or 3 positions, undergo enantioselective silylation with inferior conversions 
and selectivities (krel=5 and 4, respectively).  
Figure 3.2 Electronically Modified Substrates
O
Br
OH
O
OH
Br
21% conv.; krel=5 14% conv.; krel=4
(±)-3.91 (±)-3.92
 
 We hypothesized that the electron withdrawing group changes the electronics of 
the carbonyl group of the 4-hydroxy-2-cyclopentenones, thus effecting the substrate-
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catalyst association. These findings are mechanistically telling and might be useful for 
elucidating a reasonable transition state model.  
3.6 Mechanistic Study 
 Mechanistically, kinetic resolution of 4-hydroxy-2-cyclopentenones through 
catalytic enantioselective silylation is interesting. As shown in eq. 3.5, silylation of rac-4-
hydroxy-2-cyclopentenone 3.1 proceeds to 60% conversion with only 2 mol % catalyst 
3.38 within 1 hour at –78 ºC with good enantioselectivity (krel=14). Even when the 
catalyst loading is lowered to 0.05 mol %, 50% conversion is achieved in 10 hours and 
the silylation maintains the same selectivity. This finding of rate acceleration suggests 
that when the necessary structural requirements are met, catalytic enantioselective 
silylation can proceed with exceptional level of efficiency. Furthermore, comparison to 
an authentic sample,110 it was shown that the R enantiomer of β-hydroxyketones gets 
preferentially silylated over the S enantiomer. 
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Me Ot-Bu
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+
TESCl, (i-Pr)2EtN
THF, !78 °C, 1 h
O
OH
O
OTES
O
OH
RS
60% conv.; krel = 14
3.38
(±)-3.1 (!)-3.1 3.21
(eq. 3.5)
with 0.05 mol % 3.38, 50% conv. in 10 h, krel = 14  
  The silylation of hydroxyketone rac-3.1 is much faster and more efficient than 
that of the corresponding cis-cyclopenten-1,3-diol 3.12, which requires 20 mol % catalyst 
loading and 5 days at –78 ºC (eq. 3.6). The pro-S stereogenic center gets silylated over 
the pro-R stereogenic center. The dramatic differences between the enantioselective 
                                                
110 Mandai, T.; Matsumoto, S.; Kohama, M.; Kawada, M.; Tsuji, J. J. Org. Chem. 1990, 55, 5671−5673. 
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silylations of two classes of substrates suggest that, the two transformations may go 
through distinct mechanisms. 
OTBS
OH
S
R
OH
OH
S
R
N
H
Me
N
N
t-Bu
H
N
O
Me
t-Bu
20 mol %
TBSCl, (i-Pr)2EtN
THF, !78 °C, 120 h
81% ee, 54%
3.37
3.12 3.13
(eq. 3.6)
 
 Catalysts with modified structures were also tested for enantioselective silylation 
of β-hydroxyketones. Results are summarized in Scheme 3.8. Catalyst 3.37 containing a 
secondary amine and amide promotes the kinetic resolution with 48% conversion and a 
krel value of 9. Catalysts with a tertiary amine 3.93, an imine 3.94 and an amide 3.95 in 
place of the secondary amine fail to promote the silylation. These results clearly illustrate 
the importance of the secondary amine to afford reactivity. With a methylated amide, 
catalyst 3.96 affords much lower conversion and enantioselectivity (18% conv.; krel=5). 
Catalyst 3.97, which incorporates an ester at the C-terminus, is inactive. These findings 
indicate that the secondary amide is also critical for a positive reaction outcome.  
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 Extensive modeling studies [Merck Molecular Force Field (MMFF94) in Spartan 
‘04]111 have been carried out to elucidate the reaction mechanism. If we assume that the 
association between the β-hydroxyketones and the catalyst involves H-bonding, 
according to modeling calculations, one possible transition state model I is shown in 
Figure 3.3. One enantiomer of the β-hydrxoyketone preferentially interacts with the 
chiral catalyst through H-bonding; the ketone of the substrate serves as H-bonding 
acceptor from the amide of the catalyst, while the hydroxy group serves as H-bonding 
donor to the secondary amine of the catalyst. The N-methylimidazole moiety activates 
TESCl resulting in silylation of the R enantiomer over the S enantiomer. The Si−O 
distance is 1.9 Å. The transition state model I is consistent with the limitations of the 
substrate scope. Since the double bond is facing towards the catalyst chiral backbone 
while the methylene unit is pointing away from the catalyst, any large substituents at the 
                                                
111 Halgren, T. A. J. Comp. Chem. 1996, 17, 490−519. 
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R1 position (3.88 and 3.89 in Scheme 3.7) would have disfavored steric interactions with 
the amino acid chiral backbone of the catalyst. Subsituents at the R2 position (3.65 in 
Scheme 3.7) would have disfavored interactions with not only the backbone of the 
catalyst but also the bulky activated silicon species. With electron withdrawing groups at 
either the R1 or R2 position (3.91 and 3.92 in Figure 4.2), silylation proceeds with low 
conversion and poor enantioselectivity. The reason might be that the H-bonding between 
electron deficient ketone of the substrate and the amide of the catalyst becomes less 
available.  
 For enantioselective silylation of diols, the proposed transition state II is shown in 
Figure 3.3. The calculated Si–O distance is about 3.2 Å. In comparison with the Si–O 
distance of I (1.9 Å), this distance might be too long for efficient silylation of diols. 
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Figure 3.3 Proposed Transition State Models for Enantioselective Silylations
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 In transition state I, that substrate-catalyst interaction was assumed to proceed 
through H-bonding. This does not explain the key differences between silylation of β-
hydroxyketones and diols. The reason for which the two transformations give the 
opposite sense of enantioselectivity, and the dramatic difference in catalyst loading and 
reaction rate are not clear. With such a flexible catalyst, the distance between silicon and 
oxygen is not fixed during the causee of the reaction. Simple comparison of the 
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calculated silicon oxygen distance of the two proposed transition states might be 
inaccurate. Given these considerations, it might be possible that catalytic enantioselective 
silylation of β-hydroxyketones proceeds through a completely different mechanism, 
meaning that substrate-catalyst association can occur through interactions other than H-
bonding. Detailed mechanistic studies need to be carried out for further understanding of 
the transformation. 
 In the proposed transition state II (Figure 3.3) of enantioselective silylation of 
diols, the calculated Si–O distance is about 3.2 Å. As illustrated in Figure 3.4, catalysts 
with an extended tether reduce the Si–O distance between silicon and oxygen atoms to 
around 1.9 Å, which is significantly shorter than the distance in II. The calculated change 
of distance in the transition state might be critical to the efficiency of the silylation 
reactions. Testing catalysts with extended tethers (3.95−3 .99) will tell us whether the Si–
O distance is the key factor in determining the rate of silylation reactions. 
Figure 3.4 Catalysts with Extended Tether for Higher Reactivity
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3.7 Summary 
 In conclusion, we have developed a kinetic resolution of β-hydroxyketones 
through catalytic enantioselective silylation. A variety of 4-hydroxy-2-cyclopentenones, 
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as well as acyclic β-hydroxyketones can be catalytically resolved with high efficiency. 
Low catalyst loading (<0.1 mol %), short reaction time (1 h), ease of set up and scale up 
make this a practical protocol for accessing synthetically useful 4-hydroxy-2-
cyclopentenones in an enantiomerically enriched fashion. 
 For the first time, enantioselective silylation has been extended to substrates 
without multiple hydroxy groups and the efficiency of such silylation has been increased 
dramatically. Substrate scope, catalyst modification and modeling calculation have been 
extensively studied to elucidate the mechanism of enantioselective silylation of β-
hydroxyketones.  
3.8 Experimental and Supporting Information 
General Information 
Infrared (IR) spectra were recorded on a Perkin Elmer 781 spectrophotometer, νmax in 
cm-1.  Bands are characterized as broad (br), strong (s), medium (m), and weak (w).  1H   
NMR spectra were recorded on a Varian GN-400 (400 MHz) instrument. Chemical shifts 
are reported in ppm with the solvent reference as the internal standard (CHCl3: δ 7.26; 
CD3OD: δ 4.87, 3.31; pyridine-d5: δ 8.74, 7.58, 7.22 ppm).  Data are reported as follows: 
chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, br = broad), and coupling constants (Hz).  13C NMR spectra were recorded 
on a Varian GN-400 (100 MHz) with complete proton decoupling. Chemical shifts are 
reported in ppm with the solvent reference as the internal standard (CHCl3: δ 77.23, 
CD3OD: δ 49.15; pyridine-d5: δ 150.35, 135.91, 123.87 ppm). Melting points (mp) were 
taken with a Laboratory Devices Mel-Temp and were uncorrected.  Enantiomeric ratios 
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were determined by chiral gas liquid chromatography (GLC) on a Hewlett Packard HP 
6890 with a Beta Dex 120 (30 m x 0.25 mm x 0.25 µm film thickness), or a Gamma Dex 
120 (30 m x 0.25 mm x 0.25 µm film thickness) column. Optical rotations were 
measured on a Rudolph Research Analytical Autopol IV Automatic Polarimeter.  High 
resolution mass spectrometry (HRMS) was performed by the mass spectrometry facility 
at Boston College. 
 Chlorotriethylsilane (TESCl)  and Diisopropylethylamine (DIPEA) were distilled 
from 3Å molecular sieves prior to use. (THF) was dried on alumina columns by a solvent 
dispensing system prior to use. All other reagents were used as received. 
General procedure for the kinetic resolution through catalytic asymmetric silylation 
Catalyst 3.38 (2 mol %) and substrate (0.5 mmol, 1.0 equiv) were weighed into a 
16 x 125 mm test tube. The mixture was dissolved in THF (0.4 M, relative to substrate). 
The test tube was capped with a septum, wrapped with Teflon tape and then cooled to 
−78 °C under N2. DIPEA (1.0 equiv) was added via syringe. TESCl (0.75 equiv) in THF 
solution (0.3 M) was added over 30 min via syringe. The reaction was carefully 
monitored by GLC and quenched by at proper time by addition of DIPEA (50 µL) and 
H2O (200 µL). The mixture was diluted with CH2Cl2, dried over anhydrous MgSO4, 
filtered and concentrated to ~1 mL. Acetic anhydride (5 equiv), pyridine (5 equiv) and 
DMAP (10 mol %) were added. The mixture was stirred at 0 °C for 2 h, then diluted with 
CH2Cl2 (15 mL) and subsequently quenched by addition of 10% citric acid (10 mL). The 
aqueous layer was washed with CH2Cl2 (15 mL x 3), dried over anhydrous MgSO4, 
filtered and concentrated to afford a yellow oil. The acetate and TES ether were separated 
by silica gel chromatography and analyzed by chiral GLC. 
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Procedure for the synthesis of (2S,3R)-3-tert-butoxy-N-((R)-3,3-dimethylbutan-2-yl)-
2-((1-methyl-1H-imidazol-2-yl)methylamino)butanamide (3.38) 
Fmoc-O-t-butyl-threonine (1.59 g, 4.0 mmol) and (R)-3,3-
dimethyl-2-butylamine (590 µL, 4.4 mmol) were dissolved in 30 
mL of CH2Cl2 in a 100 mL round bottom flask.  To this solution 
were added EDC (843 mg, 4.4 mmol), HOBt (682 mg, 4.4 mmol) and DIPEA (1.4 mL, 
8.0 mmol).  The mixture was allowed to stir for 2 h at 23 °C after which time 20 mL of 
10 % citric acid was added.  The organic layer was separated and washed with 20 mL of 
a saturated solution of NaHCO3 and then 20 mL of brine, dried over anhydrous MgSO4, 
filtered, and concentrated under reduced pressure to yield a white solid.  This residue was 
dissolved in 30 mL of CH2Cl2, piperidine (1.5 mL, 15.4 mmol) was then added dropwise 
to the solution.   The mixture was allowed to stir for 1 h at 23 °C and then concentrated in 
vacuo.  The crude product was partitioned between 20 mL of CH2Cl2 and 20 mL of 10 % 
citric acid.  The aqueous phase was basified to pH 14 and then extracted with CH2Cl2 (3 
× 30 mL), the combined organic layer dried over anhydrous MgSO4.  After filtration and 
removal of the solvent, the unpurified amine was dissolved in 5 mL of CH2Cl2, followed 
by the addition of 1-methyl-2-imidazolecarboxaldehyde (436 mg, 4.0 mmol) and MgSO4.  
The mixture was allowed to stir for 12 h at 23 °C, filtered and concentrated to give a 
white solid, which was dissolved in MeOH and cooled to 0 oC.  To this solution was 
added NaBH4 (453 mg, 12 mmol.  The solution was allowed to stir for 0.5 h at 0 oC and 
then 1 h at 23 °C, after which time 10 mL of a saturated solution of NaHCO3 was slowly 
added to quench the reaction.  The product was extracted with CH2Cl2 (3 x 15 mL), the 
N
H
Me
N
N
Ot-BuMe
H
N
O
Me
t-Bu
3.38
 163 
combined organic layer was washed with brine (1 x 10 mL), dried over anhydrous 
MgSO4 and concentrated to yield a biege solid.  The resulting solid was purified by silica 
gell chromatography (CH2Cl2 to 95:5 CH2Cl2:MeOH) to afford the catalyst 3.38 as a 
white solid (986 mg, 70% yield over 4 steps).  
 
Characterization Data 
(2S,3R)-3-tert-Butoxy-N-((R)-3,3-dimethylbutan-2-yl)-2-((1-methyl-1H-imidazol-2-
yl)methylamino)butanamide (3.38): 
MP: 141.2-142.5 °C. IR: 3333 (br), 2968 (s), 2364 (w), 1665 
(s), 1539 (m), 1369 (m), 1193 (m), 1073 (w), 771 (w) cm-1. 
1H NMR (CDCl3, 400 MHz): δ 7.12 (1H, d, J = 10 Hz), 6.89 
(1H, d, J = 1.2 Hz), 6.82 (1H, d, J = 1.2 Hz), 3.96 (1H, d, J = 14.0 Hz), 3.83 (1H, d, J = 
14.0 Hz), 3.78 (1H, dq, J = 10, 6.4 Hz), 3.71 (3H, s), 3.59 (1H, dq, J = 4.4, 6.4 Hz), 3.14 
(1H, d, J = 4.4 Hz), 2.72 (1H, br, s), 1.14 (9H, s), 1.04 (3H, d, J = 6.4 Hz), 1.03 (3H, d, J 
= 6.4 Hz), 0.88 (9H, s). 13C NMR (CDCl3, 100 MHz): δ 170.94, 146.43, 127.12, 121.33, 
74.72, 68.74, 65.75, 53.15, 46.05, 34.06, 32.93, 28.60, 26.46, 18.17, 16.16. HRMS (m/z 
+ H): Calculated: 352.2923; Found: 352.2917. Optical Rotation: [α]25D  -29.9 (c = 1.0, 
CHCl3). 
ORTEP of 3.38 
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Table 1.  Crystal data and structure refinement for 3.38. 
Identification code  zy01t 
Empirical formula  C19 H36 N4 O2 
Formula weight  352.52 
Temperature  193(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1) 
Unit cell dimensions a = 9.233(2) Å α= 90°. 
 b = 11.905(3) Å β= 110.946(4)°. 
 c = 10.269(2) Å γ = 90°. 
Volume 1054.2(4) Å3 
Z 2 
Density (calculated) 1.111 Mg/m3 
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Absorption coefficient 0.073 mm-1 
F(000) 388 
Crystal size 0.15 x 0.02 x 0.01 mm3 
Theta range for data collection 2.12 to 28.40°. 
Index ranges -7<=h<=12, -14<=k<=15, -13<=l<=8 
Reflections collected 7249 
Independent reflections 4722 [R(int) = 0.0346] 
Completeness to theta = 28.40° 99.0 %  
Absorption correction Empirical 
Max. and min. transmission 0.9993 and 0.9891 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4722 / 1 / 235 
Goodness-of-fit on F2 1.051 
Final R indices [I>2sigma(I)] R1 = 0.0545, wR2 = 0.1424 
R indices (all data) R1 = 0.0709, wR2 = 0.1625 
Absolute structure parameter 0.8(14) 
Largest diff. peak and hole 0.325 and -0.312 e.Å-3 
 
Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters 
(Å2x 103) for 3.38.  U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
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________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________  
O(2) 1241(2) 3445(1) 6799(2) 29(1) 
N(4) 6456(2) 4300(2) 8774(2) 28(1) 
N(2) 4549(2) -610(2) 8691(2) 33(1) 
O(1) 5698(2) 3631(2) 6566(2) 39(1) 
N(1) 5222(2) -90(2) 6944(2) 31(1) 
C(6) 3986(2) 3322(2) 7821(2) 27(1) 
C(7) 2622(2) 3976(2) 6794(3) 28(1) 
N(3) 3822(2) 2130(2) 7479(2) 29(1) 
C(2) 5058(3) -1236(2) 6854(3) 36(1) 
C(13) 5473(2) 3764(2) 7671(2) 28(1) 
C(11) -1153(3) 2547(2) 5852(3) 38(1) 
C(4) 4906(2) 249(2) 8073(2) 28(1) 
C(14) 7883(2) 4807(2) 8715(3) 33(1) 
C(5) 4985(2) 1443(2) 8520(2) 31(1) 
C(8) 2699(3) 5208(2) 7228(3) 39(1) 
C(16) 9266(2) 4617(2) 10076(3) 36(1) 
C(3) 4647(3) -1543(2) 7950(3) 39(1) 
C(9) -37(2) 3305(2) 5485(3) 32(1) 
C(10) 479(3) 2734(3) 4407(3) 47(1) 
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C(1) 5699(3) 617(3) 6002(3) 48(1) 
C(15) 7569(4) 6023(3) 8258(4) 63(1) 
C(18) 10766(3) 4935(3) 9835(3) 56(1) 
C(19) 9161(3) 5311(3) 11283(3) 52(1) 
C(17) 9346(3) 3368(3) 10448(4) 58(1) 
C(12) -809(3) 4436(2) 4962(3) 48(1) 
________________________________________________________________________  
 
Table 3.   Bond lengths [Å] and angles [°] for 3.38. 
_____________________________________________________  
O(2)-C(7)  1.425(2) 
O(2)-C(9)  1.450(3) 
N(4)-C(13)  1.334(3) 
N(4)-C(14)  1.471(3) 
N(4)-H(20)  0.8800 
N(2)-C(4)  1.306(3) 
N(2)-C(3)  1.367(3) 
O(1)-C(13)  1.235(3) 
N(1)-C(4)  1.354(3) 
N(1)-C(2)  1.372(3) 
N(1)-C(1)  1.464(3) 
C(6)-N(3)  1.457(3) 
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C(6)-C(13)  1.528(3) 
C(6)-C(7)  1.534(3) 
C(6)-H(6)  1.0000 
C(7)-C(8)  1.528(3) 
C(7)-H(7)  1.0000 
N(3)-C(5)  1.464(3) 
N(3)-H(21)  0.8800 
C(2)-C(3)  1.361(4) 
C(2)-H(2)  0.9500 
C(11)-C(9)  1.515(3) 
C(11)-H(11A)  0.9800 
C(11)-H(11B)  0.9800 
C(11)-H(11C)  0.9800 
C(4)-C(5)  1.487(3) 
C(14)-C(15)  1.518(4) 
C(14)-C(16)  1.536(3) 
C(14)-H(14)  1.0000 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(8)-H(8A)  0.9800 
C(8)-H(8B)  0.9800 
C(8)-H(8C)  0.9800 
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C(16)-C(19)  1.522(4) 
C(16)-C(17)  1.530(4) 
C(16)-C(18)  1.539(3) 
C(3)-H(3)  0.9500 
C(9)-C(10)  1.514(4) 
C(9)-C(12)  1.528(4) 
C(10)-H(10A)  0.9800 
C(10)-H(10B)  0.9800 
C(10)-H(10C)  0.9800 
C(1)-H(1A)  0.9800 
C(1)-H(1B)  0.9800 
C(1)-H(1C)  0.9800 
C(15)-H(15A)  0.9800 
C(15)-H(15B)  0.9800 
C(15)-H(15C)  0.9800 
C(18)-H(18A)  0.9800 
C(18)-H(18B)  0.9800 
C(18)-H(18C)  0.9800 
C(19)-H(19A)  0.9800 
C(19)-H(19B)  0.9800 
C(19)-H(19C)  0.9800 
C(17)-H(17A)  0.9800 
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C(17)-H(17B)  0.9800 
C(17)-H(17C)  0.9800 
C(12)-H(12A)  0.9800 
C(12)-H(12B)  0.9800 
C(12)-H(12C)  0.9800 
 
C(7)-O(2)-C(9) 118.63(17) 
C(13)-N(4)-C(14) 120.6(2) 
C(13)-N(4)-H(20) 119.7 
C(14)-N(4)-H(20) 119.7 
C(4)-N(2)-C(3) 106.7(2) 
C(4)-N(1)-C(2) 107.6(2) 
C(4)-N(1)-C(1) 127.0(2) 
C(2)-N(1)-C(1) 125.4(2) 
N(3)-C(6)-C(13) 109.31(17) 
N(3)-C(6)-C(7) 109.83(16) 
C(13)-C(6)-C(7) 107.61(17) 
N(3)-C(6)-H(6) 110.0 
C(13)-C(6)-H(6) 110.0 
C(7)-C(6)-H(6) 110.0 
O(2)-C(7)-C(8) 111.94(18) 
O(2)-C(7)-C(6) 106.77(17) 
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C(8)-C(7)-C(6) 110.20(17) 
O(2)-C(7)-H(7) 109.3 
C(8)-C(7)-H(7) 109.3 
C(6)-C(7)-H(7) 109.3 
C(6)-N(3)-C(5) 112.46(16) 
C(6)-N(3)-H(21) 123.8 
C(5)-N(3)-H(21) 123.8 
C(3)-C(2)-N(1) 105.5(2) 
C(3)-C(2)-H(2) 127.2 
N(1)-C(2)-H(2) 127.2 
O(1)-C(13)-N(4) 123.71(19) 
O(1)-C(13)-C(6) 120.06(19) 
N(4)-C(13)-C(6) 116.2(2) 
C(9)-C(11)-H(11A) 109.5 
C(9)-C(11)-H(11B) 109.5 
H(11A)-C(11)-H(11B) 109.5 
C(9)-C(11)-H(11C) 109.5 
H(11A)-C(11)-H(11C) 109.5 
H(11B)-C(11)-H(11C) 109.5 
N(2)-C(4)-N(1) 110.6(2) 
N(2)-C(4)-C(5) 126.2(2) 
N(1)-C(4)-C(5) 123.2(2) 
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N(4)-C(14)-C(15) 109.2(2) 
N(4)-C(14)-C(16) 111.5(2) 
C(15)-C(14)-C(16) 115.2(2) 
N(4)-C(14)-H(14) 106.8 
C(15)-C(14)-H(14) 106.8 
C(16)-C(14)-H(14) 106.8 
N(3)-C(5)-C(4) 111.47(17) 
N(3)-C(5)-H(5A) 109.3 
C(4)-C(5)-H(5A) 109.3 
N(3)-C(5)-H(5B) 109.3 
C(4)-C(5)-H(5B) 109.3 
H(5A)-C(5)-H(5B) 108.0 
C(7)-C(8)-H(8A) 109.5 
C(7)-C(8)-H(8B) 109.5 
H(8A)-C(8)-H(8B) 109.5 
C(7)-C(8)-H(8C) 109.5 
H(8A)-C(8)-H(8C) 109.5 
H(8B)-C(8)-H(8C) 109.5 
C(19)-C(16)-C(17) 109.6(3) 
C(19)-C(16)-C(14) 112.8(2) 
C(17)-C(16)-C(14) 108.7(2) 
C(19)-C(16)-C(18) 108.7(2) 
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C(17)-C(16)-C(18) 108.3(2) 
C(14)-C(16)-C(18) 108.7(2) 
C(2)-C(3)-N(2) 109.6(2) 
C(2)-C(3)-H(3) 125.2 
N(2)-C(3)-H(3) 125.2 
O(2)-C(9)-C(10) 111.59(18) 
O(2)-C(9)-C(11) 103.69(19) 
C(10)-C(9)-C(11) 109.5(2) 
O(2)-C(9)-C(12) 110.41(19) 
C(10)-C(9)-C(12) 111.6(2) 
C(11)-C(9)-C(12) 109.8(2) 
C(9)-C(10)-H(10A) 109.5 
C(9)-C(10)-H(10B) 109.5 
H(10A)-C(10)-H(10B) 109.5 
C(9)-C(10)-H(10C) 109.5 
H(10A)-C(10)-H(10C) 109.5 
H(10B)-C(10)-H(10C) 109.5 
N(1)-C(1)-H(1A) 109.5 
N(1)-C(1)-H(1B) 109.5 
H(1A)-C(1)-H(1B) 109.5 
N(1)-C(1)-H(1C) 109.5 
H(1A)-C(1)-H(1C) 109.5 
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H(1B)-C(1)-H(1C) 109.5 
C(14)-C(15)-H(15A) 109.5 
C(14)-C(15)-H(15B) 109.5 
H(15A)-C(15)-H(15B) 109.5 
C(14)-C(15)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15B)-C(15)-H(15C) 109.5 
C(16)-C(18)-H(18A) 109.5 
C(16)-C(18)-H(18B) 109.5 
H(18A)-C(18)-H(18B) 109.5 
C(16)-C(18)-H(18C) 109.5 
H(18A)-C(18)-H(18C) 109.5 
H(18B)-C(18)-H(18C) 109.5 
C(16)-C(19)-H(19A) 109.5 
C(16)-C(19)-H(19B) 109.5 
H(19A)-C(19)-H(19B) 109.5 
C(16)-C(19)-H(19C) 109.5 
H(19A)-C(19)-H(19C) 109.5 
H(19B)-C(19)-H(19C) 109.5 
C(16)-C(17)-H(17A) 109.5 
C(16)-C(17)-H(17B) 109.5 
H(17A)-C(17)-H(17B) 109.5 
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C(16)-C(17)-H(17C) 109.5 
H(17A)-C(17)-H(17C) 109.5 
H(17B)-C(17)-H(17C) 109.5 
C(9)-C(12)-H(12A) 109.5 
C(9)-C(12)-H(12B) 109.5 
H(12A)-C(12)-H(12B) 109.5 
C(9)-C(12)-H(12C) 109.5 
H(12A)-C(12)-H(12C) 109.5 
H(12B)-C(12)-H(12C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
Table 4.   Anisotropic displacement parameters  (Å2x 103) for 3.38.  The anisotropic 
displacement factor exponent takes the form:  -2π2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
O(2) 23(1)  31(1) 33(1)  -1(1) 9(1)  -2(1) 
N(4) 27(1)  29(1) 30(1)  -4(1) 11(1)  -4(1) 
N(2) 37(1)  31(1) 32(1)  6(1) 14(1)  5(1) 
O(1) 34(1)  52(1) 32(1)  -7(1) 14(1)  -9(1) 
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N(1) 30(1)  33(1) 32(1)  0(1) 13(1)  1(1) 
C(6) 27(1)  24(1) 27(1)  0(1) 7(1)  0(1) 
C(7) 25(1)  27(1) 32(1)  3(1) 10(1)  0(1) 
N(3) 27(1)  25(1) 30(1)  1(1) 4(1)  -1(1) 
C(2) 37(1)  33(1) 37(1)  -3(1) 11(1)  4(1) 
C(13) 27(1)  26(1) 29(1)  0(1) 10(1)  0(1) 
C(11) 30(1)  34(1) 48(2)  -2(1) 13(1)  -4(1) 
C(4) 24(1)  32(1) 26(1)  1(1) 5(1)  3(1) 
C(14) 30(1)  35(1) 34(1)  -1(1) 11(1)  -9(1) 
C(5) 34(1)  31(1) 26(1)  -1(1) 8(1)  4(1) 
C(8) 34(1)  28(1) 55(2)  1(1) 15(1)  -2(1) 
C(16) 25(1)  43(1) 40(1)  -5(1) 10(1)  -3(1) 
C(3) 42(1)  28(1) 45(2)  7(1) 13(1)  3(1) 
C(9) 29(1)  29(1) 33(1)  0(1) 4(1)  -3(1) 
C(10) 51(1)  55(2) 36(2)  -12(1) 16(1)  -16(1) 
C(1) 60(2)  46(2) 49(2)  3(1) 34(1)  -5(1) 
C(15) 53(2)  49(2) 70(2)  18(2) 3(1)  -14(1) 
C(18) 30(1)  82(2) 58(2)  -18(2) 17(1)  -10(1) 
C(19) 41(1)  73(2) 40(2)  -22(2) 12(1)  -11(1) 
C(17) 49(1)  46(2) 67(2)  12(2) 7(1)  10(1) 
C(12) 42(1)  36(1) 50(2)  12(1) -2(1)  -1(1) 
________________________________________________________________________  
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Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 10 
3) for 3.38. 
________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________  
  
H(20) 6248 4350 9545 34 
H(6) 4023 3441 8796 32 
H(7) 2670 3925 5838 34 
H(21) 3104 1854 6730 35 
H(2) 5202 -1715 6170 44 
H(11A) -642 1831 6211 57 
H(11B) -2070 2410 5016 57 
H(11C) -1468 2910 6565 57 
H(14) 8128 4405 7963 40 
H(5A) 4815 1487 9417 37 
H(5B) 6032 1744 8668 37 
H(8A) 1759 5597 6634 59 
H(8B) 3611 5562 7125 59 
H(8C) 2777 5257 8204 59 
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H(3) 4456 -2291 8168 47 
H(10A) 1149 3243 4127 71 
H(10B) -433 2541 3590 71 
H(10C) 1054 2048 4806 71 
H(1A) 5337 282 5069 72 
H(1B) 6833 675 6352 72 
H(1C) 5248 1368 5956 72 
H(15A) 6683 6061 7378 94 
H(15B) 8486 6343 8128 94 
H(15C) 7335 6451 8975 94 
H(18A) 11664 4739 10663 85 
H(18B) 10770 5745 9664 85 
H(18C) 10818 4525 9026 85 
H(19A) 10092 5188 12111 78 
H(19B) 8242 5084 11484 78 
H(19C) 9081 6109 11033 78 
H(17A) 9348 2921 9647 87 
H(17B) 8444 3164 10688 87 
H(17C) 10298 3219 11246 87 
H(12A) -1092 4796 5696 72 
H(12B) -1744 4317 4137 72 
H(12C) -87 4920 4717 72 
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________________________________________________________________________ 
Table 6.  Torsion angles [°] for 3.38. 
________________________________________________________________  
C(9)-O(2)-C(7)-C(8) 99.9(2) 
C(9)-O(2)-C(7)-C(6) -139.41(19) 
N(3)-C(6)-C(7)-O(2) 52.7(2) 
C(13)-C(6)-C(7)-O(2) 171.65(17) 
N(3)-C(6)-C(7)-C(8) 174.5(2) 
C(13)-C(6)-C(7)-C(8) -66.6(2) 
C(13)-C(6)-N(3)-C(5) 69.1(2) 
C(7)-C(6)-N(3)-C(5) -173.06(18) 
C(4)-N(1)-C(2)-C(3) -0.1(2) 
C(1)-N(1)-C(2)-C(3) 178.2(2) 
C(14)-N(4)-C(13)-O(1) 2.0(3) 
C(14)-N(4)-C(13)-C(6) -176.94(19) 
N(3)-C(6)-C(13)-O(1) 54.4(3) 
C(7)-C(6)-C(13)-O(1) -64.8(3) 
N(3)-C(6)-C(13)-N(4) -126.6(2) 
C(7)-C(6)-C(13)-N(4) 114.1(2) 
C(3)-N(2)-C(4)-N(1) 0.5(2) 
C(3)-N(2)-C(4)-C(5) -178.9(2) 
C(2)-N(1)-C(4)-N(2) -0.3(2) 
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C(1)-N(1)-C(4)-N(2) -178.5(2) 
C(2)-N(1)-C(4)-C(5) 179.11(19) 
C(1)-N(1)-C(4)-C(5) 0.8(3) 
C(13)-N(4)-C(14)-C(15) 92.1(3) 
C(13)-N(4)-C(14)-C(16) -139.4(2) 
C(6)-N(3)-C(5)-C(4) -173.74(18) 
N(2)-C(4)-C(5)-N(3) -116.0(2) 
N(1)-C(4)-C(5)-N(3) 64.7(3) 
N(4)-C(14)-C(16)-C(19) -71.5(3) 
C(15)-C(14)-C(16)-C(19) 53.8(3) 
N(4)-C(14)-C(16)-C(17) 50.3(3) 
C(15)-C(14)-C(16)-C(17) 175.6(3) 
N(4)-C(14)-C(16)-C(18) 167.9(2) 
C(15)-C(14)-C(16)-C(18) -66.8(3) 
N(1)-C(2)-C(3)-N(2) 0.4(3) 
C(4)-N(2)-C(3)-C(2) -0.5(2) 
C(7)-O(2)-C(9)-C(10) 52.6(3) 
C(7)-O(2)-C(9)-C(11) 170.36(19) 
C(7)-O(2)-C(9)-C(12) -72.1(3) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
 Table 7.  Hydrogen bonds for 3.38  [Å and °]. 
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________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________  
 N(4)-H(20)...N(2)#1 0.88 2.19 3.062(3) 172.9 
________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+1,y+1/2,-z+2       
 
 (S)-4-Oxocyclopent-2-enyl acetate (3.59, Table 3.8) 
1H NMR (CDCl3, 400 MHz): δ 7.57 (1H, dd, J = 5.6, 2.4 Hz), 6.33 (1H, d, J = 
5.6 Hz), 5.85 (1H, m), 2.83 (1H, dd, J = 18.4, 6.4 Hz), 2.33 (1H, dd, J = 18.4, 2 
Hz), 2.10 (1H, s). 13C NMR (CDCl3, 100 MHz): δ 204.81, 170.45, 158.93, 
137.08, 72.10, 41.18, 21.02. Optical Rotation: [α]20D  −100.8 (c = 0.51, CHCl3).  
Stereochemistry Proof: Previously reported [α]20D  −111 for enantiomerically pure S 
enantiomer.110 
 Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 
120 (30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC, 2 oC/min. 25 psi.); 
chromatograms are illustrated below for a 91 % ee sample: 
O
OAc
3.59
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 (R)-4-(Triethylsilyloxy)cyclopent-2-enone (3.59, entry 1 in Table 3.8): 
1H NMR (CDCl3, 400 MHz): δ 7.45 (1H, dd, J = 5.6, 2.4 Hz), 6.18 (1H, d, J 
= 5.6 Hz), 4.97 (1H, m), 2.71 (1H, dd, J = 18.4, 6.4 Hz), 2.25 (1H, dd, J = 
18.4, 2.0 Hz), 0.97 (9H, t, J = 8.0 Hz), 0.64 (6H, q, J = 8.0 Hz). 13C NMR 
(CDCl3, 100 MHz): δ 206.50, 163.92, 134.66, 70.77, 45.23, 6.93, 4.96. Optical 
Rotation: [α]20D  +27.9 (c = 0.51, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 104 oC, 4 oC/min, hold 80 min. 25 
psi.); chromatograms are illustrated below for a 62 % ee sample: 
  
  
O
OTES
3.59
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(1R,5S)-5-Methyl-4-oxocyclopent-2-enyl acetate (3.66, entry 2 in Table 3.8): 
IR (neat, thin film): 2919 (m), 2850 (w), 1721 (s), 1453 (w), 1373 (m), 
1232(s), 1077 (w), 1024 (m), 912 (w), 822 (w), 680 (w) cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 7.47 (1H, dd, J = 5.6, 2.4 Hz), 6.29 (1H, d, J = 5.6 Hz), 
5.47 (1H, m), 2.34 (1H, dq, J = 2.4, 7.2 Hz), 2.10 (3H, s), 1.26(3H, d, J = 7.6 Hz). 13C 
NMR (CDCl3, 100 MHz): δ 207.15, 170.69, 157.59, 135.90, 79.49, 47.21, 21.09, 13.61. 
HRMS (m/z + H): Calculated: 155.07082; Found: 155.07059. Optical Rotation: [α]20D  
−91.2  (c = 0.70, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 94 % ee sample: 
  
  
 
 
O
OAc
Me
3.66
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(4S,5R)-5-Methyl-4-(triethylsilyloxy)cyclopent-2-enone (3.74, entry 2 in Table 3.8): 
IR (neat, thin film): 2957 (m), 2912 (m), 2877 (s), 1921 (s), 1457 (w), 1356 
(w), 1237 (w), 1108 (m), 1051 (w), 1005 (w), 894 (w), 856 (w), 798 (m), 746 
(m), 672 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.37 (1H, dd, J = 5.6, 2.0 
Hz), 6.16 (1H, dd, J = 5.6, 2.4 Hz), 4.50 (1H, m), 2.26 (1H, dq, J = 2.4, 7.2 Hz), 1.22(3H, 
d, J = 7.6 Hz), 0.99 (9H, t, J = 8.0 Hz), 0.66 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 
MHz): δ 208.25, 162.10, 133.50, 78.86, 50.91, 12.95, 6.93, 5.08. HRMS (m/z + H): 
Calculated: 227.1467; Found: 227.1462. Optical Rotation: [α]20D  +37.3 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 110 oC for 65 min. 25 psi.); chromatograms 
are illustrated below for a 60 % ee sample: 
  
  
 
 
 
O
OTES
Me
3.74
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(S)-3-Methyl-4-oxocyclopent-2-enyl acetate (3.67, entry 3 in Table 3.8): 
IR (neat, thin film): 2925 (w), 1718 (s), 1643 (w), 1374 (m), 1238 (s), 
1027 (w), 983 (w), 607 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.20 (1H, 
m), 5.74 (1H, m), 2.85 (1H, dd, J = 18.8, 6.4 Hz), 2.35 (1H, dd, J = 18.8, 2 
Hz), 2.08 (3H, s), 1.83(1H, t, J = 2 Hz). 13C NMR (CDCl3, 100 MHz): δ 205.03, 170.70, 
152.58, 145.75, 70.61, 41.42, 21.14, 10.26. HRMS (m/z + H): Calculated: 155.07082; 
Found: 155.07088. Optical Rotation: [α]20D  −82.8 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Gamma Dex 
120 (30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC, 2 oC/min. 25 psi.); 
chromatograms are illustrated below for a 95 % ee sample: 
  
  
 
(R)-2-Methyl-4-(triethylsilyloxy)cyclopent-2-enone (3.75, entry 3 in Table 3.8): 
IR (neat, thin film): 2955 (m), 2912 (m), 2877 (m), 1716 (s), 1351 (w), 
1241 (w), 1197 (w), 1089 (m), 1066 (m), 1006 (w), 965 (w), 896 (w), 798 
(w), 746 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.09 (1H, m), 4.86 
(1H, m), 2.73 (1H, dd, J = 18.4, 6.4 Hz), 2.27 (1H, dd, J = 18.4, 2.0 Hz), 1.78(1H, t, J = 
O
OAc
Me
3.67
O
OTES
Me
3.75
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2.0 Hz), 0.97 (9H, t, J = 8.0 Hz), 0.64 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): 
δ 206.45, 157.59, 143.01, 68.77, 45.39, 10.9, 6.91, 4.99. HRMS (m/z + H): Calculated: 
227.1467; Found: 227.1463. Optical Rotation: [α]20D  +11.6 (c = 1.21, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 110 oC for 65 min. 25 psi.); chromatograms 
are illustrated below for a 57 % ee sample: 
  
  
 
 (1R,5R)-5-Methyl-4-oxocyclopent-2-enyl acetate (3.68, entry 4 in Table 3.8): 
Acylated starting material:  26 mg, 34% yield. IR (neat, thin film): 2982 (w), 
2941 (w), 1720 (s), 1456 (m), 1372 (w), 1230 (s), 1188 (m), 1091 (w), 1034 
(m), 962 (w), 911 (w), 873 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.50 
(1H, dd, J = 6, 2 Hz), 6.32 (1H, d, J = 6 Hz), 5.92 (1H, m), 2.67 (1H, quin, J = 7.6 Hz), 
2.12 (3H, s), 1.08 (3H, d, J = 7.6 Hz).  13C NMR (CDCl3, 100 MHz): δ 208.66, 170.45, 
158.22, 135.78, 73.75, 43.29, 20.88, 10.99. HRMS (m/z + H): Calculated: 155.07082; 
Found: 155.07153. Optical Rotation: [α]20D  −87.6  (c = 0.50, CHCl3).  
O
OAc
Me
3.68
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Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 82 % ee sample: 
  
  
 
(4S,5S)-5-Methyl-4-(triethylsilyloxy)cyclopent-2-enone (3.76, entry 4 in Table 3.8): 
IR (neat, thin film): 2955 (w), 2911 (w), 2877 (w), 1717 (s), 1456 (w), 1372 
(w), 1238 (w), 1186 (w), 1132 (m), 1102 (w), 1081 (m), 1005 (m), 977 (w), 
858 (s), 778 (m), 723 (s) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.41 (1H, dd, 
J = 6.0, 2.0 Hz), 6.17 (1H, d, J = 6.0 Hz), 4.94 (1H, m), 2.49 (1H, quin, J = 7.6 Hz), 1.11 
(3H, d, J = 7.6 Hz), 0.99 (9H, t, J = 8.0 Hz), 0.66 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 
100 MHz): δ 210.35, 162.91, 133.15, 72.34, 45.58, 11.57, 6.94, 5.06. HRMS (m/z + H): 
Calculated: 227.14673; Found: 227.14769. Optical Rotation: [α]20D  +47.9 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 47 % ee sample: 
O
OTES
Me
3.76
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 (1R,5S)-5-Ethyl-4-oxocyclopent-2-enyl acetate (3.69, entry 5 in Table 3.8): 
IR (neat, thin film): 2966 (m), 2937 (m), 2878 (m), 1720 (s), 1460 (w), 1374 
(m), 1354 (m), 1326 (w), 1236 (s), 1171 (m), 1085 (m), 1024 (s), 943 (m), 
798 (m), 607 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.51 (1H, dd, J = 5.6, 
2.4 Hz), 6.30 (1H, dd, J = 5.6, 1.2Hz), 5.66 (1H, dt, J = 1.2, 2.4 Hz), 2.34 
(1H, ddd, J = 8, 4.8, 2.4 Hz), 2.11 (3H, s), 1.87 (1H, ddq, J = 14.8, 4.8, 7.6 Hz), 1.63 (1H, 
ddq, J = 14.8, 7.6, 7.6 Hz), 0.96 (3H, t, J = 7.6 Hz). 13C NMR (CDCl3, 100 MHz): 
δ 206.83, 170.63, 157.91, 136.48, 52.94, 21.79, 21.16, 11.18. HRMS (m/z + H): 
Calculated: 169.08647; Found: 169.08644. Optical Rotation: [α]20D  −46.0 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 80 % ee sample: 
O
OAc
Et
3.69
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(4S,5R)-5-Ethyl-4-(triethylsilyloxy)cyclopent-2-enone (3.77, entry 5 in Table 3.8): 
IR (neat, thin film): 2958 (m), 2877 (m), 1718 (s), 1458 (w), 1356 (w), 1108 
(m), 1061 (w), 1006 (w), 821 (w), 745 (m) cm-1. 1H NMR (CDCl3, 400 
MHz): δ 7.39 (1H, dd, J = 5.6, 2.4 Hz), 6.16 (1H, dd, J = 5.6, 0.8 Hz), 4.67 
(1H, m), 2.23 (1H, ddd, J = 7.2, 5.6, 2.4 Hz), 1.78 (1H, ddq, J = 14.8, 5.6, 7.6 Hz), 1.63 
(1H, ddq, J = 14.8, 7.6, 7.6 Hz), 0.99 (9H, t, J = 8.0 Hz), 0.96 (3H, t, J = 7.6 Hz), 0.66 
(6H, d, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 208.245, 162.285, 134.170, 76.201, 
56.720, 21.327, 11.321, 6.981, 5.204. HRMS (m/z + H): Calculated: 241.1624; Found: 
241.1615. Optical Rotation: [α]20D  +18.8 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 56% ee sample: 
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(1R,5S)-5-Allyl-4-oxocyclopent-2-enyl acetate (3.70, entry 6 in Table 3.8): 
IR (neat, thin film): 2017 (m), 2848 (w), 2359 (w), 1720 (w), 1372 w), 1233 
(s), 1024 (m), 925 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.51 (1H, dd, J 
= 5.6, 2.4 Hz), 6.31 (1H, dd, J = 5.6, 1.6 Hz), 5.70 (1H, dddd, J = 6.8, 12.0, 
6.8, 6.8 Hz), 5.66 (1H, m), 5.05−5.18 (2H, m), 2.37−2.63 (3H, m), 2.10 (3H, s). 13C 
NMR (CDCl3, 100 MHz): δ 206.110, 170.592, 158.170, 136.076, 134.076, 118.203, 
76.786, 51.289, 32.782, 21.155. HRMS (m/z + H): Calculated: 181.08647; Found: 
181.08650. Optical Rotation: [α]20D  −85.9 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 92 % ee sample: 
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(4S,5R)-5-Allyl-4-(triethylsilyloxy)cyclopent-2-enone (3.78, entry 6 in Table 3.8): 
IR (neat, thin film): 2956 (s), 2877 (s), 1716 (s), 1641 (m), 1592 (w), 1458 
(m), 1358 (m), 1239 (w), 1111 (s), 1070 (m), 1016(m), 916 (m), 855 (w), 
745 (m), 674 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.38 (1H, dd, J = 
5.6, 2.4 Hz), 6.17 (1H, dd, J = 5.6, 0.8 Hz), 5.70 (1H, dddd, J = 6.8, 12.0, 6.8, 6.8 Hz), 
5.04−5.14 (2H, m), 4.67 (1H, m), 2.33−2.54 (3H, m), 0.98 (9H, t, J = 8.0 Hz), 0.65 (6H, 
q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 207.450, 162.526, 134.964, 133.944, 
117.572, 75.461, 54.951, 32.486, 6.958, 5.181. HRMS (m/z + Na): Calculated: 
275.1443; Found: 275.1446. Optical Rotation: [α]20D  +23.2 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Alltech Associated 
Chiral dex GTA (30 m x 0.25 mm) column), 80 oC to 140 oC , 2 oC /min, hold 10 min. 15 
psi.); chromatograms are illustrated below for a 41 % ee sample: 
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 (S)-3-Ethyl-4-oxocyclopent-2-enyl acetate (3.71, entry 7 in Table 3.8): 
IR (neat, thin film): 2972 (m), 2938 (m), 2360 (w), 1716 (s), 1641 (w), 
1372 (m), 1237 (s), 1201 (m), 1026 (s), 979 (m), 946 (w), 880 (w), 607 (w) 
cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.16 (1H, m), 5.75 (1H, m), 2.86 (1H, 
dd, J = 18.4, 6.4 Hz), 2.37 (1H, dd, J = 18.4, 2.0 Hz), 2.24 (1H, ddq, J = 1.2, 1.2, 7.2 Hz), 
2.9 (3H, s), 1.12 (3H, t, J = 7.6 Hz). 13C NMR (CDCl3, 100 MHz): δ 204.77, 170.74, 
151.52, 151.03, 70.63, 41.81, 21.12, 18.16, 11.73. HRMS (m/z + H): Calculated: 
169.08647; Found: 169.08665. Optical Rotation: [α]20D  −38.0 (c = 0.50, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 74 % ee sample: 
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(R)-2-Ethyl-4-(triethylsilyloxy)cyclopent-2-enone (3.79, entry 7 in Table 3.8): 
IR (neat, thin film): 2955 (s), 2877 (s), 1712 (m), 1458 (m), 1238 (m), 
1072 (s), 1004 (m), 740 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.04 
(1H, m), 4.87 (1H, m), 2.73 (1H, dd, J = 18.4, 6.4 Hz), 2.31 (1H, dd, J = 
18.4, 2.0 Hz), 2.18 (1H, ddq, J = 1.2, 1.2, 7.6 Hz), 1.10 (3H, t, J = 7.6 Hz), 0.98 (9H, q, J 
= 8.0 Hz), 0.65 (6H, t, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 206.16, 155.94, 
148.90, 68.85, 49.90, 18.03, 11.87, 6.94, 5.00. HRMS (m/z + H): Calculated: 241.16238; 
Found: 241.16197. Optical Rotation: [α]20D  +6.8 (c = 0.50, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 110 oC to 150 oC , 1 oC /min, hold 10 min. 
15 psi.); chromatograms are illustrated below for a 36 % ee sample: 
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(S)-3-Allyl-4-oxocyclopent-2-enyl acetate (3.72, entry 8 in Table 3.8): 
 IR (neat, thin film): 2935 (w), 1742 (s), 1712 (s), 1642 (w), 1372 (w), 
1237 (s), 1026 (m), 919 (w) cm-1. 1H NMR (CDCl3, 400 MHz): δ 7.17 
(1H, m), 5.85 (1H, dddd, J = 17.2, 9.6, 6.8, 6.8 Hz), 5,76 (1H,m), 
5.11−5.15 (2H, m), 2.96 (2H, d, J = 6.8 Hz), 2.87 (1H, dd, J = 18.8, 6.4 Hz), 2.38 (1H, 
dd, J = 18.8, 2.0 Hz), 2.07 (3H, s). 13C NMR (CDCl3, 100 MHz): δ 204.169, 170.685, 
152.529, 148.266, 133.406, 117.782, 70.560, 41.681, 29.236, 21.140. HRMS (m/z + Na): 
Calculated: 203.0684; Found: 203.0694. Optical Rotation: [α]20D  −49.5 (c = 0.9, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 83 % ee sample: 
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(R)-2-Allyl-4-(triethylsilyloxy)cyclopent-2-enone (3.80, entry 8 in Table 3.8): 
IR (neat, thin film): 2956 (m), 2877 (m), 1716 (S), 1642 (w), 1414 (w), 
1353 (w), 1239 (w), 1083 (s), 1005 (m), 968 (w), 793 (w), 747 (m) cm-1. 
1H NMR (CDCl3, 400 MHz): δ 7.08 (1H, m), 5.85 (1H, dddd, J = 17.2, 
9.6, 6.8, 6.8 Hz), 5.09−5.13 (2H, m), 4.89 (1H, m), 2.92 (2H, d, J = 6.8 Hz), 2.77 (1H, dd, 
J = 18.4, 6.4 Hz), 2.31 (1H, dd, J = 18.4, 2.0 Hz), 0.98 (9H, t, J = 8.0 Hz), 0.64 (6H, q, J 
= 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 205.502, 157.430, 145.523, 133.951, 
117.299, 68.838, 45,678, 29.143, 6.903, 4.986. HRMS (m/z + H): Calculated: 253.1624; 
Found: 253.1614. Optical Rotation: [α]20D  +6.8 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 39 % ee sample: 
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(S)-2-Methyl-4-oxocyclopent-2-enyl acetate (3.73, entry 9 in Table 3.8): 
IR (neat, thin film): 3508 (br), 1724 (s), 1629 (m), 1374 (m), 1232 (s), 
1024 (m), 1168 (w), 993 (w), 850 (w) cm-1. 1H NMR (CDCl3, 400 MHz): 
δ 6.07 (1H, m), 5.73 (1H, m), 2.88 (1H, dd, J = 18.4, 6.4 Hz), 2.30 (1H, dd, 
J = 18.4, 2 Hz), 2.12 (3H, s), 2.11 (3H, s). 13C NMR (CDCl3, 100 MHz): δ 204.12, 
172.79, 170.62, 133.55, 73.90, 42.87, 21.01, 16.23. HRMS (m/z + H): Calculated: 
155.07082; Found: 155.07009. Optical Rotation: [α]20D  +4.2 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 31 % ee sample: 
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(R)-3-Methyl-4-(triethylsilyloxy)cyclopent-2-enone (3.81, entry 9 in Table 3.8): 
IR (neat, thin film): 2956 (s), 2877 (s), 1719 (s), 1629 (m), 1094 (s), 
1006 (m), 728 (m) cm-1. 1H NMR (CDCl3, 400 MHz): δ δ 5.92 (1H, m), 
4.73 (1H, m), 2.72 (1H, dd, J = 18.4, 6.4 Hz), 2.28 (1H, dd, J = 18.4, 2.0 
Hz), 2.11(1H, s), 0.99 (9H, t, J = 8.0 Hz), 0.65 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 
100 MHz): δ 205.17, 177.52, 131.17, 72.94, 46.30, 16.12, 6.94, 5.01. HRMS (m/z + H): 
Calculated: 227.14673; Found: 227.14763. Optical Rotation: [α]20D  −1.7 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 80 oC to 180 oC , 2 oC /min. 25 psi.); 
chromatograms are illustrated below for a 44 % ee sample: 
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(S)-4-Hydroxypentan-2-one (3.82, entry 1 in Table 3.9): 
 1H NMR (CDCl3, 400 MHz): δ 4.21 (1H, m), 3.06 (1H, br), 2.63 (1H, 
dd, J = 18, 3.2 Hz), 2.53 (1H, dd, J = 18.0, 8.8 Hz), 2.17 (3H, s), 1.18 
(3H, d, J = 6.4 Hz). 13C NMR (CDCl3, 100 MHz): δ 209.59, 64.00, 51.72, 30.87, 22.60. 
Optical Rotation: [α]20D  +64.6 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 55 oC hold 55 min. 15 psi.); chromatograms 
are illustrated below for a 84 % ee sample: 
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(R)-4-(Triethylsilyloxy)pentan-2-one (3.82, entry 1 in Table 3.9): 
IR (neat, thin film): 2956 (s), 2877 (s), 1719 (s), 1373 (m), 1239 (w), 
1173 (m), 1134 (m), 1090 (m), 1018 (s), 927 (w), 744 (s), 672 (w) cm-1. 
1H NMR (CDCl3, 400 MHz): δ 4.28 (1H, sex, J = 6.0 Hz), 2.65 (1H, dd, J = 15.2, 6.8 
Hz), 2.44 (1H, dd, J = 15.2, 6.4 Hz), 1.18 (3H, d, J = 6.0 Hz), 0.938 (9H, t, J = 8.0 Hz), 
0.58 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 207.90, 65.58, 53.56, 31.72, 
24.36, 7.05, 5.17. HRMS (m/z + Na): Calculated: 239.1443; Found: 239.1435. Optical 
Rotation: [α]20D  +11.1 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 55 oC hold 55 min, 5 oC /min to 180 oC. 15 
psi.); chromatograms are illustrated below for a 47 % ee sample: 
  
  
 
(S)-5-Hydroxyhexan-2-one (3.83, entry 2 in Table 3.9):  
1H NMR (CDCl3, 400 MHz): δ 4.22 (1H, m), 3.13 (1H, d, J = 2.8 Hz), 
2.61 (1H, dd, J = 17.6, 3.2 Hz), 2.50 (1H, dd, J = 17.6, 8.8 Hz), 2,44 
(2H, q, J = 7.2 Hz), 1.18 (3H, d, J = 6.4 Hz), 1.06 (3H, t, J = 7.2 Hz). 13C NMR (CDCl3, 
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TESO O
Me
3.82
Me
OH O
Et
3.83
 200 
100 MHz): δ 212.515, 64.084, 50.330, 36.888, 22.620, 7.737. Optical Rotation: [α]2D  
+42.1 (c = 1.0, CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Gamma Dex 
120 (30 m x 0.15 mm x 0.25 µm film thickness), 80 oC hold 10 min, 20 oC to 180 oC. 25 
psi.); chromatograms are illustrated below for a 68 % ee sample: 
 
 
  
 
(S)-5-(Triethylsilyloxy)hexan-3-one (3.86, entry 2 in Table 3.9): 
IR (neat, thin film): 2956 (s), 2877 (s), 1717 (s), 1459 (w), 1413 (w), 
1375 (m), 1134 (m), 1094 (m), 1045 (m), 1005 (m), 766 (w), 743 (s) cm-
1. 1H NMR (CDCl3, 400 MHz): δ 4.30 (1H, m), 2.64 (1H, dd, J = 15.2, 
7.2 Hz), 2,46 (2H, q, J = 7.2 Hz), 2.40 (1H, dd, J = 15.2, 5.6 Hz), 1.17 (3H, d, J = 6.0 
Hz), 1.03 (3H, t, J = 7.2 Hz), 0.93 (9H, t, J = 8.0 Hz), 0.57 (6H, q, J = 8.0 Hz). 13C NMR 
(CDCl3, 100 MHz): δ 210.349, 65.705, 52.341, 37.831, 24.428, 7.729, 7.028, 5.134. 
HRMS (m/z + H): Calculated: 231.17803; Found: 231.17897. Optical Rotation: [α]20D  
−15.7 (c = 1.0, CHCl3).  
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Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 90 oC hold 50 min. 25 psi.); chromatograms 
are illustrated below for a 47 % ee sample: 
 
 
 
  
 
(S)-4-Hydroxyheptan-2-one (3.84, entry 3 in Table 3.9): 
1H NMR (CDCl3, 400 MHz): δ 4.04 (1H, m), 2.95 (1H, d, J = 3.2 Hz), 
2.62 (1H, dd, J = 18, 3.2 Hz), 2.52 (1H, dd, J = 18, 8.8 Hz), 2.18 (3H, 
s), 1.34-1.50 (4H, m), 0.92 (3H, t, J = 6.8 Hz). 13C NMR (CDCl3, 100 MHz): δ 209.998, 
67.536, 50.245, 38.821, 31.005, 18.919, 14.236. Optical Rotation: [α]20D  +8.3 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Gamma Dex 
120 (30 m x 0.15 mm x 0.25 µm film thickness), 70 oC hold 60 min. 25 psi.); 
chromatograms are illustrated below for a 22 % ee sample: 
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(R)-2-(Triethylsilyloxy)heptan-4-one (3.87, entry 3 in Table 3.9): 
IR (neat, thin film): 2958 (s), 2876 (s), 1719 (s), 1459 (w), 1415 (w), 
1356 (w), 1129 (m), 1068 (m), 1007 (m), 740 (s) cm-1. 1H NMR 
(CDCl3, 400 MHz): δ 4.30 (1H, quin, J = 5.6 Hz), 2.61 (1H, dd, J = 17.2, 6.8 Hz), 2.47 
(1H, dd, J = 17.2, 5.6 Hz), 2.16 (3H, s), 1.28-1.48 (4H, m), 0.94 (9H, t, J = 8.0 Hz), 0.92 
(3H, t, J = 7.2 Hz), 0.59 (6H, q, J = 8.0 Hz). 13C NMR (CDCl3, 100 MHz): δ 208.042, 
69.059, 51.414, 40.395, 31.823, 18.709. 14.415, 7.121, 5.290. HRMS (m/z + H): 
Calculated: 245.19368; Found: 245.19359. Optical Rotation: [α]20D  −7.6 (c = 1.0, 
CHCl3).  
Enantiomeric purity was established by chiral GLC analysis (Supelco Beta Dex 120 
(30 m x 0.15 mm x 0.25 µm film thickness), 70 oC hold 50 min. 25 psi.) of the desilylated 
product; chromatograms are illustrated below for a 59 % ee sample: 
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Chapter 4 Design and Development of Practical Methods for Catalytic 
Enantioselective Tosylation of Alcohols 
4.1 Introduction and Background 
 The p-toluenesulfonylation (tosylation) and methanesulfonylation (mesylation) of 
alcohols are well recognized as fundamental processes in various fields of organic 
synthesis.112 Formation of a sulfonyl ester is an effective and most widely used method 
for activation of a C–O bond. The activated alcohol can be displaced by various 
nucleophiles to generate C–C, C–N, C–O and C–H bonds in a stereoselective fashion. 
Thus, enantioselective protocols of sulfonylation would be invaluable for chemical 
synthesis.  
 There is an impressive example of catalytic enantioselective sulfonylation of meso 
1,2-diols. Onomura, Matsumura and coworkers reported a copper–catalyzed 
enantioselective tosylation in 2007.113 As shown in Scheme 4.1, in the presence of p-
TsCl, 10 mol % Ph–BOX ligand114 and Cu(OTf)2, meso 1,2-diols undergo tosylation 
efficiently and with high enantioselectivity. This methodology is applicable to various 
1,2-diols. Mono-tosylated products, including cyclic meso diols with different ring sizes 
(4.2–4.4), heterocyclic diols (4.5–4.7), an unsaturated diol (4.8) and an acyclic diol (4.9) 
are all obtained with excellent enantiomeric purity in good yield. The proposed working 
model is based on the recognition of the 1,2-diol moiety by a copper(II) ion associated 
with the chiral Ph-BOX ligand (4.1) to afford the activated 1,2-diol intermediate I 
                                                
112 (a) Smith, M. B. and March, J. Advanced Organic Chemistry, 5th ed.; Wiley, New York, 2001, pp. 576. 
(b) Fieser, L. F.; Fieser, M. Reagent for Organic Synthsis, Wiley, New York, 1967, vol 1, pp. 1179. 
113 Demizu, Y.; Matsumoto, K.; Onomura, O.; Matsumura, Y. Tetrahedron Lett. 2007, 48, 7605–7609. 
114 For (S,S)-Ph-Box, see: (a) Corey, E. J.; Imai, N.; Zhang, H.-Y. J. Am. Chem. Soc. 1991, 113, 728–729; 
A recent review of chiral bis(oxazoline) ligands: (b) Desimoni, G.; Faita, G.; Jørgensen, K. A. Chem. Rev. 
2006, 106, 3561–3651. 
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(Scheme 4.1) followed by tosylation of one enantiotopic hydroxy group. 115  The 
corresponding mesylation of meso 1,2-cyclohexanediol using MsCl affords 77% ee.  
O
O
H
H
Cu2+ L*
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OHHO
Scheme 4.1 Copper-catalyzed Enantioselective Sulfonylation of meso 1,2-Diols
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TsO OH
Me Me
OTs
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 97% ee, >99% >99% ee, 88%
4.8 4.9
10 mol % 4.1, 10 mol % Cu(OTf)2, 
p-TsCl, K2CO3,
CH2Cl2, 23 °C, 12 h
 
 Later that year, Onomura and co-workers extended copper-catalyzed 
enantioselective tosylation to α-hydroxyamides.116 They found that in the presence of 10 
mol % Cu(OTf)2 and (R,R)-Ph-BOX ligand in acetonitrile a variety of α-hydroxyamides 
can be efficiently resolved. Tosylated products are obtained in 80% to 92% ee, giving krel 
values ranging from 17 to 61 (substrates 4.10, 4.11 and 4.12, Scheme 4.2). Onomura and 
co-workers proposed a plausible mechanism based on molecular recognition of 
preferentially one enantiomer of the α-hydroxyamides by the Cu(II)-(R,R)-Ph-BOX 
complex to form intermediate II (Scheme 4.2), in which the C–O bond is activated 
towards tosylation. Enantioselective tosylation of cyclic lactam 4.13 is ineffective and 
non-selective (8% yield, 6% ee). It is likely that the geometry of the cyclic lactams 
                                                
115 The same strategy has been used for benzoylation of diols, see: Matsumura, Y.; Maki, T.; Murakami, S.; 
Onomura, O. J. Am. Chem. Soc. 2003, 125, 2052–2053. 
116 Onomura, O.; Mitsuda, M.; Nguyen, M.; Demizu, Y. Tetrahedron Lett. 2007, 48, 9080–9084. 
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prohibits the formation of the active N,O-chelated intermediate II. 
Scheme 4.2 Copper-catalyzed Kinetic Resolution of !-Hydroxyamides through Tosylation
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 Although the copper-catalyzed enantioselective tosylation reactions of meso 1,2-
diols and α-hydroxyamides are impressive advances, there are several shortcoming of 
this methodology. The enantioselective protocol requires strictly anhydrous conditions 
due to the required use of Cu(OTf)2, thus making the method costly and cumbersome to 
perform on large scale, and therefore less practical. Enantioselective tosylation is highly 
effective and selective only for meso 1,2-diols. Since the copper-catalyzed processes are 
likely to have a strong preference of five-membered ring chelate derived from 1,2-diols, 
the protocol might not be applicable to 1,3-diols or various polyols. Thus development of 
a metal-free protocol of catalytic enantioselective tosylation reaction is critical to achieve 
maximum utility and will likely be complementary to the copper-catalyzed processes.  
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4.2 Design and Rationale for Enantioselective Tosylation of Alcohols 
 In chapter 2, total syntheses of cleroindicins D, F and C demonstrate the synthetic 
utility of enantioselective silylation of polyols.93 The key reaction of the synthesis is the 
catalytic enantioselective silylation of tetrol 4.14 (Scheme 4.3) to selectively protect one 
of the secondary alcohols to afford chiral silyl ether 4.15. The remaining secondary 
alcohol can then be converted 4.15 into a sulfonyl ester 4.16. We envision that 
enantioselective sulfonylation reaction in which one of the enantiotopic hydroxy groups 
is directly activated to form a chiral sulfonyl ester, would further streamline the synthesis. 
Enantioselective Sulfonylation?
>98%ee, 83% yield
OH
HO
HO OH
MeO OMe
OH
TESO
HO OTES
MeO OMe
MsCl, DIPEA
92% yield
OH
OHO
H
O
(!)cleroindicin D 
>98% ee (8 steps)
45% yield
OH
TESO
MsO OTES
MeO OMeCatalytic 
Enantioselective 
Silylation
HCl
Scheme 4.3 Key Step of Enantioselective Synthesis of Cleroindicin D
4.14 4.15 4.16
 
 
 Even though sulfonylation and silylation are different types of reactions, 
sulfonylation is activation of an alcohol to increase its reactivity while silylation is a 
protection of a hydroxy group to lower its reactivity, the initial thoughts of developing 
enantioselective sulfonylation for alcohols is inspired from enantioselective silylation.  
As mentioned in the above chapters, the proposed mechanism of enantioselective 
silylation of diols involves activation of chlorosilane by imidazole moiety and diol 
interacting with catalyst’s chiral backbone through H-bonding. One of the enantiotopic 
alcohols closer to the activated silicon gets selectively silylated (intermediate III, Figure 
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4.1).  
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 The same concept might be applicable to enantioselective sulfonylation of 
alcohols. If the diol substrates interact with the catalyst through H-bonding while sulfonyl 
chloride is activated by imidazole moiety by forming a sulfonylimidazolium salt117 
(intermediate IV in Figure 1), this dual activation of substrate and sulfonyl chloride might 
lead to an enantioselective tosylation of diols.  
4.3 Initial Discovery of Enantioselective Tosylation and Mesylation of 1,2-Diols 
 We began our study by investigating enantioselective sulfonylation reactions of 
cis-1,2-cyclohexanediol. Chiral catalyst 4.17 (eq. 4.1) was used to test if an asymmetric 
induction would be observed for mesylation. In the presence of 100 mol % catalyst and 1 
equivalent of MsCl, mono mesylate 4.19 was obtained, however, in a racemic form (eq. 
4.1). This finding suggests that catalyst-substrate, or more likely catalyst-MsCl do not 
have the interaction shown in IV Figure 4.1. It is known that mesylation reaction 
proceeds through the sulfene formation,118 thus catalyst-MsCl association by forming a 
sulfonylammonium salt becomes unavailable. In comparison to mesylation, p-TsCl was 
                                                
117 Morita, J.; Nakatsuji, H.; Misaki, T.; Tanabe, Y. Green Chem. 2005, 7, 711–715. 
118 (a)Wakasugi, K.; Nakamura, A.; Iida, A.; Nishii, N.; Nakatani, S.; Fukushima, S.; Tanabe, Y. 
Tetrahedron 2003, 59, 5337. (b) Opitz, G.; Ehlis, T.; Rieth, K. Chem. Ber. 1990, 123, 1989. 
 259 
used for enantioselective tosylation of diol 4.18 in the presence of 100 mol % catalyst. In 
contrast, the desired mono-tosylate 4.20 was obtained in 70% ee (eq. 4.2). This result is 
promising and suggests that, unlike mesylation, enantioselective tosylation is more likely 
to form the active intermediate IV (Figure 4.1) between catalyst and p-TsCl. 
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S
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O
ClMe+
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OH
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4.17
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4.17
1 equiv
70% ee, 32%
(eq. 4.2)
4.18 4.20
 
 At this point, we know that tosylation promoted by catalyst 4.17 is 
enantioselective. The next question will be if there is catalytic turn over. By incorporating 
an organic base (iPr)2EtN in the presence of 20 mol % catalyst at –30 ºC, mono-tosylate 
product was obtained in 60% yield with 76% ee (eq. 4.3). This finding clearly shows that 
catalyst 4.17 can promote catalytic enantioselective tosylation.  
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O
ClMe
Me
N
N
N
H
t-Bu
O
H
N
t-Bu
Me
toluene, !30 °C, 72 h
20 mol %
OH
OH
+
OTs
OH
4.17
1.2  equiv
76% ee, 60%
(eq. 4.3)
4.18 4.20
+ (iPr)2EtN
 
 Even though enantioselectivity and yield of the reaction is still moderate, this 
result is promising and leaves room for improvement. We were hoping that through 
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reaction condition optimization and modification of catalyst structure, the outcome of 
enantioselective tosylation would be improved.  
4.4 Reaction Conditions Optimization  
Solvent Effect  
 Solvent is one the most important parameter for enantioselective synthesis.119 
Different solvents were tested for enantioselective tosylation and the data is summarized 
in Table 4.1. tert-Butyl methyl ether is the best solvent in terms of enantioselectivity and 
yield for the tosylation reaction (entry 4, Table 4.1); mono-tosylate 4.20 is obtained in 
88% ee. Diethyl ether is equally enantioselective, but affords more bis-tosylated by-
product 4.21 (entry 3). Toluene is slightly less enantioselective compared to tert-butyl 
methyl ether (entry 1). Reactions in THF and ethyl acetate afford around 50% ee but only 
mono-tosylated product 4.20 (entries 2 and 5), while DMF is ineffective for tosylation 
reaction (entry 8). One trend of solvent study results is noteworthy: the solvent affords 
better enantioselective also forms more of the bis-tosylated product (entries 1, 3 and 4).  
                                                
119 For a recent review of solvent effects on stereoselectivity, see: Cainelli, G.; Galletti, P.; Giacomini, D. 
Chem. Soc. Rev. 2009, 38, 990–1001. 
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S
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4
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6
7
8
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PhMe
THF
Et2O
tBuOMe
EtOAc
CH2Cl2
CH3CN
DMF
ee[%]
76
56
88
88
59
16
34
-
conversion[%][a]
60
40
43
62
27
30
19
<5
mono:bis[b]
3:1
>10
2:1
3:1
>10
5:1
5:1
-
1.2 equiv
OTs
OTs
+
[a] Conversion determined by NMR with internal standard.
[b] Mono:bis ratio determined by NMR.
4.17
20 mol %
4.18 4.20 4.21
Table 4.1 Solvent Study of Catalytic Enantioselective Tosylation
  
Base Effect 
 We next examined the effect of different bases for enantioselective tosylation. 
Organic base (iPr)2EtN affords 84% ee in 82% conversion to desired product 4.20 (entry 
1, Table 4.2). Triethylamine is much less effective and enantioselective (entry 2). Proton 
sponge and affords good enantioselectivity (83% ee) but much lower conversion (entry 
3). Weaker bases, such as N,N-dimethylaniline, pyridine and lutidines afford low 
conversion (entries 4–7). The pKa’s of protonated dimethylaniline, pyridine and lutidines 
are 5, 5 and 7, respectively,120 and pKa of a protonated secondary amine is around 11. 
With a more Lewis basic site on the catalyst, its secondary amine will serve as a general 
base and will be protonated by HCl generated in tosylation reaction. A base such as 
aniline, pyridine or lutidine will not accomplish the proton transfer from catalyst•HCl 
salt, thus deactivating the catalyst. Therefore, the choice of a base with appropriate pKa is 
                                                
120 pKa data obtained from: (a) Evans pKa table (b) Smith, M. B.; March, J. March’s Advanced Organic 
Chemistry, 4th ed., Wiley, New York, 1985. 
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critical to the catalytic turn over of the tosylation reaction. Inorganic base, such as 
potassium carbonate is ineffective for the reaction, presumably due to insolubility (entry 
9). No background reactions were detected in the absence of catalyst 4.17. Thus, the fact 
that different bases afford different enantioselectivities is not due to uncatalyzed 
background reaction and may indicate that the base might be involved in the enantio-
determining (or stereoinduction) step.  
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55
31
27
24
51
48
<5
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+
Table 4.2 Base Effect Study of Catalytic Enantioselective Tosylation
4.17
4.18 4.20 4.21
entry
1
2
3
4
5
6
7
8
9
 
Additive Study 
 Enantioselective tosylation is a relatively slow reaction; it typically takes 3 days 
with 30 mol % catalyst loading. Enantioselective reactions are often very sensitive to 
small changes in reaction conditions.121 Therefore different additives were tested in order 
to improve the efficiency of enantioselective tosylation. Sodium iodide and 
tetrabutylammonium iodide were added to the reaction. We were hoping that through 
                                                
121 For a review of additive effect, see: Vol, E. M.; Gröger, H.; Shibasaki, M. Angew. Chem., Int. Ed. 1999, 
38, 1570–1577. 
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halogen exchange, more reactive pTsI would form in situ, leading to an increase of the 
reaction rate. Unfortunately, as shown in Table 4.3, additives do not affect the reactions. 
A more facile enantioselective tosylation reaction may need a better catalyst.  
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1.25 equiv (i-Pr)2EtN
0.25 M in t-BuOMe, additive
!30 °C, 72 h
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entry
1
2
3
additive (1 equiv)
NaI
(nBu)4NI
none
ee[%]
82
84
84
conversion[%]
82
73
78
mono:bis
4:1
4:1
4:1
1.25 equiv
OTs
OTs
+
4.17
30 mol %
4.18 4.20 4.21
Table 4.3 Additive for Enantioselective Tosylation
 
Tosylating Reagents Study 
 Different aryl substituted sulfonyl chlorides were tested. Scheme 4.3 summarizes 
the results of tosylating reagents with steric differences. Phenyl sulfonyl chloride and m-
TsCl afford slightly lower enantioselectivity compared to p-TsCl. Reaction with mesityl 
sulfonyl chloride does not convert; a substituent at the ortho position is not tolerated 
either. This is presumably due to steric hindrance of the sulfonyl chloride, which affects 
the association with catalyst. Investigation of electronically modified sulfonyl chlorides is 
currently ongoing.  
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Summary of the Reaction Conditions Optimization  
 From testing reagents, solvents, and additives, as well as fine tune the reaction 
conditions, the optimized catalytic enantioselective tosylation of cis-1,2-cyclohexanediol 
is shown in eq. 4.4. In the presence of 30 mol % catalyst 4.17, 1.25 equivalents of p-TsCl 
and (iPr)2EtN at –30 ºC, the desired mono-tosylated product 4.20 is obtained with 85% ee 
in 63% isolated yield.  
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 1.25 equiv (i-Pr)2EtN
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(eq. 4.4)
 
4.5 Catalyst Structure Modification for Enantioselective Tosylation 
Effect of Lewis Basic Site of Catalyst for Enantioselective Tosylation 
 To further improve the outcome of enantioselective tosylation reaction, catalysts 
with different structures were tested. We think that sulfonyl chloride is activated by the 
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imidazole moiety. In order to improve the reactivity of the reaction, catalysts with 
different Lewis basic sites were examined (Scheme 4.5). As the size of the groups on the 
imidazole increases, the conversion drops significantly (50% conv. for 4.22 and <5% 
conv. for 4.23). With unprotected imidazole catalyst 4.24, no conversion was observed. 
Presumably the imidazole nitrogen gets tosylated over the diol, thus reducing the 
nucleophilicity of the catalyst. With a substituent at the 4 position on imidazole ring 4.25, 
the tosylation reaction is shut down. It is likely that the phenyl group close to the 
nucleophilic nitrogen of imidazole makes interaction between p-TsCl and the catalyst less 
favorable. Catalyst with amino acid side chain connected to the 5 position of imidazole 
4.26 is ineffective. Catalysts with other Lewis basic site such as DMAP 4.27, pyridine 
4.28 and thiozole 4.29 do not afford any conversion. From the study of different Lewis 
basic site of catalyst, catalyst 4.17 incorparating a N-methylimidazole turns out to be the 
optimal. 
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Effect of Side Chain Modification of Catalyst for Enantioselective Tosylation 
 With N-methylimidazole identified as the optimal Lewis basic site for 
enantioselective tosylation, we next examined modifications of amino acid side chain of 
the catalyst. It has been shown in the previous study that secondary amine and amide of 
the catalyst is critical to both reactivity and enantioselectivity.61 Catalyst with a tertiary 
amine 4.30 (Scheme 4.5) is ineffective. We think that there’s disfavored steric interaction 
between methyl group of the tertiary amine and tert-Leucine moiety. Catalyst with a 
tertiary amide 4.31 affords much lower conversion as well as enantioselectivity, 
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presumably due to sterics as well. Catalyst 4.32, with an ester functionality on the side 
chain, is ineffective. Ester is a weaker H-bonding acceptor, and that may affect the 
catalyst-substrate association. A substituent in between the imidazole moiety and the 
amino acid side chain is not tolerated; diastereomeric catalysts 4.33 and 4.34 do not 
promote the tosylation. From the catalyst screen, 4.17 turns out to be the most efficient 
catalyst. 
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4.6 Enantioselective Secondary Tosylation 
 Enantioselective tosylation of meso 1,2-diols generates certain amount of 
bistosylated product; the ratio of mono:bis tosylation is around 4 with the optimized 
reaction conditions and catalyst. There is less than 2% background reaction at –30 ºC 
without catalyst. Given the fact that the secondary tosylation is more sterically 
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demanding than the first one, it is more likely that the secondary tosylation is also 
catalyzed by the catalyst. To test this hypothesis, racemic mono-tosylate 4.20 was 
subjected to enantioselective tosylation reaction. In the presence of 30 mol % chiral 
catalyst, 0.75 equivalent of p-TsCl and (i-Pr)2EtN, racemic mono-tosylate 4.20 is 
catalytically resolved; recovered starting material is enantioenriched with 45% ee (eq. 
4.5). Kinetic resolution of racemic tosylate 4.20 proceeds with 50% conversion with a krel 
value of 4. The finding indicates that the secondary tosylation is also enantioselective and 
catalyzed by chiral catalyst 4.17. The secondary tosylation improves the 
enantioselectivity of the desired mono-tosylated product. 
50% conv., krel=4
(±)-4.20
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+4.17
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(eq. 4.5)
 
 Catalytic kinetic resolution of racemic 4.20 promoted by catalyst 4.17 
demonstrates that sulfonyl group could potentially interact with the catalyst. More 
detailed study of the interaction between sulfonyl group and the catalyst is ongoing.  
4.7 Current Substrate Scope  
 With the optimized reaction conditions and the optimal catalyst identified so far, 
the substrate scope is shown in Scheme 4.7. Enantioselective tosylation of cis-1,2-
cyclopentanediol yields the desired product 4.35 with 74% ee. Mono tosylated cis-1,2-
cyclohexanediol 4.20 and cis-1,2-cyclohexenediol 4.36 are obtained with 87% ee. 
Medium size rings, such as cis-1,2-cycloheptanediol and cis-1,2-cyclooctanediol undergo 
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tosylation to afford product 4.37 and 4.38 with 65% ee and 66% ee. Interestingly, 
enantioselective tosylation of cis-1,2-cyclooctenediol affords desired product 4.39 with 
91% ee and 90% isolated yield. Unlike enantioselective silylations that proceed 
uniformly well regardless of the ring size of substrates,61 enantioselective tosylation is 
substrate dependent. Acyclic substrates with slightly modified sterics also change the 
reaction outcome. Meso-2,3-butanediol undergoes tosylation with 72% ee and 60% 
isolated yield of 4.40, while meso-3,4-hexanediol only converts 15% to product 4.41. 
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4.8 Outlooks of Catalytic Enantioselective Tosylation of Alcohols 
 With the optimal catalyst 4.17 identified so far, enantioselective tosylation is 
applicable to a variety of cyclic and acyclic meso 1,2-diols, with 65%–91% enantiomeric 
excess and 66%–91% yield (Scheme 4.7). Clearly, a more reactive as well as more 
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enantioselective catalyst is needed for enantioselective tosylation reaction. The direct of 
catalyst optimization is shown is Chapter 3.  
 The substrate scope of the enantioselective tosylation will be explored. Other than 
meso 1,2-diols, chiral racemic 1,2-diols, 1,3-diols, 1,4-diols as well as polyols will be 
tested in the near future.  
 Activated C–O bond can be displaced by various nucleophiles to generate C–C, 
C–N and C–O bonds in a stereoselective fashion. Furnished products are otherwise 
difficult to excess by other catalytic protocols. 
Scheme 4.8 Representative Examples of Functionalization of Tosylation Products
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 Representative examples of functionalization are shown in Scheme 4.8. Cuprate 
addition of a carbon-based nucleophile122 followed by oxidation of tosylate 4.20 will 
deliver cyclic chiral ketone 4.42. It is noteworthy that there are no general effective 
methods for enantioselective α-alkylation of cyclic ketones.123 Enantioenriched acid 4.43 
                                                
122 Lipschutz, B. H.; Wilhelm, R. S.; Rloyd, D. M. J. Am. Chem. Soc. 1981, 103, 7672–7674 
123 For catalytic enantioselective alkylation of tetrasubstituted tributyltin enotales with alkyl halides, see: (a) 
Doyle, A. G.; Jacobsen, E. N. J. Am. Chem. Soc. 2005, 127, 62–63. For catalytic enantioselective alkylation 
of acyclic α,α-disubstituted tributyltin enolates, see: Doyle, A. G.; Jacobsen, E. N. Angew. Chem., Int. Ed. 
2007, 46, 3701–3705. 
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can be obtained from cyanide addition and hydrolysis of 4.20. 124  Nitrogen-based 
nucleophiles, such as readily available pyrrole, can be added to eight-membered ring 
tosylate 4.39.125 Synthesis of complex bicyclic diene 4.46 involves addition of oxygen-
based nucleophile126 to the tosylated triol 4.45 followed by enyne metathesis.127  
 A fully developed catalytic enantioselective tosylation, especially with a more 
reactive and selective catalyst as well as extended substrate scope, will be truly practical 
and invaluable for organic synthesis. 
4.9 Experimental and Supporting Information 
General Information  
Infrared (IR) spectra were recorded on a Perkin Elmer 781 spectrophotometer, νmax in 
cm-1.  Bands are characterized as broad (br), strong (s), medium (m), and weak (w).  1H   
NMR spectra were recorded on a Varian GN-400 (400 MHz). Chemical shifts are 
reported in ppm with the solvent reference as the internal standard (CHCl3: δ 7.26; 
CD3OD: δ 4.87, 3.31; pyridine-d5: δ 8.74, 7.58, 7.22 ppm).  Data are reported as follows: 
chemical shift, integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m 
= multiplet, br = broad), and coupling constants (Hz).  13C NMR spectra were recorded 
on a Varian GN-400 (100 MHz) with complete proton decoupling. Chemical shifts are 
reported in ppm with the solvent reference as the internal standard (CHCl3: δ 77.23, 
                                                
124 Ogino, Y.; Ohtake, N.; Nagae, Y.; Matsuda, K.; Ishikawa, M.; Moriya, M.; Kanesaka, M.; Mitobe, Y.; 
Ito, J.; Kanno, T.; Ishihara, A.; Hisashi, I.; Ohe, T.; Kanatani, A.; Fukami, T. Bioorg. Med. Chem. Lett. 
2008, 18, 4997–5001. 
125 Yasohara, Y.; Miyamoto, K.; Kizaki, N.; Hasegawa, J.; Ohashi, T. Tetrahedron Lett. 2001, 42, 3331–
3333. 
126 (a) Qiu, L.; Qi, J.; Pai, C.; Chan, S.; Zhou, Z.; Choi, M.; Chan, A. Org. Lett. 2002, 4, 4599–4602. (b) 
Kim, H.; Kasper, A.C.; Moon, E. J.; Park, Y.; Wooten, C. M.; Derwhirst, M. W.; Hong, J. Org. Lett. 2009, 
11, 89–92. 
127 For a review of enyne metathesis, see: Diver, S. T.; Giessert, A. J. Chem. Rev. 2004, 104, 1317–1382. 
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CD3OD: δ 49.15; pyridine-d5: δ 150.35, 135.91, 123.87 ppm).   Melting points (mp) were 
taken with a Laboratory Devices Melt-Temp and were uncorrected.  Enantiomeric ratios 
were determined by analytical liquid chromatography (HPLC) Shimadzu chromatograph 
(Chiral Technologies Chiralpak OD (4.6 x 250 mm)).  Optical rotations were measured 
on a Rudolph Research Analytical Autopol IV Automatic Polarimeter. High resolution 
mass spectrometry (HRMS) was performed by mass spectrometry facility at Boston 
College. All reagents were used as received. 
 
General Procedure for Catalytic Enantioselective Tosylation of meso-1,2-diols 
Catalyst 4.17 (19 mg, 0.06 mmol) and the diol substrate (0.2 mmol) were weighed into a 
10 x 75 mm test tube. t-BuOMe (360 µL) and DIPEA (44 µL, 0.25 mmol) were added 
with a Gilson Pipetman. The tube was capped with a septum, and the mixture was 
allowed to cool to –78 oC.  p-TsCl (48 mg, 0.25 mmol) was dissolved in t-BuOMe (400 
µL) and added to the test tube with a Gilson Pipetman.  The test tube was capped with a 
septum, wrapped with Teflon tape and the mixture was allowed to stir at –30 ºC in a 
cryocool apparatus for the reported period of time.  The reaction was quenched by 
addition of methanol (25 µL).  The mixture was allowed to warm to 23 oC and directly 
purified by silica gel chromatography (1:3 diethyl ether:hexanes to 1:1 diethyl 
ether:hexanes) and analyzed by HPLC. 
 
Characterization Data 
(1R,2S)-2-Hydroxycyclohexyl-4-methylbenzenesulfonate (4.20): 
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1H NMR (CDCl3, 400 MHz): δ 7.81 (2H, d, J = 8.4 Hz), 7.34 (2H, d, J = 8.4 Hz), 4.63 
(1H, m), 3.82 (1H, m), 2.45 (3H, s), 1.98 (1H, d, J = 5.2 Hz), 1.91 (1H, m), 1.73 (1H, m), 
1.63-1.44 (4H, m), 1.32-1.25 (2H, m). 13C NMR (CDCl3, 100 MHz): δ 145.01, 134.40, 
130.09, 127.89, 83.40, 69.23, 30.48, 27.98, 21.97, 21.87, 20.96. Optical Rotation: [α]20D  
6.4 (c = 1.0, CHCl3). 
Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm); chromatograms are 
illustrated below for a 87% ee sample: 
  
 
 
 
 
 
(1R,2S)-2-Hydroxycyclopentyl-4-methylbenzenesulfonate (4.35):  
1H NMR (CDCl3, 400 MHz): δ 7.81 (2H, d, J = 8.4 Hz), 7.34 (2H, d, J = 8.4 Hz), 4.66 
(1H, m), 4.12 (1H, m), 2.45 (3H, s), 2.16 (1H, br), 1.89-1.77 (4H, m), 1.74-1.66 (1H, m), 
1.56-1.45 (1H, m). 13C NMR (CDCl3, 100 MHz): δ 145.18, 133.85, 130.12, 128.01, 
84.44, 72.98, 30.20, 28.09, 21.86, 19.08. Optical Rotation: [α]20D  4.5 (c = 1.0, CHCl3). 
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Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm); chromatograms are 
illustrated below for a 74% ee sample: 
  
 
 
 
 
 
(1R,6S)-6-Hydroxycyclohex-3-enyl-4-methylbenzenesulfonate (4.36):  
IR (neat, thin film): 3527 (br), 3034 (w), 2924 (w), 1598 (w), 1350 (m), 1188 (m), 1172 
(s), 1096 (m), 1070 (w), 975 (m), 945 (m), 903 (s), 876 (s), 832 (m), 813 (m), 756 (w), 
729 (m), 662 (s), 607 (m), 552 (s) cm-1.1H NMR (CDCl3, 400 MHz): δ 7.79 (2H, d, J = 
8.4 Hz), 7.32 (2H, d, J = 8.4 Hz), 5.54 (1H, m), 5.44 (1H, m), 4.73 (1H, m), 4.01 (1H, m), 
2.42 (3H, s), 2.37 (1H, s), 2.34-2.16 (4H, m). 13C NMR (CDCl3, 100 MHz): δ 145.03, 
134.03, 130.02, 127.84, 124.08, 122.53, 80.76, 67.15, 31.54, 28.57, 21.76. HRMS 
[M++NH4]: Calculated for C13H20N1O4S1: 286.1113; Found: 286.1118. Optical 
Rotation: [α]20D  10.6 (c = 1.0, CHCl3). 
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Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.7 mL/min, 220 nm); chromatograms are 
illustrated below for a 87% ee sample: 
  
 
 
 
 
 
(1R,2S)-2-Hydroxycycloheptyl 4-methylbenzenesulfonate (4.37):  
IR (neat, thin film): 3534 (br), 2931 (w), 2864 (w), 1458 (w), 1351 (m), 1172 (s), 1096 
(m), 903 (s), 868 (m), 814 (m), 670 (s), 555 (m) cm-1.1H NMR (CDCl3, 400 MHz): δ 
7.77 (2H, d, J = 8.4 Hz), 7.30 (2H, d, J = 8.4 Hz), 4.64 (1H, dt, J = 8.8 Hz, J = 2.6 Hz), 
3.90 (1H, dt, J = 8.0 Hz, J = 2.8 Hz), 2.41 (3H, s), 2.11 (1H, s), 1.92 (1H, m), 1.77-1.25 
(9H, m). 13C NMR (CDCl3, 100 MHz): δ 144.98, 130.05, 127.89, 86.96, 72.51, 31.17, 
28.78, 26.78, 22.44, 21.84, 21.70. HRMS [M++NH4]: Calculated for C14H24N1O4S1: 
302.1426; Found: 302.1434. Optical Rotation: [α]20D  6.4 (c = 1.0, CHCl3). 
Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm); chromatograms are 
illustrated below for a 65% ee sample: 
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(1R,2S)-2-Hydroxycyclooctyl-4-methylbenzenesulfonate (4.38):  
IR (neat, thin film): 3529 (br), 2925 (w), 2860 (w), 1598 (w), 1450 (w), 1188 (w), 1173 
(m), 1097 (w), 904 (s), 863 (w), 814 (w), 726 (s), 688 (m), 648 (w), 554 (m) cm-1.1H 
NMR (CDCl3, 400 MHz): δ 7.79 (2H, d, J = 8.4 Hz), 7.33 (2H, d, J = 8.4 Hz), 4.74 (1H, 
m), 3.93 (1H, m), 2.43 (3H, s), 2.28 (1H, s), 2.06 (1H, m), 1.76-1.34 (11H, m). 13C NMR 
(CDCl3, 100 MHz): δ 144.97, 134.16, 130.02, 127.87, 86.11, 71.78, 30.28, 28.20, 27.00, 
25.55, 24.05, 21.89, 21.79. HRMS [M++H]: Calculated for C15H23O4S1: 299.1317; 
Found: 299.1303. Optical Rotation: [α]20D  9.6 (c = 1.0, CHCl3). 
Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.7 mL/min, 220 nm); chromatograms are 
illustrated below for a 66% ee sample: 
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(1R,8S,Z)-8-Hydroxycyclooct-4-enyl-4-methylbenzenesulfonate (4.39):  
IR (neat, thin film): 3530 (br), 3019 (w), 2939 (w), 1598 (w), 1352 (w), 1188 (w), 1173 
(m), 1097 (s), 1033 (w), 902 (s), 873 (m), 837 (w), 813 (w), 725 (s), 670 (m), 648 (w), 
573 (w), 555 (m) cm-1.1H NMR (CDCl3, 400 MHz): δ 7.78 (2H, d, J = 8.4 Hz), 7.33 (2H, 
d, J = 8.4 Hz), 5.62 (2H, m), 4.77 (1H, m), 4.01(1H, m), 2.50 (2H, m), 2.43 (3H, s), 2.33 
(1H, s), 2.12-1.54 (6H, m). 13C NMR (CDCl3, 100 MHz): δ 144.99, 133.86, 130.79, 
130.02, 129.27, 127.94, 87.88, 73.55, 33.24, 30.78, 21.87, 21.81, 21.35. HRMS 
[M++NH4]: Calculated for C15H24N1O4S1: 314.1426; Found: 314.1429. Optical 
Rotation: [α]20D  31.8 (c = 1.0, CHCl3). 
Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm); chromatograms are 
illustrated below for a 91% ee sample: 
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 (2R,3S)-3-Hydroxybutan-2-yl-4-methylbenzenesulfonate (4.40):  
IR (neat, thin film): 3528 (br), 2985 (w), 1599 (w), 1449 (w), 1352 (w), 1189 (w), 1174 
(m), 1099 (w), 1019 (w), 901 (s), 814 (w), 786 (w), 726 (s), 666 (m), 648 (w), 555 (s), 
465 (w) cm-1.1H NMR (CDCl3, 400 MHz): δ 7.79 (2H, d, J = 8.4 Hz), 7.33 (2H, d, J = 
8.4 Hz), 4.54 (1H, m), 3.86 (1H, m), 2.43 (3H, s), 2.22 (1H, br), 1.19 (3H, d, J = 6.4 Hz), 
1.09 (3H, d, J = 6.4 Hz). 13C NMR (CDCl3, 100 MHz): δ 145.00, 134.15, 130.03, 127.89, 
83.36, 69.47, 21.79, 17.79, 15.03. HRMS [M++NH4]: Calculated for C11H20N1O4S1: 
262.1113; Found: 262.1114. Optical Rotation: [α]20D  5.2 (c = 1.0, CHCl3). 
Enantiomeric purity was established by HPLC analysis (Chiralpak OJ-H column (25 
cm × 0.46 cm), 90/10 hexanes/i-PrOH, 0.5 mL/min, 220 nm); chromatograms are 
illustrated below for a 72% ee sample: 
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